1
EXCHANGE AGREEMENT
THIS EXCHANGE AGREEMENT, dated as of December 10, 1998 (this
"Agreement"), by and between SHAMAN PHARMACEUTICALS, INC., a Delaware
corporation (the "Company"), and the undersigned holders of the Company's Senior
Subordinated Convertible Notes (each, a "Holder" and collectively, the
"Holders").
W I T N E S S E T H:
WHEREAS, the Company and each Holder are parties to a Note
Purchase Agreement, dated as of June 30, 1997 (each, as amended to the date
hereof, a "Note Purchase Agreement"), pursuant to which the Company issued to
the respective Holder one or more Senior Subordinated Convertible Notes (each, a
"Note" and collectively, the "Notes"); and
WHEREAS, the Company and each Holder wish to exchange each such
Note for shares of the Company's Series D Convertible Preferred Stock, $0.001
par value per share (the "Series D Preferred"), in connection with which the
Company will issue to the Holders common stock purchase warrants;
NOW THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:
1. EXCHANGE OF NOTES; ISSUANCE OF WARRANTS.
a. EXCHANGE OF NOTES; WARRANTS. Subject to the terms and
conditions of this Agreement, each Holder agrees to deliver to the Company at
the Closing such Holder's Note or Notes and the Company agrees (x) to deliver to
such Holder or its designee at the Closing in exchange for each such Note a
certificate representing that number of shares of Series D Preferred equal to
the quotient obtained by dividing (i) the sum of (A) the outstanding principal
amount of such Note on the date of the Closing plus (B) accrued and unpaid
interest on such Note (including Default Interest (as defined in such Note), if
any) to the date of the Closing by (ii) $1,000, which quotient shall be rounded
down to the nearest whole share of Series D Preferred and (y) to pay such Holder
an amount in cash equal to the portion, if any, of the sum of the amount in
clauses (A) and (B) of the preceding clause (x)(i) which would otherwise result
in issuance of a fractional share of Series D Preferred. The outstanding amount
of each Note, together with interest accrued thereon, and the number of shares
of Series D Preferred to be issued to each Holder is set forth on Schedule A
hereto. The Company agrees to cancel in full immediately after the Closing each
Note so exchanged. In connection with the issuance of shares of Series D
Preferred in exchange for each Holder's Note or Notes, and in consideration of
the waiver or revocation by each Holder who has given an Inconvertibility Notice
(as defined in the Notes) of such Inconvertibility Notice effective at the time
of the Closing, at the Closing the Company shall issue to each Holder a Warrant,
registered in the name of such Holder or its nominee, initially entitling the
holder to purchase the number of shares of Common Stock set forth on Schedule A.
Nothing in this Agreement shall limit the right of any Holder to convert such
Holder's Notes in accordance with the terms thereof at any time prior to the
Closing.
2
b. CLOSING. The closing of the exchange described in Section 1.a.
shall take place at the offices of Xxxxxxx, Xxxxxxx & Xxxxxxxx LLP, Two
Embarcadero Place, 0000 Xxxx Xxxx, Xxxx Xxxx, Xxxxxxxxxx 00000, at 10:00 A.M.,
Pacific Standard Time, as soon as practicable, but no later than (x) the date
which is two business days after the SEC Effective Date, if an Additional
Registration Statement relating to the Conversion Shares is required to be filed
with the SEC prior to the date of the Closing in accordance with Section 3.a. of
this Agreement or (y) December 10, 1998 if no such Additional Registration
Statement is required, or at such other time and place as the Company and the
Holders mutually agree upon orally or in writing (which time and place are
designated as the "Closing").
2. RIGHTS, PREFERENCES AND PRIVILEGES OF SERIES D PREFERRED. The Series D
Preferred Stock shall have the rights, preferences and privileges set forth on
the Certificate of Designation the form of which is attached hereto as Schedule
B.
3. REGISTRATION RIGHTS.
a. REGISTRATION.
(1) If at any time the number of Registrable Securities
included in the Existing Registration Statement for resale by any Investor shall
be insufficient to cover the number of shares of Common Stock issuable on
conversion in full of the unconverted shares of Series D Preferred held by any
Investor (determined without regard to any limitation on conversion contained in
the Certificate of Designation), then the Company shall promptly, but in no
event later than 15 days after such insufficiency occurs, file with the SEC an
additional registration statement (which shall not constitute a post-effective
amendment to any other Registration Statement) covering such number of shares of
Common Stock as shall be at least equal to 175% of the number of shares so
issuable, based on the Conversion Price in effect at the time of filing thereof
with the SEC and not covered by any other Registration Statement; provided,
however, that prior to the Stockholder Approval the number of shares of Common
Stock covered by such Registration Statement may be based on a Conversion Price
of $1.00 if the Company shall not have available at the time of such filing
authorized shares of Common Stock in excess of the number computed based on a
Conversion Price of $1.00; and provided further, however, that nothing herein
shall require the Company to so register a number of shares in excess of the
number permitted by the rules and requirements of the SEC. For all purposes of
this Agreement the Existing Registration Statement shall be deemed to be a
Registration Statement required to be filed by the Company pursuant to this
Section 3.a.(1), and the Company and the Investors shall have all of the rights
and obligations with respect to the Existing Registration Statement as they have
under this Agreement with respect to the other Registration Statements.
(2) Within 15 days after the date of the Closing, the Company
shall prepare and file with the SEC the Warrant Share Registration Statement
(which shall not constitute a post-effective amendment to any other Registration
Statement) covering the resale by the Holders of at least that number of shares
of Common Stock as is issuable to the Holders upon exercise of the Warrants as
shown opposite their respective names on Schedule A attached hereto and which
Registration Statement shall state that, in accordance with Rule 416 under the
1933 Act, such Registration Statement also covers such indeterminate number of
additional
-2-
3
shares of Common Stock as may become issuable upon exercise of the Warrants to
prevent dilution resulting from stock splits, stock dividends or similar
transactions.
(3) At any time subsequent to the Closing when any
Registration Statement for any reason is not available for use by any Investor
for the resale of any Registrable Securities, the Company shall not file any
other registration statement or any amendment thereto with the SEC under the
1933 Act or request the acceleration of the effectiveness of any other
registration statement previously filed with the SEC other than (A) any
registration statement on Form S-8, (B) any registration statement or amendment
which the Company is required to file or as to which the Company is required to
request acceleration pursuant to any obligation in effect on the date of
execution and delivery of this Agreement, (C) any amendment to the Company's
Registration Statement on Form S-3 (Registration No. 333-67023), (D) the Warrant
Share Registration Statement or (E) the filing with the SEC (but not a request
for acceleration of effectiveness) of any registration statement registering up
to 1,500,000 shares of the Company's Common Stock, or covering the resale
thereof, issuable upon conversion of an aggregate of 1,500 shares of Series D
Preferred Stock issued to MMC/GATX or its designee.
(4) The Company's obligation to register the Registrable
Securities under this Section 3 shall constitute a registration pursuant to a
demand registration right held by the Holders.
(5) At any time after December 31, 2000, any Investor who
holds Warrants or Warrant Shares shall have the right, exercisable by notice to
the Company, to require the Company to file a Warrant Share Registration
Statement with the SEC relating to resale of Warrant Shares. If any Investor
shall exercise such right, then within five days thereafter the Company shall
notify all other Investors of the proposed filing of such Warrant Share
Registration Statement and shall include therein all Warrant Shares issued or
issuable to Investors who hold any Warrants or Warrant Shares, except Warrant
Shares issued or issuable to any Investor who notifies the Company within five
days after such notice is given that such Investor does not wish such Investor's
Warrant Shares to be included in such Registration Statement. The Company shall
file such Warrant Share Registration Statement with the SEC within 20 days after
the exercise of such right by any Investor. The Company shall be required to
file only one Warrant Share Registration Statement pursuant to this Section
3.a.(5).
b. OBLIGATIONS OF THE COMPANY. In connection with the registration
of the Registrable Securities, the Company shall:
(1) use its best efforts to cause each Registration Statement
to become effective as promptly as possible after the execution and delivery of
this Agreement by the parties hereto, and keep each Registration Statement
effective pursuant to Rule 415 under the 1933 Act at all times during the
Registration Period. The Company shall submit to the SEC, within three Business
Days after the Company learns that no review of any Registration Statement will
be made by the staff of the SEC or that the staff of the SEC has no further
comments on such Registration Statement, as the case may be, a request for
acceleration of effectiveness of such Registration Statement to a time and date
not later than 48 hours after the submission of such request. The Company
represents and warrants to the Investors that (a) each Registration Statement
(including any amendments or supplements thereto and prospectuses
-3-
4
contained therein), at the time it is first filed with the SEC, at the time it
is ordered effective by the SEC and at all times during which it is required to
be effective hereunder (and each such amendment and supplement at the time it is
filed with the SEC and at all times during which it is available for use in
connection with the offer and sale of the Registrable Securities) shall not
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading and (b) each Prospectus shall not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein, or
necessary to make the statements therein, in light of the circumstances in which
they were made, not misleading;
(2) prepare and file with the SEC such amendments (including
post-effective amendments) and supplements to each Registration Statement and
Prospectus as may be necessary to keep such Registration Statement effective,
and such Prospectus current, at all times during the Registration Period, and,
during the Registration Period, comply with the provisions of the 1933 Act
applicable to the Company in order to permit the disposition by the Investors of
all Registrable Securities covered by such Registration Statement;
(3) furnish to each Investor whose Registrable Securities are
included in any Registration Statement (1) promptly after the same is prepared
and publicly distributed, filed with the SEC or received by the Company, one
copy of such Registration Statement and any amendment thereto, each Prospectus
and each amendment or supplement thereto, (2) each letter written by or on
behalf of the Company to the SEC or the staff of the SEC and each item of
correspondence from the SEC or the staff of the SEC relating to such
Registration Statement (other than any portion of any such letter or item which
contains information for which the Company has sought confidential treatment),
each of which the Company hereby determines to be confidential information and
which each Investor hereby agrees to keep confidential as a confidential Record
in accordance with Section 3.b(9) and (3) such number of copies of each
Prospectus and all amendments and supplements thereto and such other documents,
as such Investor may reasonably request in order to facilitate the disposition
of the Registrable Securities owned by such Investor;
(4) use its best efforts to (i) register and qualify the
Registrable Securities covered by each Registration Statement under the
securities or blue sky laws of such jurisdictions as any Investor who holds any
of the Registrable Securities reasonably requests, (ii) prepare and file in
those jurisdictions such amendments (including post-effective amendments) and
supplements to such registrations and qualifications as may be necessary to
maintain the effectiveness thereof at all times during the Registration Period
and (iii) take all other actions reasonably necessary or advisable to qualify
the Registrable Securities for sale by the Investors in such jurisdictions;
provided, however, that the Company shall not be required in connection
therewith or as a condition thereto (I) to qualify to do business in any
jurisdiction where it would not otherwise be required to qualify but for this
Section 3.b(4), (II) to subject itself to general taxation in any such
jurisdiction, (III) to file a general consent to service of process in any such
jurisdiction, (IV) to provide any undertakings that cause more than nominal
expense or burden to the Company or (V) to make any change in its charter or
bylaws which the Board of Directors of the Company determines to be contrary to
the best interests of the Company and its stockholders;
-4-
5
(5) (A) as promptly as practicable after becoming aware of
such event or circumstance, notify each Investor of any event or circumstance of
which the Company has knowledge, as a result of which the Prospectus included in
any Registration Statement, as then in effect, includes an untrue statement of a
material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, and use its best efforts promptly to
prepare a supplement or amendment to such Registration Statement and Prospectus
to correct such untrue statement or omission or to add any new or additional
information, and deliver a number of copies of such supplement or amendment to
each Investor as such Investor may reasonably request;
(B) notwithstanding Section 3.b(5)(A) above, if at any time
after the date which is 90 days after the date of the Closing the Company
notifies the Investors as contemplated by Section 3.b(5)(A) that the event
giving rise to such notice relates to a development involving the Company which
occurred subsequent to the later of (x) the date of the Closing and (y) the
latest date prior to such notice on which the Company has amended or
supplemented any Registration Statement, then the Company shall not be required
to use best efforts to make such amendment during a Blackout Period; provided,
however, that in any period of 360 consecutive days the Company shall not be
entitled to avail itself of its rights under this Section 3.b(5)(B) with respect
to more than (i) two Blackout Periods, if the Company does not make an election
pursuant to the next succeeding clause (ii) of this proviso or (ii) if the
Company so elects by notice to the Investor given not later than 18 days after
the commencement of a Blackout Period, one Blackout Period of up to 30
consecutive days and; provided further, however, that no Blackout Period may
commence sooner than 45 days after the end of another Blackout Period.
(6) as promptly as practicable after becoming aware of such
event, notify each Investor who holds Registrable Securities being sold of the
issuance by the SEC of any stop order or other suspension of effectiveness of
any Registration Statement at the earliest possible time;
(7) permit the Investors who hold Registrable Securities being
sold and up to two firms of counsel for Investors who are offering the two
largest amounts of Registrable Securities offered to review at such Investors'
sole expense each Registration Statement and all amendments and supplements
thereto a reasonable period of time prior to their filing with the SEC;
(8) make generally available to its security holders as soon
as practical, but not later than 90 days after the close of the period covered
thereby, an earning statement (in form complying with the provisions of Rule 158
under the 0000 Xxx) covering a 12-month period beginning not later than the
first day of the Company's fiscal quarter next following the effective date of
each Registration Statement;
(9) make available for inspection by any Investor and any
Inspectors retained by any such Investor at such Investor's sole expense, all
Records as shall be reasonably necessary to enable each Investor to exercise its
due diligence responsibility and cause the Company's officers, directors and
employees to supply all information which any Inspector may reasonably request
for purposes of such due diligence; provided, however, that each Inspector
-5-
6
shall hold in confidence and shall not make any disclosure (except to an
Investor) of any Record or other information which the Company determines in
good faith to be confidential, and of which determination the Inspectors are so
notified, unless (i) the release of such Records is ordered pursuant to a
subpoena or other order from a court or government body of competent
jurisdiction or (ii) the information in such Records has been made generally
available to the public other than by disclosure in violation of this or any
other agreement; provided further, however, that each Investor understands that
in the course of exercising the rights provided in this Section 3.b(9) such
Investor may come into possession of material non-public information about the
Company and that by reason of the requirements of the 1934 Act any such Investor
who possesses such material non-public information may be restricted in making
purchases and sales of the Common Stock unless such information has been
publicly disclosed. The Company shall not be required to disclose any
confidential information in such Records to any Inspector until and unless such
Inspector shall have entered into confidentiality agreements (in form and
substance satisfactory to the Company) with the Company with respect thereto,
substantially in the form of this Section 3.b(9). Each Investor agrees that it
shall, upon learning that disclosure of such Records is sought in or by a court
or governmental body of competent jurisdiction or through other means, give
prompt notice to the Company and allow the Company, at the Company's expense, to
undertake appropriate action to prevent disclosure of, or to obtain a protective
order for, the Records deemed confidential. The Company shall hold in confidence
and shall not make any disclosure of information concerning an Investor provided
to the Company pursuant to this Agreement unless the disclosure of such
information is necessary to comply with federal or state securities laws, (ii)
the disclosure of such information is necessary to avoid or correct a
misstatement or omission in any Registration Statement, (iii) the release of
such information is ordered pursuant to a subpoena or other order from a court
or governmental body of competent jurisdiction or (iv) such information has been
made generally available to the public other than by disclosure in violation of
this or any other agreement. The Company agrees that it shall, upon learning
that disclosure of such information concerning an Investor is sought in or by a
court or governmental body of competent jurisdiction or through other means,
give prompt notice to such Investor and allow such Investor, at such Investor's
expense, to undertake appropriate action to prevent disclosure of, or to obtain
a protective order for, such information;
(10) use its best efforts to cause all the Registrable
Securities covered by any Registration Statement as of the SEC Effective Date to
be listed on Nasdaq or such other principal securities market on which
securities of the same class or series issued by the Company are then listed or
traded;
(11) provide a transfer agent and registrar, which may be a
single entity, for the Registrable Securities at all times;
(12) cooperate with the Investors who hold Registrable
Securities being offered to facilitate the timely preparation and delivery of
certificates (not bearing any restrictive legends) representing Registrable
Securities to be offered pursuant to any Registration Statement and enable such
certificates to be in such denominations or amounts as the Investors may
reasonably request and registered in such names as the Investors may request;
(13) during the Registration Period, the Company shall not bid
for or purchase any Common Stock or any right to purchase Common Stock or
attempt to induce any
-6-
7
person to purchase any such security or right if such bid, purchase or attempt
would in any way limit the right of the Investors to sell Registrable Securities
by reason of the limitations set forth in Regulation M under the 1934 Act;
(14) in order that the Holders shall be able to use the
Prospectus relating to the Existing Registration Statement for resales of
Conversion Shares as promptly as possible following the date of the Closing, not
later than the close of business on the business day following the date of the
Closing, the Company will file with the SEC a Current Report on Form 8-K in the
form attached as Schedule C and, if determined by the Company and its counsel to
be appropriate, a revised Prospectus pursuant to Rule 424(c) under the 1933 Act
(copies of which the Company shall furnish to the Holders not later than the
close of business on the second business day after the date of the Closing) to
make public disclosure of the material information relating to this Agreement
and the transactions contemplated hereby and to reflect in the Prospectus
relating to the Existing Registration Statement all information relating to this
Agreement and the transactions contemplated hereby that is necessary in order
that such Prospectus will be available for use at such time by the Holders; and
(15) take all other reasonable actions necessary to expedite
and facilitate disposition by the Investor of the Registrable Securities
pursuant to each Registration Statement.
c. OBLIGATIONS OF THE INVESTORS. In connection with the registration
of the Registrable Securities, the Investors shall have the following
obligations:
(1) It shall be a condition precedent to the obligations of
the Company to complete the registration pursuant to this Agreement with respect
to the Registrable Securities of a particular Investor that such Investor shall
furnish to the Company such information regarding itself, the Registrable
Securities held by it and the intended method of disposition of the Registrable
Securities held by it as shall be reasonably required to effect the registration
of such Registrable Securities and shall execute such documents in connection
with such registration as the Company may reasonably request. At least five
Business Days prior to the first anticipated filing date of each Registration
Statement, the Company shall notify each Investor of the Required Information if
any of such Investor's Registrable Securities are eligible for inclusion in such
Registration Statement. If at least two Business Days prior to the filing date
the Company has not received the Required Information from an Investor, then the
Company may postpone filing such Registration Statement until the date which is
two Business Days after the Company receives the Required Information from such
Non-Responsive Investor; provided that on the same day the Company gives notice
to each Investor by telephone line facsimile transmission of such postponement,
identifying the Non-Responsive Investor and, if the failure of a Non-Responsive
Investor to provide Required Information to the Company causes the Company to be
unable to file such Registration Statement with the SEC by the deadline
specified in Section 3.a., the Company shall not have any liability to any
Investor by reason of such failure to file such Registration Statement on a
timely basis in accordance with Section 3.a. so long as in such circumstance the
Company files such Registration Statement with the SEC within one business day
after the date on which the Company receives the Required Information from all
Non-Responsive Investors;
-7-
8
(2) Each Investor by such Investor's acceptance of the
Registrable Securities agrees to cooperate with the Company as reasonably
requested by the Company in connection with the preparation and filing of each
Registration Statement hereunder, unless such Investor has notified the Company
in writing of such Investor's election to exclude all of such Investor's
Registrable Securities from such Registration Statement;
(3) Each Investor agrees that it will not effect any
disposition of the Registrable Securities except as contemplated in the
Registration Statement covering such Registrable Securities or as otherwise in
compliance with applicable securities laws and that it will promptly notify the
Company of any material changes in the information regarding such Investor or
its plan of distribution set forth in any Registration Statement which names
such Investor as a selling stockholder; each Investor agrees (a) to notify the
Company in writing in the event that such Investor enters into any material
agreement with a broker or a dealer for the sale of the Registrable Securities
through a block trade, special offering, exchange distribution or a purchase by
a broker or dealer and (b) in connection with such agreement, to provide to the
Company in writing the information necessary to prepare any supplemental
prospectus pursuant to Rule 424(c) under the 1933 Act which is required with
respect to such transaction;
(4) Each Investor acknowledges that during the times specified
in Section 3.b(5) or 3.b(6) the Company must suspend the use of the Prospectus
until such time as an amendment to a Registration Statement has been filed by
the Company and declared effective by the SEC, the Company has prepared a
supplement to the Prospectus or the Company has filed an appropriate report with
the SEC pursuant to the 1934 Act. Each Investor hereby covenants that it will
not sell any Registrable Securities pursuant to the Prospectus relating to such
Registration Statement during the period commencing at the time at which the
Company gives such Investor notice in accordance with Section 3.b(5) or 3.b(6)
of the suspension of the use of such Prospectus and ending at the time the
Company gives such Investor notice that such Investor may thereafter effect
sales pursuant to such Prospectus, or until the Company delivers to such
Investor an amended or supplemented Prospectus;
(5) In connection with any sale of Registrable Securities
which is made pursuant to a Registration Statement through a broker, each
Investor shall instruct its broker or brokers to deliver the Prospectus relating
to such Registration Statement to the purchaser or purchasers in connection with
such sale, shall supply copies of such Prospectus to such broker or brokers and
shall otherwise use its reasonable best efforts to comply with the prospectus
delivery requirements of the 1933 Act;
(6) Each Investor agrees to notify the Company promptly after
the event of the completion of the sale by such Investor of all Registrable
Securities to be sold by such Investor pursuant to any Registration Statement;
and
(7) Each Investor agrees not to use Registrable Securities for
the purpose of covering any Short Sale by such Investor of Common Stock unless
at the time of such Short Sale such Investor shall have complied with the
requirements of Section 3.c(5) with respect to such Short Sale to the extent
compliance with such requirements is necessary under the 1933 Act.
-8-
9
d. INDEMNIFICATION.
(1) To the extent permitted by law, the Company will indemnify
and hold harmless each Indemnified Person against any Claims to which any of
them may become subject under the 1933 Act, the 1934 Act or otherwise, insofar
as such Claims (or actions or proceedings, whether commenced or threatened, in
respect thereof) arise out of or are based upon any of the following statements,
omissions or violations in any Registration Statement, or any post-effective
amendment thereof, or any prospectus relating thereto: (i) any untrue statement
or alleged untrue statement of a material fact contained in such Registration
Statement or any post-effective amendment thereof or the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, (ii) any untrue
statement or alleged untrue statement of a material fact contained in any
Prospectus (as amended or supplemented, if the Company files any amendment
thereof or supplement thereto with the SEC) or the omission or alleged omission
to state therein any material fact necessary to make the statements made
therein, in light of the circumstances under which the statements therein were
made, not misleading or (iii) any violation or alleged violation by the Company
of the 1933 Act, the 1934 Act, any state securities law or any rule or
regulation under the 1933 Act, the 1934 Act or any state securities law (the
matters in the foregoing clauses (i) through (iii) being, collectively,
"Violations"). Subject to the restrictions set forth in Section 3.d(3) with
respect to the number of legal counsel, the Company shall reimburse the
Investors and each such controlling person, promptly as such expenses are
incurred and are due and payable, for any reasonable legal fees or other
expenses incurred by them in connection with investigating or defending any such
Claim. Notwithstanding anything to the contrary contained herein, the
indemnification agreement contained in this Section 3.d(1) shall not apply to:
(I) a Claim arising out of or based upon a Violation which occurs in reliance
upon and in conformity with information relating to an Indemnified Person
furnished in writing to the Company by any Indemnified Person expressly for use
in connection with the preparation of such Registration Statement or any such
amendment thereof or supplement thereto, if such Prospectus was timely made
available by the Company pursuant to Section 3.b(3) hereof; (II) an Indemnified
Person with respect to a Claim which arises solely from the failure of such
Indemnified Person to comply in any material respect with Section 3.c(4); and
(III) amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Company. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of
the Indemnified Person and shall survive the transfer of the Registrable
Securities by the Investors.
(2) In connection with each Registration Statement, each
Investor agrees to indemnify and hold harmless, to the same extent and in the
same manner set forth in Section 3.d(1), each Indemnified Party against any
Claim to which any of them may become subject, under the 1933 Act, the 1934 Act
or otherwise, insofar as such Claim arises out of or is based upon any
Violation, in each case to the extent (and only to the extent) that such
Violation occurs (A) in reliance upon and in conformity with written information
furnished to the Company by such Investor expressly for use in connection with
such Registration Statement or any amendment thereof or supplement thereto or
(B) the failure of such Indemnified Person to comply in any material respect
with Section 3.c(4); and such Investor will reimburse any legal or other
expenses reasonably incurred by such Indemnified Party in connection with
investigating or defending any such Claim; provided, however, that the indemnity
agreement contained in this
-9-
10
Section 3.d(2) shall not apply to amounts paid in settlement of any Claim if
such settlement is effected without the prior written consent of such Investor,
which consent shall not be unreasonably withheld; provided further, however,
that the Investor shall be liable under this Section 3.d(2) for only the greater
of (i) that amount of a Claim as does not exceed the amount by which the
proceeds to such Investor as a result of the sale of Registrable Securities
pursuant to such Registration Statement exceeds the amount paid by such Investor
for such Registrable Securities and (ii) $40,000. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of
such Indemnified Party and shall survive the transfer of the Registrable
Securities by the Investors. Notwithstanding anything to the contrary contained
herein, the indemnification agreement contained in this Section 3.d(2) with
respect to any preliminary prospectus shall not inure to the benefit of any
Indemnified Party if the untrue statement or omission of material fact contained
in the preliminary prospectus was corrected on a timely basis in the Prospectus,
as then amended or supplemented.
(3) Promptly after receipt by an Indemnified Person or
Indemnified Party under this Section 3.d. of notice of the commencement of any
action (including any governmental action), such Indemnified Person or
Indemnified Party shall, if a Claim in respect thereof is to be made against any
indemnifying party under this Section 3.d., deliver to the indemnifying party a
written notice of the commencement thereof and the indemnifying party shall have
the right to participate in, and, to the extent the indemnifying party so
desires, jointly with any other indemnifying party similarly noticed, to assume
control of the defense thereof with counsel reasonably satisfactory to the
Indemnified Person or the Indemnified Party, as the case may be; provided,
however, that an Indemnified Person or Indemnified Party shall have the right to
retain its own counsel with the fees and expenses to be paid by the indemnifying
party, if, in the reasonable opinion of counsel retained by the indemnifying
party, the representation by such counsel of the Indemnified Person or
Indemnified Party and the indemnifying party would be inappropriate due to
actual or potential differing interests between such Indemnified Person or
Indemnified Party and any other party represented by such counsel in such
proceeding. The failure to deliver written notice to the indemnifying party
within a reasonable time of the commencement of any such action shall not
relieve such indemnifying party of any liability to the Indemnified Person or
Indemnified Party under this Section 3.d., except to the extent that the
indemnifying party is prejudiced in its ability to defend such action. The
indemnification required by this Section 3.d. shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as such
expense, loss, damage or liability is incurred and is due and payable.
e. CONTRIBUTION. To the extent any indemnification by an
indemnifying party as set forth in Section 3.e. above is applicable by its terms
but is prohibited or limited by law, the indemnifying party agrees to make the
maximum contribution with respect to any amounts for which it would otherwise be
liable under Section 3.d. to the fullest extent permitted by law. In determining
the amount of contribution to which the respective parties are entitled, there
shall be considered the relative fault of each party, the parties' relative
knowledge of and access to information concerning the matter with respect to
which the claim was asserted, the opportunity to correct and prevent any
statement or omission and any other equitable considerations appropriate under
the circumstances; provided, however, that (a) no contribution shall be made
under circumstances where the maker would not have been liable for
indemnification under the fault standards set forth in Section 3.d., (b) no
person guilty of
-10-
11
fraudulent misrepresentation (within the meaning of Section 11(f) of the 0000
Xxx) shall be entitled to contribution from any other person who was not guilty
of such fraudulent misrepresentation and (c) contribution by any seller of
Registrable Securities shall be limited to the greater of (i) the amount by
which the proceeds received by such seller from the sale of such Registrable
Securities exceeds the amount paid by such Investor for such Registrable
Securities and (ii) $40,000.
f. RULE 144. With a view to making available to the Investors the
benefits of Rule 144, the Company agrees:
(1) to promptly furnish to each Investor so long as such
Investor owns Registrable Securities, such information as may be necessary to
permit the Investors to sell Registrable Securities pursuant to Rule 144 without
registration; and
(2) if at any time the Company is not required to file such
reports with the SEC under Sections 13 or 15(d) of the 1934 Act, to use its best
efforts to, upon the request of an Investor, make publicly available other
information so long as is necessary to permit publication by brokers and dealers
of quotations for the Common Stock and sales of the Registrable Securities in
accordance with Rule 15c2-11 under the 1934 Act.
4. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company represents
and warrants to, and covenants and agrees with, each Holder as follows:
a. ORGANIZATION AND AUTHORITY. The Company is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Delaware, and has all requisite corporate power and authority to (i) own, lease
and operate its properties and to carry on its business as described in the SEC
Reports and as currently conducted, and (ii) to execute, deliver and perform its
obligations under this Agreement and the other Transaction Documents to be
executed and delivered by the Company in connection herewith, and to consummate
the transactions contemplated hereby and thereby.
b. CAPITALIZATION. The authorized capital stock of the Company
consists of (a) 40,000,000 shares of Common Stock of which 24,060,360 shares
were outstanding as of the close of business on November 30, 1998, all of which
are fully paid and nonassessable; and (b) 1,000,000 shares of Preferred Stock,
$0.001 par value, of which 400,000 shares have been designated Series A
Preferred Stock, of which 400,000 shares were outstanding at the close of
business on November 30, 1998, 140,880 shares have been designated Series C
Preferred Stock, of which 115,958 shares were outstanding on November 30, 1998,
and of which up to 6,285 shares will be designated as shares of Series D
Preferred, of which up to 4,785 may be issued pursuant to this Agreement and of
which up to 1,500 shares may be issued to MMC/GATX or its designee; from
November 30, 1998 to the date of the Closing, there will be (x) no material
increase in the number of shares of Common Stock outstanding (except for (1)
shares issued upon conversion of the Series A Preferred Stock, the Series C
Preferred Stock or the Notes, (2) shares issued upon exercise of options and
warrants outstanding on the date hereof or options or similar rights granted
subsequent to the date of this Agreement pursuant to the Company's stock option
plans in effect on the date of this Agreement), (3) up to 4,812,071 shares
covered by the Company's Registration Statement on Form S-3 (Registration No.
333-67023) to be sold at a
-11-
12
price at least equal to $1.50 per share in cash, and (4) up to 350,000 shares to
be issued to LIPHA, s.a.), and (y) no issuance of shares of preferred stock of
the Company (except for (1) shares of Series D Preferred Stock issued pursuant
to this Agreement and (2) up to 1,500 shares of Series D Preferred Stock or
other preferred stock issued in exchange for indebtedness of the Company to
MMC/GATX, which have powers, rights, preferences, qualifications, limitations
and restrictions which would be in compliance with the Certificate of
Designation as if the Certificate of Designation were filed with the Secretary
of State of the State of Delaware and shares of Series D Preferred Stock were
outstanding). The Company has duly reserved from its authorized and unissued
shares of Common Stock the full number of shares required for all options
exercisable through May 31, 1999, warrants, convertible securities (other than
the shares of Common Stock issuable upon conversion of the Series C Preferred),
exchangeable securities and other rights to acquire shares of Common Stock which
are outstanding (other than puts (including, without limitation, puts pursuant
to the Xxxxxxxx Stock Purchase Agreement)); and, immediately following the date
of the Closing, after giving effect to any antidilution or similar adjustment
arising by reason of issuance of the shares of Series D Preferred and the
Warrants, the total number of shares of Common Stock reserved and required to be
reserved from the authorized and unissued shares of Common Stock for purposes of
all such options exercisable through May 31, 1999, warrants, convertible
securities, other rights and stock option and similar plans (excluding the
shares of Series D Preferred, the Warrants, the Common Stock issuable upon
conversion of the Series C Preferred and shares issuable pursuant to puts
(including, without limitation, puts pursuant to the Xxxxxxxx Stock Purchase
Agreement) will be 8,650,032 in the respective amounts for each class, series or
category of securities as set forth on Schedule 4(b) attached hereto. Each
outstanding class or series of securities for which any such antidilution
adjustment will occur is identified on Schedule 4(b) attached hereto, together
with the amount of such antidilution adjustment for each such class or series.
No holder of any of the Company's securities has any rights, "demand,"
"piggy-back" or otherwise, to have such securities registered by reason of the
intention to file, filing or effectiveness of any Registration Statement.
c. CONCERNING THE SHARES AND THE COMMON STOCK. The Shares have been
duly authorized and the shares of Series D Preferred, when issued in exchange
for the Notes in accordance with this Agreement, the Conversion Shares, when
issued upon conversion of the shares of Series D Preferred, and the Warrant
Shares, when issued upon exercise of the Warrants, will be duly and validly
issued, fully paid and non-assessable and will not subject the holder thereof to
personal liability by reason of being such holder. There are no preemptive or
similar rights of any stockholder of the Company or any other Person to acquire
any of the Securities. The Company has duly reserved (1) (a) prior to the
Stockholder Approval, 6,285,000 of Common Stock for issuance upon conversion of
the shares of Series D Preferred and (b) subsequent and subject to the
Stockholder Approval, a number of shares of Common Stock at least equal to 175%
of the number of shares of Common Stock which would be issuable on the date the
Stockholder Approval is obtained based on the number of shares of Series D
Preferred outstanding on such date, and (2) a number of shares of Common Stock
at least equal to the number of shares of Common Stock issuable upon exercise of
the Warrants, and such shares shall remain so reserved (subject to reduction
from time to time for shares of Common Stock issued upon conversion of shares of
Series D Preferred and upon exercise of the Warrants), and the Company shall
from time to time reserve such additional shares of Common Stock as shall be
required to be reserved pursuant to the Certificate of Designation, as long as
the shares of Series
-12-
13
D Preferred are convertible, and pursuant to the Warrants, so long as the
Warrants are exercisable. The Common Stock is listed for trading on Nasdaq and
the Company and the Common Stock meet the criteria for continued listing and
trading on Nasdaq, except for the failure or potential failure of the Company to
meet the Nasdaq Tangible Asset Criterion. The Company (x) has furnished to each
Holder true and correct copies of all correspondence from the NASD or the Nasdaq
Stock Market received by the Company and dated on or after January 1, 1996
relating to the failure of potential failure of the Company to meet the criteria
for continued listing and trading on Nasdaq and (y) has not been notified since
October 26, 1998 (which is the latest date of any correspondence referred to in
the immediately preceding clause (x)) by the NASD or the Nasdaq Stock Market of
any failure or potential failure to meet the criteria for continued listing and
trading on Nasdaq. No suspension of trading in the Common Stock is in effect.
The Company knows of no reason, other than the failure or potential failure of
the Company to meet the Nasdaq Tangible Asset Criterion, that the Common Shares
will not be eligible for listing on Nasdaq.
d. CORPORATE AUTHORIZATION. The Transaction Documents have been duly
and validly authorized by the Company, this Agreement has been duly executed and
delivered on behalf of the Company and, assuming due execution and delivery by
such Holder, this Agreement is, the Certificate of Designation, when executed by
the Company and filed with the Secretary of State of the State of Delaware, will
be, and the Conversion Agent Agreement, when executed and delivered by the
Company, will be, valid and binding obligations of the Company enforceable in
accordance with their respective terms, except as the enforceability hereof may
be limited by bankruptcy, insolvency, reorganization, moratorium or other
similar laws now or hereafter in effect relating to or affecting creditors'
rights generally and general principles of equity, regardless of whether
enforcement is considered in a proceeding in equity or at law.
e. NON-CONTRAVENTION. The execution and delivery of the Transaction
Documents by the Company and the consummation by the Company of the issuance of
the Securities as contemplated by this Agreement and the other transactions
contemplated by the Transaction Documents do not and will not, with or without
the giving of notice or the lapse of time, or both, (i) result in any violation
of any term of the certificate of incorporation or bylaws of the Company, (ii)
conflict with or result in a breach by the Company of any of the terms or
provisions of, or constitute a default under, or result in the modification of,
or result in the creation or imposition of any lien, security interest, charge
or encumbrance upon any of the properties or assets of the Company pursuant to,
any indenture, mortgage, deed of trust or other agreement or instrument to which
the Company is a party or by which the Company or any of its properties or
assets are bound or affected, (iii) violate or contravene any applicable law,
rule or regulation or any applicable decree, judgment or order of any court,
United States federal or state regulatory body, administrative agency or other
governmental body having jurisdiction over the Company or any of its properties
or assets or (iv) have any material adverse effect on any permit, certification,
registration, approval, consent, license or franchise necessary for the Company
to own or lease and operate any of its properties and to conduct any of its
business or the ability of the Company to make use thereof.
f. APPROVALS. No authorization, approval or consent of any court,
governmental body, regulatory agency, self-regulatory organization, or stock
exchange or market or the stockholders of the Company is required to be obtained
by the Company for (1) the
-13-
14
execution, delivery and performance by the Company of the Transaction Documents,
(2) the issuance and sale of Common Shares upon conversion of the shares of
Series D Preferred or exercise of the Warrants, as the case may be, as
contemplated by this Agreement and the other Transaction Documents and (3) the
performance by the Company of its other obligations under the Transaction
Documents, other than (1) listing of the Common Shares on Nasdaq, (2)
registration of the resale of the Common Shares under the 1933 Act as
contemplated by Section 3, if applicable, and (3) as may be required under
applicable state securities or "blue sky" laws. The issuance of the shares of
Series D Preferred and the Warrants and the issuance of Conversion Shares upon
conversion of the shares of Series D Preferred and the issuance of the Warrant
Shares upon exercise of the Warrants are not subject to the requirements of Rule
4460(i) of the Nasdaq Stock Market due to a waiver of the requirements of such
rule by Nasdaq and the Company is in compliance in all material respects with
the requirements of such waiver.
g. SEC FILINGS. The Company has timely filed all reports required to
be filed under the 1934 Act and any other material reports or documents required
to be filed with the SEC since January 1, 1995. All of such reports and
documents complied, when filed, in all material respects, with all applicable
requirements of the 1933 Act and the 1934 Act. The Company meets the
requirements for the use of Form S-3 for the registration of the resale of the
Common Shares by the Holders and any other Investors. The Company has not filed
any reports with the SEC under the 1934 Act since December 31, 1997 other than
the SEC Reports.
h. ABSENCE OF CERTAIN PROCEEDINGS. There is no action, suit or
proceeding, before or by any court, public board or body or governmental agency
pending or, to the knowledge of the Company, threatened against the Company and,
to the knowledge of the Company, there is no inquiry or investigation before or
by any court, public board or body or governmental agency pending or threatened
against the Company, in any such case wherein an unfavorable decision, ruling or
finding could have a material adverse effect on the transactions contemplated by
the Transaction Documents or which could adversely affect the validity or
enforceability of, or the authority or ability of the Company to perform its
obligations under, the Transaction Documents; the Company does not have pending
before the SEC any request for confidential treatment of information and to the
best of the Company's knowledge no such request will be made by the Company
prior to the later SEC Effective Date; and to the best of the Company's
knowledge there is not pending or contemplated, and there has been no,
investigation by the SEC involving the Company or any current or former director
or officer of the Company.
i. ABSENCE OF BROKERS, FINDERS, SOLICITATION COMPENSATION, ETC. No
broker, finder or similar Person is entitled to any commission, fee or other
compensation by reason of the transactions contemplated by this Agreement, and
the Company shall pay, and indemnify and hold harmless the Holders from, any
claim made against any Holder by any Person for any such commission, fee or
other compensation. The Company has not and will not pay any commission or other
remuneration to any Person for solicitation of exchanges of Notes for shares of
Series D Preferred pursuant to this Agreement or the issuance of Warrants in
connection therewith.
j. INVESTMENT COMPANY. Neither the Company nor the Subsidiary is an
"investment company" within the meaning of such term under the Investment
Company Act of 1940, as amended and the rules and regulations of the SEC
thereunder.
-14-
15
k. CLASSIFICATION OF SERIES D PREFERRED. The Company believes, after
discussions with Ernst & Young LLP, its independent public accountants, and
review by Ernst & Young LLP of this Agreement and the Certificate of
Designation, that under Generally Accepted Accounting Principles and applicable
accounting principles and practices of the SEC in effect on the date of this
Agreement the shares of Series D Preferred, when issued, will be classified as
equity on the Company's balance sheet and not as redeemable preferred stock.
l. RIGHTS PLAN. As of the date of execution and delivery of this
Agreement by the Company, the Company has not adopted a shareholder rights plan
or similar arrangement relating to accumulations of beneficial ownership of
Common Stock or a change in control of the Company. If on or after the date of
execution and delivery of this Agreement the Company adopts any such plan or
arrangement, the terms of such plan or arrangement will be such that, assuming
(x) that a Holder does not hold any outstanding shares of Common Stock other
than as acquired upon conversion of the Series D Preferred, the Warrants, shares
of Series C Preferred Stock or any Outstanding Warrants and (y) compliance by
such Holder with the limitation on the number of outstanding shares of Common
Stock that may be held by such Holder as contained in the Certificate of
Designation, the execution and delivery of this Agreement by the Company, the
issuance of the shares of Series D Preferred and Warrants as contemplated by
this Agreement, the issuance of the Conversion Shares upon conversion of the
shares of Series D Preferred, the issuance of the Warrant shares upon exercise
of the Warrants and the issuance of shares of Common Stock upon conversion of
shares of Series C Preferred Stock or exercise of Outstanding Warrants, as the
case may be, and the other transactions contemplated by the Transaction
Documents will not result in such Holder becoming an "acquiring person" or
obtaining similar status under such plan or arrangement; and the Holders will be
entitled with respect to the Common Shares and the shares of Common Stock issued
or issuable upon conversion of shares of Series C Preferred Stock or exercise of
Outstanding Warrants, as the case may be, to the benefits available to the
holders of Common Stock generally under such plan or arrangement.
m. CERTAIN SECURITIES LAW MATTERS. The shares of Series D Preferred
and the Warrants may be issued to the several Holders pursuant to this Agreement
without registration under the 1933 Act by reason of Section 3(a)(9). For
purposes of Rule 144 under the 1933 Act, each Holder will be entitled to tack
the holding period of its Note to the holding period of the shares of Series D
Preferred issued to such holder in exchange for such Note.
5. REPRESENTATIONS AND WARRANTIES OF THE SEVERAL HOLDERS. Each Holder
severally and not jointly represents and warrants to the Company that such
Holder has all requisite power and authority, corporate or otherwise, to
execute, deliver and perform its obligations under this Agreement and to
consummate the transactions contemplated hereby; and this Agreement has been
duly and validly authorized, duly executed and delivered by such Holder and,
assuming due execution and delivery by the Company, is a valid and binding
agreement of such Holder enforceable in accordance with its terms, except as the
enforceability hereof may be limited by bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or other similar laws now or hereafter in
effect relating to or affecting creditors' rights generally and general
principles of equity, regardless of whether enforcement is considered in a
proceeding in equity or at law.
-15-
16
6. CONDITIONS TO THE COMPANY'S OBLIGATION TO ISSUE SERIES D PREFERRED AND
WARRANTS AND EACH HOLDER'S OBLIGATION TO EXCHANGE NOTES.
a. COMPANY'S CONDITIONS. The Company's obligation to issue the
shares of Series D Preferred and Warrants to each Holder pursuant to this
Agreement on the date of the Closing is conditioned upon the satisfaction of the
following conditions precedent on or before the date of the Closing (any or all
of which may be waived by the Company in its sole discretion):
(1) On the date of the Closing, no legal action, suit or
proceeding shall be pending or threatened which seeks to restrain or prohibit
the transactions contemplated by this Agreement;
(2) The representations and warranties of such Holder
contained in this Agreement shall be true and correct on the date of the Closing
as if made on the date of the Closing and such Holder shall have performed on or
before the date of the Closing all covenants and agreements of such Holder
required to be performed on or before the date of the Closing;
(3) No stop order or similar proceeding relating to any
Registration Statement shall be pending or threatened (it being understood that
the inclusion of the closing condition set forth in this Section 6.a(3) shall
not limit the Company's obligations set forth in Section 3 hereof); and on the
date of the Closing all Registration Statements relating to Conversion Shares
shall be effective and available for use by the Holders for resale of the Common
Shares; and
(4) The Company shall have received on the date of the Closing
an opinion of Law Offices of Xxxxx X Xxxxx, dated the date of the Closing,
addressed to the Company, to the effect set forth in Schedule D attached hereto.
x. XXXXXX'X CONDITIONS. Each Holder's obligation to exchange such
Holder's Notes for shares of Series D Preferred on the date of the Closing is
conditioned upon the satisfaction of the following conditions precedent on or
before the date of the Closing (any or all of which may be waived by such Holder
in its sole discretion):
(1) No stop order or similar proceeding relating to any
Registration Statement shall be pending or threatened (it being understood that
the inclusion of the closing condition set forth in this Section 6.b(1) shall
not limit the Company's obligations set forth in Section 3 hereof); and on the
date of the Closing all Registration Statements relating to Conversion Shares
shall be effective and available for use by the Holders for resale of the
Conversion Shares.
(2) The Conversion Agent shall have executed and delivered the
Conversion Agent Agreement in the form attached hereto as Schedule E;
(3) On the date of the Closing, no legal action, suit or
proceeding shall be pending or threatened which seeks to restrain or prohibit
the transactions contemplated by this Agreement;
-16-
17
(4) The representations and warranties of the Company
contained in this Agreement and the other Transaction Documents shall be true
and correct on the date of the Closing as if made on the date of the Closing;
and on or before the date of the Closing the Company shall have performed all
covenants and agreements of the Company contained in the Transaction Documents
and required to be performed by the Company on or before the date of the
Closing;
(5) No Event of Default (as defined in the Notes) or event
which, with the giving of notice or the lapse of time, or both, would constitute
an Event of Default (as defined in the Notes) shall have occurred and be
continuing; and no event which, if the shares of Series D Preferred were
outstanding, would constitute an Optional Redemption Event or, with the giving
of notice or the lapse of time, or both, would constitute an Optional Redemption
Event shall have occurred and be continuing;
(6) The Company shall have delivered to such Holder its
certificate, dated the date of the Closing, duly executed by its Chief Executive
Officer, to the effect set forth in subparagraphs (3), (4), and (5) of this
Section 6.b.; (7) Such Holder shall have received satisfactory confirmation of
the filing with the Secretary of State of the State of Delaware of the
Certificate of Designation;
(8) The Common Shares shall have been approved for listing,
subject to official notice of issuance, by Nasdaq;
(9) Such Holder shall have received a certificate, dated the
date of the Closing, of the Secretary of the Company certifying (1) the
Certificate of Incorporation and Bylaws of the Company as in effect on the date
of the Closing, (2) all resolutions of the Board of Directors (and committees
thereof) of the Company relating to this Agreement and the transactions
contemplated hereby and (3) such other matters as reasonably requested by such
Holder;
(10) Such Holder shall have received on the date of the
Closing an opinion of Xxxxxxx, Xxxxxxx & Xxxxxxxx LLP, counsel for the Company,
dated the date of the Closing, addressed to such Holder, in form, scope and
substance reasonably satisfactory to such Holder, as set forth in Schedule F
attached hereto;
(11) Holders who are identified as addressees of the opinion
of Law Offices of Xxxxx X Xxxxx in the form thereof set forth in Schedule D
attached hereto shall have received on the date of the Closing such opinion,
dated the date of the Closing, addressed to them, to the effect set forth in
Schedule D attached hereto; and
(12) On the date of the Closing, (i) trading in securities on
the New York Stock Exchange, Inc., AMEX, Nasdaq or Nasdaq SmallCap shall not
have been suspended or materially limited and (ii) a general moratorium on
commercial banking activities in the State of California or the State of New
York shall not have been declared by either federal or state authorities.
-17-
18
7. CERTAIN COVENANTS.
a. RESTRICTIVE LEGENDS.
(1) Each Holder acknowledges and agrees that the certificates
for the shares of Series D Preferred issued to such Holder shall bear
restrictive legends in substantially the following form (and a stop-transfer
order may be placed against transfer of such shares of Series D Preferred):
These securities have not been registered under the Securities Act of
1933, as amended (the "Act"). The sale to the holder of these securities
of the shares of common stock issuable upon conversion of these securities
is not covered by a registration statement under the Act. These securities
have been acquired, and such shares of common stock must be acquired, for
investment and may not be resold, transferred or assigned in the absence
of an effective registration statement under the Act or an opinion of
counsel reasonably satisfactory in form, scope and substance to the
Company that registration is not required under the Act.
Section 9b(3)(A) of the Certificate of Designation permits a holder of the
securities represented by this certificate to convert such securities in
accordance with the Certificate of Designation without being required to
physically surrender this certificate to the Company unless all of the
securities represented hereby are so converted. Consequently, following
conversion of any of the securities represented by this certificate, the
number of shares represented by this certificate may be less than the
number of shares stated hereon.
(2) Each Holder further acknowledges and agrees that the
Warrants issued to such Holder shall bear a restrictive legend in substantially
the following form (and a stop-transfer order may be placed against transfer of
such Warrants):
The securities represented by this certificate have not been registered
under the Securities Act of 1933, as amended. The securities have been
acquired for investment and may not be resold, transferred or assigned in
the absence of an effective registration statement for the securities
under the Securities Act of 1933, as amended, or an opinion of counsel
that registration is not required under said Act.
(3) Each Holder further acknowledges and agrees that until
such time as the Common Shares issued or issuable have been registered for
resale under the 1933 Act as contemplated by Section 3, the certificates for the
Common Shares which are not so registered may bear a restrictive legend in
substantially the following form (and a stop-transfer order may be placed
against transfer of the certificates for the Common Shares):
The securities represented by this certificate have not been registered
under the Securities Act of 1933, as amended (the "Act"). The securities
have been acquired for investment and may not be resold, transferred or
assigned in the absence of an effective registration statement for the
securities under the Act, or an opinion of counsel reasonably
-18-
19
satisfactory in form, scope and substance to the Company that registration
is not required under the Act.
(4) Once an Additional Registration Statement or the Warrant
Share Registration Statement has been declared effective, thereafter (1) upon
request of any Holder the Company will substitute certificates without
restrictive legend for certificates for any Common Shares issued prior to the
SEC Effective Date of such Registration Statement and which are covered by such
Registration Statement which bear such restrictive legend and remove any
stop-transfer restriction relating thereto promptly, but in no event later than
three days after surrender of such certificates by such Holder and (2) the
Company shall not place any restrictive legend on certificates for Conversion
Shares issued on conversion of the shares of Series D Preferred or Warrant
Shares issued on exercise of Warrants which shares are covered by such
Registration Statement or impose any stop-transfer restriction thereon.
b. CONVERSION AGENT AGREEMENT. Prior to the date of the Closing, the
Company will (1) enter into the Conversion Agent Agreement substantially in the
form attached hereto as Schedule E and perform all of its obligations pursuant
thereto, and (2) appoint the Conversion Agent the conversion agent for the
Preferred Stock and the exercise agent for the Warrants. The certificates for
the Common Shares may bear the restrictive legend specified in Section 7.a.(3)
prior to registration of the resale of the Common Shares under the 1933 Act. The
certificates for the Common Shares shall be registered in the name of the
respective Holder or its nominee and in such denominations to be specified by
such Holder in connection with each conversion of shares of Series D Preferred
or exercise of Warrants, as the case may be. The Company warrants that, except
as otherwise expressly permitted by the Conversion Agent Agreement, no
instruction other than (x) such instructions referred to in this Section 7.b.,
and (y) the instructions required by Section 3.b(12) will be given by the
Company to the Conversion Agent and that the Common Shares shall otherwise be
freely transferable on the books and records of the Company. Nothing in this
Section 7.b. shall limit in any way a Holder's obligations and agreement to
comply with the registration requirements of the 1933 Act or an exemption
therefrom upon resale of the Shares. If a Holder provides the Company with an
opinion of counsel reasonably satisfactory in form, scope and substance to the
Company that registration of a resale by such Holder of any of the Shares is not
required under the 1933 Act, the Company shall permit the transfer of such
Shares and, in the case of the Common Shares, promptly, but in no event later
than three days after receipt of such opinion, instruct the Conversion Agent to
issue upon transfer one or more share certificates in such names and in such
denominations as specified by such Holder. Nothing in this Section 7.b. shall
limit the obligations of the Company under Section 3.
c. NASDAQ LISTING; REPORTING STATUS. Prior to the date of the
Closing, the Company shall file an application for listing of additional shares
with the Nasdaq Stock Market covering such of the Conversion Shares as shall not
previously have been listed for trading on the Nasdaq Stock Market and the
Warrant Shares and shall provide evidence of such filing to the Holders. The
Company shall use its best efforts to obtain the listing, subject to official
notice of issuance, of such Conversion Shares and the Warrant Shares on Nasdaq.
So long as the Holder beneficially owns any shares of Series D Preferred or
Common Shares, (1) the Company will use its best efforts to maintain the listing
of the Common Stock on Nasdaq or a registered national securities exchange or,
if Nasdaq or such exchange is not available, on the first available
-19-
20
of (i) Nasdaq SmallCap, and (ii) such other securities exchange, OTC Bulletin
Board or other market as may then be available, and (2) the Company shall assure
that at all times there are at least two broker-dealers who are members of the
NASD who are market makers in the Common Stock. During the Registration Period,
the Company shall timely file all reports required to be filed with the SEC
pursuant to Section 13 or 15(d) of the 1934 Act, and the Company shall not
terminate its status as an issuer required to file reports under the 1934 Act
even if the 1934 Act or the rules and regulations thereunder would permit such
termination. So long as any Holder owns any Securities, the Company shall
furnish to such Holder copies of all reports and other information filed by the
Company with the SEC pursuant to Sections 13, 14(a), 14(c) and 15(d) of the 1934
Act promptly, but in no event later than five days, after the same are filed
with the SEC.
d. STATE SECURITIES LAWS. On or before the date of the Closing, the
Company shall take such action as shall be necessary to qualify, or to obtain an
exemption for, the shares of Series D Preferred and Warrants for issuance to the
Holders pursuant to this Agreement and the Common Shares for issuance to the
Holders on conversion of the Preferred Shares or exercise of the Warrants, as
the case may be, under such of the securities or "blue sky" laws of
jurisdictions as shall be applicable to the issuance of the shares of Series D
Preferred and the Warrants pursuant to this Agreement and the issuance to the
Holders of Conversion Shares on conversion of the Preferred Shares and Warrant
Shares upon exercise of the Warrants. In connection with the foregoing
obligations of the Company in this Section 7.d., the Company shall not be
required (1) to qualify to do business in any jurisdiction where it would not
otherwise be required to qualify but for this Section 7.d., (2) to subject
itself to general taxation in any such jurisdiction, (3) to file a general
consent to service of process in any such jurisdiction, (4) to provide any
undertakings that cause more than nominal expense or burden to the Company, or
(5) to make any change in its charter or by-laws which the Board of Directors of
the Company determines to be contrary to the best interests of the Company and
its stockholders. The Company shall furnish copies of all filings, applications,
orders and grants or confirmations of exemptions relating to such securities or
"blue sky" laws on or prior to the date of the Closing.
e. RULE 144. The Company shall not, directly or indirectly, dispute
or otherwise interfere with any claim by a holder of shares of Series D
Preferred that such holder's holding period of such security (and the Conversion
Shares issued upon conversion thereof) for purposes of Rule 144 under the 1933
Act ("Rule 144") relates back (i.e., tacks) to the holding period for the Notes;
provided, however, that nothing contained in this Section 7.e. shall obligate
the Company or its legal counsel to take a position that is inconsistent with
the provisions of applicable law or regulations and the administrative and
judicial interpretations thereof in effect from time to time in the future. The
Company acknowledges and agrees that, as of the date hereof, under Rule 144,
interpretations thereof by the SEC and "no-action" letters from the staff of the
SEC, such tacking is permitted.
f. STOCKHOLDER APPROVAL. The Company shall seek and use its best
efforts to obtain approval by its stockholders of an amendment to its
Certificate of Incorporation to increase the number of authorized shares of
Common Stock to at least 70,000,000 shares. The Company shall (1) call a meeting
of stockholders to be held not later than the date determined in accordance
herewith, (2) prepare and file with the SEC preliminary proxy materials relating
to
-20-
21
such meeting, (3) mail to its stockholders not later than the date which is 30
days prior to such meeting a notice of such meeting and definitive proxy
materials for such meeting, and (4) recommend approval thereof by its
stockholders. The Company shall provide two firms of counsel designated by a
majority of the Holders an opportunity to review and comment on such preliminary
proxy materials and any revised preliminary proxy materials proposed to be filed
by the Company with the SEC relating to such meeting by providing copies thereof
to the Holders at least five days prior to such filing. The Company shall
furnish to each Holder a copy of each amendment or supplement to such notice and
proxy materials promptly after the same are mailed to stockholders, shall inform
the Holders at least weekly of the progress of solicitation of proxies for such
meeting, shall inform the Holders of any adjournment of such meeting on the date
of such adjournment, and shall report to the Holders the result of the vote of
stockholders on such proposition on the day such vote is taken. The meeting of
stockholders of the Company required by this Section 7.f. shall be held not
later than May 31, 1999; provided, however, that if the closing bid price of the
Common Stock on the principal market on which the Common Stock trades is $1.00
or less, as reported by Bloomberg, L.P., for a period of ten consecutive trading
days occurring after the date of the Closing then such meeting of stockholders
shall be held not later than the date which is 60 days after the last day of
such period of ten consecutive trading days.
g. REGISTRATION STATEMENT. Based in part on the opinion of counsel
referred to in Section 6.a(4), the Company believes that the existing
Registration Statement may be used by the Holders for resale of the Conversion
Shares. The Company shall not, directly or indirectly, dispute or otherwise
interfere with any claim by an Investor that such Investor may use the Existing
Registration Statement for resales of the Conversion Shares; provided, however,
that nothing contained in this Section 7.g. shall obligate the Company or its
legal counsel to take a position that is inconsistent with the provisions of
applicable law, rules or regulations and the administrative and judicial
interpretations thereof in effect from time to time in the future.
h. CONVERSION SHARE UPDATES. Upon the request of the Company from
time to time, so long as the Holder holds any shares of Series D Preferred, such
Holder shall provide confirmation to the Company of the aggregate number of
Conversion Shares issued to such Holder.
i. BEST EFFORTS. Each of the parties shall use its best efforts to
satisfy on a timely basis each of the conditions to the other party's
obligations to exchange Notes for shares of Series D Preferred and issuance of
Warrants set forth in Section 6.a. or 6.b., as the case may be, on or before the
date of the Closing.
8. DEFINITIONS.
a. As used in this Agreement, the terms "Agreement", Company and
"Holder" shall have the respective meanings assigned to such terms in the
introductory paragraph of this Agreement.
b. All the agreements or instruments herein defined shall mean such
agreements or instruments as the same may from time to time be supplemented or
amended or
-21-
22
the terms thereof waived or modified to the extent permitted by, and in
accordance with, the terms thereof and of this Agreement.
c. The following terms shall have the following meanings (such
meanings to be equally applicable to both the singular and plural forms of the
terms defined):
"Additional Registration Statement" means each registration
statement of the Company under the 1933 Act filed with the SEC on or after the
date of execution and delivery of this Agreement pursuant to Section 3.a.(1),
including any amendment thereto, which names the Holders or any of them as
selling stockholders.
"Blackout Period" means the period of up to 20 consecutive days
after the date the Company notifies the Investors that they are required,
pursuant to Section 3.c(4), to suspend offers and sales of Registrable
Securities as a result of an event or circumstance described in Section
3.b(5)(A), which period commences after the date which is 90 days after the date
of the Closing and during which period, by reason of Section 3.b(5)(B), the
Company is not required to amend a Registration Statement or to supplement the
Prospectus relating to such Registration Statement; provided, however, that such
period may be up to 30 consecutive days if the Company so elects in accordance
with Section 3.b(5)(B), subject to the limitations provided therein.
"Business Day" means any day other than a Saturday, Sunday or other
day on which commercial banks in The City of New York are authorized or required
by law to remain closed.
"Certificate of Designation" means the Certificate of Designation of
Series D Convertible Preferred Stock in the form attached hereto as Schedule B,
as the same is filed with the Secretary of State of the State of Delaware.
"Claim" means any loss, claim, damage, liability or expense (joint
or several), incurred by a Person or entity.
"Common Shares" means the Conversion Shares and the Warrant Shares.
"Common Stock" means the Common Stock, $0.001 par value per share,
of the Company.
"Conversion Agent Agreement" means the Conversion Agent Agreement in
the form attached hereto as Schedule E.
"Conversion Price" shall have the meaning provided in the
Certificate of Designation.
"Conversion Shares" means the shares of Common Stock issuable or
issued upon conversion of the Series D Preferred.
-22-
23
"Existing Registration Statement" means the Company's Registration
Statement on Form S-3 (Registration No. 333-31843) which names the Holders as
selling stockholders.
"Xxxxxxxx" means Xxxxxxxx International Limited, a company organized
under the laws of the Cayman Islands.
"Xxxxxxxx Stock Purchase Agreement" means the Stock Purchase
Agreement, dated July 25, 1996, between the Company and Xxxxxxxx.
"Generally Accepted Accounting Principles" shall have the meaning
provided in the Certificate of Designations.
"Indemnified Party" means the Company, each of its directors, each
of its officers who signs a particular Registration Statement, each Person, if
any, who controls the Company within the meaning of the 1933 Act or the 1934
Act, any underwriter and any other stockholder selling securities pursuant to
such Registration Statement or any of its directors or officers or any Person
who controls such stockholder or underwriter within the meaning of the 1933 Act
or the 1934 Act.
"Indemnified Person" means each Investor and each Investor who sells
Registrable Securities in the manner permitted under this Agreement, the
directors, if any, of such Investor, the officers and agents, if any, of such
Investor, each Person, if any, who controls any Investor within the meaning of
the 1933 Act or the 1934 Act, any underwriter (as defined in the 0000 Xxx)
acting on behalf of an Investor who participates in the offering of Registrable
Securities of such Investor in accordance with the plan of distribution
contained in the applicable Prospectus, the directors, if any, of such
underwriter and the officers, if any, of such underwriter, and each Person, if
any, who controls any such underwriter within the meaning of the 1933 Act or the
1934 Act.
"Inspector" means any attorney, accountant or other agent retained
by an Investor for the purposes provided in Section 3.b(9).
"Investor" means the Holder and any permitted transferee or assignee
who agrees to become bound by the provisions of Sections 3, 7 and 9 of this
Agreement.
"MMC/GATX" means MMC/GATX Partnership No. 1, a California general
partnership.
"NASD" means the National Association of Securities Dealers, Inc.
"Nasdaq" means The Nasdaq National Market.
"Nasdaq SmallCap" means The Nasdaq SmallCap Market.
"Nasdaq Tangible Asset Criterion" means the requirement of Section
4450(a)(3) of the rules of the NASD that an issuer maintain net tangible assets
of at least $4 million in order that securities of such issuer be eligible for
continued inclusion in Nasdaq.
-23-
24
"1933 Act" means the Securities Act of 1933, as amended.
"1934 Act" means the Securities Exchange Act of 1934, as amended.
"1997 10-K" means the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 1997, as amended by Amendments No. 1 and No. 2
thereto on Form 10-K/A.
"Non-Responsive Investor" means an Investor who does not provide the
Required Information to the Company at least one Business Day prior to the
filing of a Registration Statement with the SEC.
"Outstanding Warrants" means the common stock purchase warrants
issued by the Company, outstanding on the date of execution and delivery of this
Agreement and held by any Holder.
"Person" means any natural person, corporation, partnership, limited
liability company, trust, incorporated organization, unincorporated association
or similar entity or any government, governmental agency or political
subdivision.
"Prospectus" means the prospectus, including any preliminary
prospectus, used in connection with any Registration Statement and any amendment
or supplement thereto (including any documents or information incorporated
therein by reference).
"Record" shall mean all pertinent financial and other records,
pertinent corporate documents and properties of the Company and the Subsidiaries
subject to inspection for the purposes provided in Section 3.b.(9).
"Registrable Securities" means the Conversion Shares and the Warrant
Shares and any stock or other securities into which or for which the Common
Stock may hereafter be changed, converted or exchanged by the Company or its
successor, as the case may be, and any other securities issued to holders of
such Common Stock (or such shares into which or for which such shares are so
changed, converted or exchanged) upon any reclassification, share combination,
share subdivision, share dividend, merger, consolidation or similar transaction
or event.
"Registration Period" means the period from the date of this
Agreement to the earlier of (i) December 31, 2000 and (ii) the date on which the
Investors no longer own any Registrable Securities (or, if (x) the shares of
Series D Preferred have been fully converted into shares of Common Stock and the
Warrants have been exercised in full or (y) neither any shares of Series D
Preferred nor any Warrants remain outstanding, such date after which each
Investor may sell all of its Registrable Securities without registration under
the 1933 Act pursuant to Rule 144, free of any limitation on the volume of such
securities which may be sold during any period and any limitation on the manner
of sale); provided, however, that in the case of the Warrant Share Registration
Statement filed with the SEC pursuant to Section 3.a.(5), the "Registration
Period" shall begin on the date such Registration Statement is filed with the
SEC and shall end
-24-
25
on the date which is two years after the later of (A) the latest date of
exercise of any Warrant, if all of the Warrants are exercised prior to the
expiration date of the Warrants and (B) the expiration date of the Warrants.
"Registration Statement" means the Existing Registration Statement,
each Additional Registration Statement and the Warrant Share Registration
Statement (including any documents or information incorporated in any
Registration Statement by reference).
"Required Information" means, with respect to each Investor, all
information regarding such Investor, the Registrable Securities held by such
Investor or which such Investor has the right to acquire and the intended method
of disposition of the Registrable Securities held by such Investor or which such
Investor has the right to acquire as shall be required by the 1933 Act to effect
the registration of the resale by such Investor of such Registrable Securities.
"SEC" means the Securities and Exchange Commission.
"SEC Effective Date" means the date the Additional Registration
Statement relating to the Conversion Shares is declared effective by the SEC, if
a new Registration Statement relating to the Conversion Shares is required
pursuant to Section 3.a. and the date the Warrant Share Registration Statement
is declared effective by the SEC.
"SEC Reports" means (i) the 1997 10-K, (ii) the Company's Quarterly
Report on Form 10-Q for the fiscal quarter ended March 31, 1998, as amended by
Amendments Xx. 0 xxx Xx. 0 xxxxxxx xx Xxxx 00-X/X, (xxx) the Company's Quarterly
Report on Form 10-Q for the fiscal quarter ended June 30, 1998, (iv) the
Company's Quarterly Report on Form 10-Q for the fiscal quarter ended September
30, 1998, (v) the Company's Proxy Statement filed in connection with the
Company's 1998 Annual Meeting of Stockholders and (vi) all registration
statements filed under the 1933 Act, in each case as filed with the SEC.
"Securities" means the Shares and the Warrants.
"Series C Preferred Stock" means the Company's Series C Convertible
Preferred Stock, par value $0.001 per share.
"Shares" means the shares of Series D Preferred and the Common
Shares.
"Short Sale" shall have the meaning given such term in Rule 3b-3
under the 1934 Act as in effect on the date of this Agreement.
"Stockholder Approval" means approval by the stockholders of the
Company in accordance with the General Corporation Law of the State of Delaware
of the amendment to the Company's Certificate of Incorporation as contemplated
by Section 7.f.
"Transaction Documents" means, individually or collectively, this
Agreement, the Certificate of Designation, the Warrants, the Conversion Agent
Agreement and the other agreements, instruments and documents contemplated
hereby and thereby.
-25-
26
"Warrants" means Common Stock Purchase Warrants in the form attached
hereto as Schedule G initially entitling the holder to purchase the number of
shares of Common Stock specified in Section 1.a.
"Warrant Share Registration Statement" means one or more
registration statements on Form S-3 (which shall not constitute a post-effective
amendment to any other Registration Statement) covering the resale by the
Holders of at least that number of shares of Common Stock as is issuable to the
Holders upon exercise of the Warrants.
"Warrant Shares" means the shares of Common Stock issuable or issued
upon exercise of the Warrants.
9. MISCELLANEOUS.
a. This Agreement shall be construed and interpreted in accordance
with the laws of the State of New York.
b. This Agreement may be executed in any number of counterparts and
by different parties hereto on separate counterparts, each of which counterparts
when so executed and delivered, shall be deemed to be an original and all of
which counterparts, taken together, shall constitute but one and the same
instrument. This Agreement may be executed and delivered by a party by a
telephone line facsimile transmission bearing a signature on behalf of such
party transmitted by such party to the other party.
c. Section and paragraph headings in this Agreement are included
herein for convenience of reference only and shall not constitute a part of this
Agreement for any other purpose.
d. Any provision of this Agreement that is prohibited, unenforceable
or not authorized in any jurisdiction shall, as to such jurisdiction, be
ineffective to the extent of such prohibition, unenforceability or
non-authorization without invalidating the remaining provisions hereof or
affecting the validity, enforceability or legality of such provision in any
other jurisdiction.
e. No amendment or waiver of any provision of this Agreement shall
in any event be effective unless the same shall be in writing and signed by the
party to be charged with enforcement thereof and any such waiver shall be
effective only in the specific instance and for the specific purpose for which
given. No failure on the part of any party to exercise, and no delay in
exercising, any right under this Agreement, and no course of dealing between or
among the parties to this Agreement, shall operate as a waiver thereof by such
party. No single or partial exercise of any right under this Agreement shall
preclude any other or further exercise thereof or the exercise of any other
right. No course of dealing between or among the parties hereto shall operate as
an amendment of this Agreement.
f. This Agreement, including the Schedules hereto, constitutes the
entire agreement among the parties hereto with respect to the subject matter
hereof. There are no restrictions, promises, warranties, or undertakings, other
than those set forth or referred to herein.
-26-
27
This Agreement, including the Schedules hereto, supersedes all prior agreements
and understandings, whether written or oral among the parties hereto with
respect to the subject matter hereof. This Agreement and the terms and
provisions hereof are for the sole benefit of the Company, the Holders and their
respective successors and permitted assigns.
g. Any notices required or permitted to be given under the terms of
this Agreement shall be sent by mail or delivered personally (which shall
include telephone line facsimile transmission) or by courier and shall be
effective five days after being placed in the mail, if mailed, or upon receipt,
if delivered personally or by courier, in the case of the Company addressed to
the Company at 000 Xxxx Xxxxx Xxxxxx, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000,
Attention: President and Chief Executive Officer (telephone line facsimile
transmission number (000) 000-0000) and a copy shall also be given to: Xxxxxxx,
Xxxxxxx & Xxxxxxxx LLP, Two Embarcadero Place, 0000 Xxxx Xxxx, Xxxx Xxxx,
Xxxxxxxxxx 00000-0000, Attention: J. Xxxxxxx Xxxxxxxxx, Esq. (telephone line
facsimile transmission number (000) 000-0000) or, in the case of any Holder, at
its address or telephone line facsimile transmission number in effect on the
date of execution and delivery of this Agreement for purposes of the applicable
Note Purchase Agreement to which such Holder is a party, or such other address
as a Company shall have provided by notice to the Holders or any Holder shall
have provided by notice to the Company in accordance with this provision. Each
Holder hereby designates as its address for any notice required or permitted to
be given to such Holder pursuant to the Certificate of Designation the address
of such Holder as provided in this Section 9.g., until such Holder shall
designate another address for such purpose.
h. Each party to this Agreement will perform any and all acts and
execute any and all documents as may be necessary and proper under the
circumstances in order to accomplish the intents and purposes of this Agreement
and to carry out its provisions.
i. The rights of any Holder or any other Investor under Sections 3,
7 and 9 shall be automatically assigned by such Holder or other Investor to any
transferee of all or any portion of such Investor's Registrable Securities (or
all or any portion of the shares of Series D Preferred or Warrants) only if: (1)
such Investor agrees in writing with the transferee or assignee to assign such
rights, and a copy of such agreement is furnished to the Company within a
reasonable time after such assignment, (2) the Company is, within a reasonable
time after such transfer or assignment, furnished with written notice of (A) the
name and address of such transferee or assignee and (B) the securities with
respect to which such registration rights are being transferred or assigned, (3)
in the case of any transfer of rights under Section 3, immediately following
such transfer or assignment the further disposition of such securities by the
transferee or assignee is restricted under the 1933 Act and applicable state
securities laws, and (4) at or before the time the Company received the written
notice contemplated by clause (2) of this sentence the transferee or assignee
agrees in writing with the Company to be bound by all of the provisions
contained in Sections 3, 7 and 9. Upon any such assignment, the Company shall be
obligated to such transferee to perform all of its covenants under Sections 3, 7
and 9 of this Agreement as if such transferee were a Holder. In connection with
any such assignment the Company shall, at its sole cost and expense, promptly
after such assignment take such actions as shall be reasonably acceptable to the
Holder or other assigning Investor and such assignee to assure that all
Registration Statements and related Prospectuses are available for use by such
-28-
28
transferee for sales of the Registrable Securities in respect of which the
rights to registration have been so assigned.
j. The Company and each Holder shall be responsible for their
expenses (including, without limitation, the respective legal fees and expenses
of their counsel) incurred by them in connection with the negotiation and
execution of, and closing under, this Agreement, except that the Company will
pay or reimburse such expenses of the Holders not in excess of $15,000 (in
addition to the obligation of the Company for payment of legal fees for the
opinion contemplated by Sections 6.a.(4) and 6.b.(11)). All expenses incurred in
connection with securities registrations, filings or qualifications pursuant to
this Agreement shall be paid by the Company, including, without limitation, all
registration, listing and qualifications fees, printers and accounting fees and
the fees and disbursements of counsel for the Company, but excluding (a) fees
and expenses of investment bankers retained by any Investor, (b) brokerage
commissions incurred by any Investors and (c), except as otherwise specifically
provided in the next succeeding sentence, fees and disbursements of counsel for
the Investors. The Company shall pay on demand all expenses incurred by the
Holders, including reasonable attorneys' fees and expenses, as a consequence of,
or in connection with (1) any default or breach of any of the Company's
obligations set forth in any of the Transaction Documents and (2) the
enforcement or restructuring of any right of, including the collection of any
payments due, any Holder under any of the Transaction Documents, including any
action or proceeding relating to such enforcement or any order, injunction or
other process seeking to restrain the Company from paying any amount due to any
Holder.
k. Each Holder shall have the right to terminate this Agreement by
giving notice to the Company at any time at or prior to the time of the Closing
if:
(1) the Company shall have failed, refused, or been unable at
or prior to the date of such termination of this Agreement to perform any of its
material obligations hereunder;
(2) any other condition of such Holder's obligations hereunder
is not fulfilled; or
(3) the Closing shall not have occurred on a date on or before
December 14, 1998, other than solely by reason of a breach of this Agreement by
such Holder.
Any such termination shall be effective upon the giving of notice
thereof by a Holder. Upon such termination, the terminating Holder shall have no
further obligation to the Company hereunder and the Company shall remain liable
for any breach of this Agreement or the other documents contemplated hereby
which occurred on or prior to the date of such termination.
l. The language used in this Agreement will be deemed to be the
language chosen by the parties to express their mutual intent, and no rules of
strict construction will be applied against any party.
-28-
29
m. All representations, warranties and agreements of the Company and
of the Holders contained herein or in any of the other Transaction Documents
will survive the execution and delivery hereof and the Closing hereunder and
delivery of the Notes and issuance of the shares of Series D Preferred in
exchange therefor, and shall remain operative and in full force and effect
regardless of any investigation made by or on behalf of any Holder or any person
who controls any Holder within the meaning of the 1933 Act, or by or on behalf
of the Company or any person who controls the Company within the meaning of the
1933 Act.
-29-
30
IN WITNESS WHEREOF, the parties hereto have caused their duly
authorized officers or other representatives to execute and deliver this
Agreement as of the date first above written.
SHAMAN PHARMACEUTICALS, INC.
By: /s/ Xxxx X. Xxxxx
--------------------------------------
Name: Xxxx X. Xxxxx
Title: President and Chief
Executive Officer
DELTA OPPORTUNITY FUND, LTD.
By: /s/ Xxxxx X. Xxxx
--------------------------------------
Name: Xxxxx X. Xxxx
Title: Director
XXXX & XXXXXXXX GROUP, LLC
By: /s/ Xxxxxx X. Xxxxxxxx
--------------------------------------
Name: Xxxxxx X. Xxxxxxxx, Xx.
Title:
NP PARTNERS
By: /s/ Xxxxxxx X. Simpler
--------------------------------------
Name: Xxxxxxx X. Simpler
Title: Authorized Signatory
OLYMPUS SECURITIES, LTD.
By: /s/ Xxxxxxx X. Simpler
--------------------------------------
Name: Xxxxxxx X. Simpler
Title: Authorized Signatory
31
OMICRON PARTNERS, L.P.
BY: OMICRON CAPITAL, L.P., SUBADVISOR
By: /s/ Xxxxxxx X. Xxxxxx
--------------------------------------
Name: Xxxxxxx X. Xxxxxx
Title: Authorized Signatory
OTATO LIMITED PARTNERSHIP
BY: OTA GRAND CAYMAN
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------------
Name: Xxxxxxx X. Xxxxx
Title: General Counsel
OVERBROOK FUND I, LLC
By: /s/ Xxxxxx X. Xxxxxxxx
---------------------------------------
Name: Xxxxxx X. Xxxxxxxx, Xx.
Title: Managing Member
32
SCHEDULE A
Outstanding Note Amount and Shares of Series D Preferred
Note Amount Number of Shares
Name of Holder (Principal and Interest) of Series D Preferred
-------------- ------------------------ ---------------------
Delta Opportunity Fund, Ltd. $1,566,201.38 1,566
NP Partners $1,055,410.56 1,055
Olympus Securities, Ltd. $1,055,410.56 1,055
Omicron Partners, L.P. $ 625,032.49 625
OTATO Limited Partnership $ 291,307.93 291
Overbrook Fund I, LLC $ 192,862.50 192
Registrable Securities and Warrants
Number of Number of
Name of Holder Warrant Shares Registrable Securities
-------------- -------------- ----------------------
Delta Opportunity Fund, Ltd. 281,682 281,682
NP Partners 150,000 150,000
Olympus Securities, Ltd. 150,000 150,000
Omicron Partners, L.P. 98,761 98,761
OTATO Limited Partnership 52,334 52,334
Overbrook Fund I, LLC 34,691 34,691
A-1
33
SCHEDULE B
Form of Certificate of Designation
B-1
34
SHAMAN PHARMACEUTICALS, INC.
CERTIFICATE OF DESIGNATION
OF
SERIES D CONVERTIBLE PREFERRED STOCK
(Pursuant to Section 151 of the General Corporation
Law of the State of Delaware)
--------------
Shaman Pharmaceuticals, Inc., a Delaware corporation (the
"Corporation"), in accordance with the provisions of Section 103 of the General
Corporation Law of the State of Delaware DOES HEREBY CERTIFY:
That pursuant to authority vested in the Board of Directors of
the Corporation (the "Board of Directors" or the "Board") by paragraph (B) of
Article IV of the Corporation's Amended and Restated Certificate of
Incorporation (the "Certificate"), the Board of Directors, at a meeting duly
called and held on October 20, 1998, adopted certain recitals and resolutions
providing for the creation of a series of the Corporation's Preferred Stock,
$0.001 par value, which series is designated "Series D Convertible Preferred
Stock", which recitals and resolution are as follows:
WHEREAS, the Certificate provides for a class of shares known as
Preferred Stock, issuable from time to time in one or more series;
WHEREAS, the Board is granted the power in the Certificate to
determine the powers, rights, preferences, qualifications, limitations and
restrictions granted to or imposed upon any wholly unissued series of Preferred
Stock, to fix the number of shares constituting any such series, and to
determine the designation thereof;
WHEREAS, the Board of Directors of the Corporation desires,
pursuant to its authority as aforesaid, to determine and fix the powers, rights,
preferences, qualifications, limitations and restrictions relating to a new
series of Preferred Stock, designated Series D Preferred Stock, and the number
of shares constituting such series:
NOW, THEREFORE, BE IT RESOLVED, that pursuant to the authority
vested in the Board of Directors of the Corporation in accordance with the
provisions of the Certificate, the Board of Directors does hereby create a
series of Preferred Stock, par value $0.001 per share (hereinafter called the
"Preferred Stock"), of the Corporation, and the Board of Directors hereby fixes
and determines the designation of, the number of shares constituting, and the
rights, preferences, privileges and restrictions relating to, such series of
Preferred Stock as follows:
35
SERIES D CONVERTIBLE PREFERRED STOCK
1. CERTAIN DEFINED TERMS.
(a) All the agreements or instruments defined in this
Certificate of Designation shall mean such agreements or instruments as the same
may from time to time be supplemented or amended or the terms thereof waived or
modified to the extent permitted by, and in accordance with, the terms thereof
and of this Certificate of Designation.
(b) The following terms shall have the following meanings
(such meanings to be equally applicable to both the singular and plural forms of
the terms defined):
"Adjustment Notice" means an Adjustment Notice substantially in the
form set forth in Section 13(f).
"Affiliate" means, with respect to any Person, any other Person that
directly, or indirectly through one or more intermediaries, controls, is
controlled by, or is under common control with, the subject Person. For purposes
of the term "Affiliate," the term "control" (including the terms "controlling,"
"controlled by" and "under common control with") means the possession, direct or
indirect, of the power to direct or to cause the direction of the management and
policies of a Person, whether through the ownership of securities, by contract
or otherwise.
"Aggregated Person" means, with respect to any holder of shares of
Series D Preferred Stock, any Person whose beneficial ownership of shares of
Common Stock would be aggregated with such holder's beneficial ownership of
shares of Common Stock for purposes of Section 13(d) of the 1934 Act and
Regulation 13D-G thereunder.
"AMEX" means the American Stock Exchange, Inc.
"Arrearage Interest" means interest at the rate of 12% per annum on
any dividend on shares of Series D Preferred Stock which dividend is not paid on
a Dividend Payment Date, whether or not declared, from such Dividend Payment
Date.
"Auditors" means Ernst & Young LLP or such other firm of independent
public accountants of recognized national standing as shall have been engaged by
the Corporation to audit its financial statements.
"Auditors' Determination" means a determination requested by the
Corporation and signed by the Auditors concurring with the Corporation's
conclusion that a requirement of the Corporation to redeem, or a right of any
holder of shares of Series D Preferred Stock to require redemption of, shares of
Series D Preferred Stock by reason of the occurrence of a specified Optional
Redemption Event which occurs by reason of an event described in clause (1), (2)
or (3) of the definition of Optional Redemption Event would result in the
Corporation being required to classify the Series D Preferred Stock as
redeemable preferred stock on a balance sheet of the Corporation in accordance
with Generally Accepted Accounting Principles. The Auditors' Determination shall
(i) set forth in reasonable detail all relevant facts considered by the Auditors
in connection therewith, (ii) set forth all applicable accounting principles and
assumptions used,
2
36
and (iii) set forth in reasonable detail or attach copies of all legal, expert
and other advice or information used by the Auditors in reaching their
conclusion. To the extent any facts are assumed for purposes of either the
Corporation's conclusion or the Auditor's Determination, the validity of such
conclusion or determination shall depend upon such assumed facts being true and
complete in all material respects.
"Blackout Period" means the period of up to 20 consecutive days
after the date the Corporation notifies the holders of shares of Series D
Preferred Stock that they are required, pursuant to Section 3.c.(4) of the
Exchange Agreement, to suspend offers and sales of Registrable Securities as a
result of an event or circumstance described in Section 3.b.(5)(A) of the
Exchange Agreement, which period commences after the date which is 90 days after
the date of the Closing and during which period, by reason of Section 3.b.(5)(B)
of the Exchange Agreement, the Corporation is not required to amend any
Registration Statement or to supplement the Prospectus relating to any
Registration Statement; provided, however, that such period may be up to 30
consecutive days if the Corporation so elects in accordance with Section
3.b.(5)(B) of the Exchange Agreement, subject to the limitations provided
therein.
"Board of Directors" or "Board" means the Board of Directors of the
Corporation.
"Business Combination Redemption Percentage" means 118% with respect
to a redemption of shares of Series D Preferred Stock in accordance with Section
9(b)(6).
"Business Combination Redemption Price" means an amount in cash
equal to the product obtained by multiplying (A) the sum of (i) $1,000 plus (ii)
an amount equal to the accrued but unpaid dividends on the share of Series D
Preferred Stock to be redeemed and any Arrearage Interest on dividends thereon
in arrears to the date of payment of the redemption price pursuant to Section
9(b)(6) times (B) the Business Combination Redemption Percentage.
"Business Day" means any day other than a Saturday, Sunday or other
day on which commercial banks in The City of New York are authorized or required
by law to remain closed.
"Cash and Cash Equivalent Balances" of any Person on any date shall
be determined from such Person's books maintained in accordance with Generally
Accepted Accounting Principles, and means, without duplication, the sum of (1)
the cash accrued by such Person and its subsidiaries on a consolidated basis on
such date and available for use by such Person and its subsidiaries on such date
and (2) all assets which would, on a consolidated balance sheet of such Person
and its subsidiaries prepared as of such date in accordance with Generally
Accepted Accounting Principles, be classified as cash or cash equivalents.
"Common Stock" means the Common Stock, $0.001 par value, of the
Corporation or any shares of capital stock into which such stock shall be
changed or reclassified after the Issuance Date.
"Control Notice" means a Control Notice substantially in the form
set forth in Section 13(e).
3
37
"Conversion Agent" means BankBoston, N.A., as Conversion Agent
for the Series D Preferred Stock.
"Conversion Date" means the date on which a Conversion Notice is
actually received by the Conversion Agent, whether by mail, courier, personal
service, telephone line facsimile transmission or other means, in case of a
conversion of shares of Series D Preferred Stock pursuant to Section 9(a).
"Conversion Notice" means a Notice of Conversion of Series D
Convertible Preferred Stock substantially in the form set forth in Section
13(a).
"Conversion Price" means the lesser of (a) $1.125 per share
(subject to equitable adjustments from time to time on terms reasonably
acceptable to the Majority Holders for (i) stock splits, (ii) stock dividends,
(iii) combinations, (iv) capital reorganizations, (v) issuance to all holders of
Common Stock of rights or warrants to purchase shares of Common Stock, (vi)
distribution by the Corporation to all holders of Common Stock of evidences of
indebtedness of the Corporation or cash (other than regular quarterly cash
dividends), (vii) Tender Offers by the Corporation or any Subsidiary for, or
other repurchases of shares of, Common Stock in one or more transactions which,
individually or in the aggregate, result in the purchase of more than 10% of the
Common Stock outstanding, and (viii) similar events relating to the Common
Stock, in each case which occur, or with respect to which "ex-" trading of the
Common Stock begins, on or after the date this Certificate of Designation is
filed with the Secretary of State of the State of Delaware and on or before the
applicable Conversion Date) and (b) on any Conversion Date, 90% of the lowest
per share Trading Price during the applicable Measurement Period for such
Conversion Date in a trade in which neither the Holder nor any of its Affiliates
was the seller, subject to adjustment in the case of such clause (a) and clause
(b) in accordance with Section 10(b).
"Converted Restriction Amount" means on any date of determination a
number of shares of Common Stock equal to 4.9% of the shares of Common Stock
outstanding on such date.
"Corporation Notice" means a Corporation Notice substantially in the
form set forth in Section 13(c).
"Dividend Payment Date" means each February 1, May 1, August 1 and
November 1.
"Exchange Agreement" means the Exchange Agreement, dated as of
December 10, 1998, by and between the Corporation and the several original
holders of the Senior Subordinated Convertible Notes pursuant to which such
Senior Subordinated Convertible Notes will be exchanged for shares of Series D
Preferred Stock.
"Generally Accepted Accounting Principles" for any Person means the
generally accepted accounting principles and practices applied by such Person
from time to time in the preparation of its audited financial statements.
4
38
"Holder Notice" means a Holder Notice substantially in the form set
forth in Section 13(d).
"Indebtedness" as used in reference to any Person means all
indebtedness of such Person for borrowed money, the deferred purchase price of
property, goods and services and obligations under leases which are required to
be capitalized in accordance with Generally Accepted Accounting Principles and
shall include all such indebtedness guaranteed in any manner by such Person or
in effect guaranteed by such Person through a contingent agreement to purchase
and all indebtedness for the payment or purchase of which such Person has
contingently agreed to advance or supply funds and all indebtedness secured by
mortgage or other lien upon property owned by such Person, although such Person
has not assumed or become liable for the payment of such indebtedness, and, for
all purposes hereof, such indebtedness shall be treated as though it has been
assumed by such Person.
"Initial Reserve Amount" means 6,285,000 shares of Common Stock
reserved by the Corporation for issuance upon conversion of the shares of Series
D Preferred Stock.
"Issuance Date" means the date of original issuance of the shares of
Series D Preferred Stock pursuant to the Exchange Agreement.
"Junior Dividend Stock" means, collectively, the Series A Preferred
Stock, the Common Stock and any other class or series of capital stock of the
Corporation ranking junior as to dividends to the Series D Preferred Stock.
"Junior Liquidation Stock" means, collectively, the Series A
Preferred Stock, the Common Stock and any other class or series of capital stock
of the Corporation ranking junior as to liquidation rights to the Series D
Preferred Stock.
"Liquidation Preference" means, for each share of Series D Preferred
Stock, the sum of (i) $1,000, plus (ii) an amount equal to the accrued but
unpaid dividends and any Arrearage Interest on dividends thereon in arrears with
respect to each such share to the date of final distribution to the holders of
shares of Series D Preferred Stock in connection with the liquidation,
dissolution or winding up of the Corporation.
"Majority Holders" means at any time the holders of shares of Series
D Preferred Stock which shares constitute a majority of the outstanding shares
of Series D Preferred Stock outstanding at such time.
"Market Price" of any security on any date means the closing bid
price of such security on such date on the Nasdaq or such other securities
exchange or other market on which such security is listed for trading which
constitutes the principal securities market for such security, as reported by
Bloomberg, L.P.
"Measurement Period" means with respect to any Conversion Date, the
period consisting of 12 consecutive Trading Days ending on and including the
Trading Day immediately preceding such Conversion Date.
5
39
"Nasdaq" means The Nasdaq National Market.
"Nasdaq SmallCap" means The Nasdaq SmallCap Market.
"1934 Act" means the Securities Exchange Act of 1934, as amended.
"1933 Act" means the Securities Act of 1933, as amended.
"NYSE" means the New York Stock Exchange, Inc.
"Optional Redemption Date" means the date which is three Business
Days after a holder of shares of Series D Preferred Stock who is entitled to
redemption rights under Section 10(a) and 10(b) gives a Holder Notice.
"Optional Redemption Event" means any one of the following events:
(1) For any period of five consecutive Trading Days following
the Issuance Date there shall be no reported sale price of the Common Stock on
any of the Nasdaq, the Nasdaq SmallCap, the NYSE or the AMEX;
(2) The Common Stock ceases to be listed for trading on the
Nasdaq, the Nasdaq SmallCap, the NYSE or the AMEX;
(3) Any consolidation or merger of the Corporation or any
subsidiary of the Corporation with or into another entity or other business
combination transaction involving the Corporation or any subsidiary of the
Corporation (other than a merger or consolidation of a subsidiary of the
Corporation into the Corporation or a wholly-owned subsidiary of the
Corporation) where the stockholders of the Corporation immediately prior to such
transaction do not collectively own at least 51% of the outstanding voting
securities of the surviving corporation of such transaction immediately
following such transaction or the common stock of such surviving corporation is
not listed for trading on the Nasdaq, the Nasdaq SmallCap, the NYSE or the AMEX;
or the sale of all or substantially all of the assets of the Corporation and its
subsidiaries;
(4) The adoption of any amendment to the Certificate of
Incorporation of the Corporation (other than any certificate designating a
series of preferred stock of the Corporation which does not contravene the
rights of the holders of shares of Series D Preferred Stock) which materially
and adversely affects the rights of the holders of shares of Series D Preferred
Stock in respect of their interest in the Common Stock in a different and more
adverse manner than it affects the rights of holders of Common Stock generally
or the taking of any other action which materially and adversely affects the
rights of the holders of Series D Preferred Stock;
(5) The inability of any holder of shares of Series D
Preferred Stock for (x) (i) 20 days (whether or not consecutive) or (ii) if in
accordance with Section 3.b.(5)(B) of the Exchange Agreement the Corporation
elects a Blackout Period of up to 30 consecutive days
6
40
which commences more than 90 days after the Issuance Date, such greater number
of days as shall equal the number of days the Blackout Period so elected is in
effect (but in no event more than 30 days), in either the case of such clause
(i) or such clause (ii) during the period commencing on the Issuance Date and
ending on the first anniversary of the Issuance Date or (y) 60 days (whether or
not consecutive) subsequent to August 29, 1997, to sell shares of Common Stock
issued or issuable upon conversion of shares of Series D Preferred Stock
pursuant to any Registration Statement (1) by reason of the requirements of the
1933 Act, the 1934 Act or any of the rules or regulations under either thereof
or (2) due to such Registration Statement containing any untrue statement of
material fact or omitting to state a material fact required to be stated therein
or necessary to make the statements therein not misleading or any other failure
of such Registration Statement to comply with the rules and regulations of the
SEC; or
(6) The Corporation shall fail or default in the timely
performance of any material obligation to a holder of shares of Series D
Preferred Stock under the terms of this Certificate of Designation or under the
Exchange Agreement or any other agreement or document entered into in connection
with the issuance of shares of Series D Preferred Stock, as such agreements and
instruments may be amended from time to time.
"Optional Redemption Percentage" means 118%.
"Optional Redemption Price" means an amount in cash equal to the
product obtained by multiplying (a) the sum of (i) $1,000 plus (ii) an amount
equal to the accrued but unpaid dividends on the share of Series D Preferred
Stock to be redeemed and any Arrearage Interest on dividends thereon in arrears
to the applicable Optional Redemption Date times (b) the Optional Redemption
Percentage.
"Parity Dividend Stock" means any class or series or the
Corporation's capital stock ranking, as to dividends, on a parity with the
Series D Preferred Stock.
"Parity Liquidation Stock" means any class or series of the
Corporation's capital stock ranking, as to liquidation rights, on a parity with
the Series D Preferred Stock.
"Permitted Indebtedness" means (i) Indebtedness which is outstanding
and which would be reflected on a balance sheet of the Corporation as of the
Issuance Date prepared in accordance with Generally Accepted Accounting
Principles and (ii) Indebtedness incurred to finance (A) inventory or (B) the
lease or purchase of equipment (which Indebtedness shall be secured by such
equipment) used in the Corporation's business, the outstanding amount thereof
which does not exceed $10,000,000 during the first year after the Issuance Date,
$15,000,000 during the second year after the Issuance Date and $30,000,000
during the third year after the Issuance Date.
"Person" means an individual, partnership, corporation, limited
liability company, trust, incorporated organization, unincorporated association,
joint stock company, government, governmental agency or political subdivision.
"Redemption Date" means December 30, 1998.
7
41
"Redemption Notice" means a Redemption Notice substantially in the
form set forth in Section 13(d).
"Redemption Price" means an amount in cash equal to the product
obtained by multiplying (i) the sum of (A) $1,000 plus (B) an amount equal to
the accrued but unpaid dividends on such share of Series D Preferred Stock to be
redeemed and any Arrearage Interest on dividends thereon in arrears to the date
of payment of the Redemption Price times (ii) 130%.
"Registrable Securities" means the shares of Common Stock issuable
upon conversion of shares of Series D Preferred Stock and the shares of Common
Stock issuable as dividends on the Series D Preferred Stock, and any stock or
other securities into which or for which the Common Stock may hereafter be
changed, converted or exchanged by the Corporation or its successor, as the case
may be, and any other securities issued to holders of such Common Stock (or such
shares into which or for which such shares are so changed, converted or
exchanged) upon any reclassification, share combination, share subdivision,
share dividend, merger, consolidation or similar transaction or event.
"Registration Statement" shall have the meaning provided in the
Exchange Agreement.
"SEC" means the United States Securities and Exchange Commission.
"Senior Dividend Stock" means the Series C Preferred Stock of the
Corporation and any other class or series of capital stock of the Corporation
ranking senior as to dividends to the Series D Preferred Stock.
"Senior Liquidation Stock" means the Series C Preferred Stock of the
Corporation and any other class or series of capital stock of the Corporation
ranking senior as to liquidation rights to the Series D Preferred Stock.
"Series D Preferred Stock" means the Series D Convertible Preferred
Stock of the Corporation.
"Stockholder Approval" shall have the meaning provided in the
Exchange Agreement.
"Tender Offer" means a tender offer or exchange offer.
"Trading Day" means a day on whichever of (x) the national
securities exchange or (y) the Nasdaq which at the time constitutes the
principal securities market for the Common Stock is open for general trading of
securities.
"Trading Price" on any date means the lowest sale price (regular
way) for one share of the Common Stock on such date, on the first applicable
among the following: (a) the national securities exchange on which the shares of
Common Stock are listed which constitutes the principal securities market for
the Common Stock, (b) Nasdaq, (c) Nasdaq SmallCap or (d)
8
42
such other securities market which constitutes the principal securities market
for the Common Stock, in any such case as reported by Bloomberg, L.P. or if no
such sale prices are so reported, then the representative bid price of the
Common Stock as quoted by a broker or dealer which is a member firm of the NASD
(in each such case subject to equitable adjustment from time to time on terms
reasonably acceptable to the Majority Holders for (i) stock splits, (ii) stock
dividends, (iii) combinations, (iv) capital reorganizations, (v) issuance to all
holders of Common Stock of rights or warrants to purchase shares of Common Stock
at a price per share less than the Trading Price which would otherwise be
applicable, (vi) the distribution by the Corporation to all holders of Common
Stock of evidences of indebtedness of the Corporation or cash (other than
regular quarterly cash dividends), (vii) Tender Offers by the Corporation or any
subsidiary of the Corporation or other repurchases of shares of Common Stock in
one or more transactions which, individually or in the aggregate, result in the
purchase of more than 10% of the Common Stock outstanding, and (viii) similar
events relating to the Common Stock, in each such case which occur on or after
the Issuance Date); provided, however, that if on any Trading Day there shall be
no reported sale price (regular way) of such security, the "Trading Price" on
such Trading Day shall be the lowest sale price (regular way) of such security
on the Trading Day next preceding such Trading Day on which a sale price
(regular way) for such security has been so reported.
2. DESIGNATION AND AMOUNT. The shares of such series shall be
designated as "Series D Convertible Preferred Stock", and the number of shares
constituting the Series D Preferred Stock shall be 6,285 and shall not be
subject to increase. The Corporation shall not issue any shares of Series D
Preferred Stock after the Issuance Date, except that on or prior to May 31, 1999
the Corporation may issue up to 1,500 shares of Series D Preferred Stock (and no
more) to MMC/GATX in exchange for indebtedness of the Corporation to MMC/GATX on
a basis of one share of Series D Preferred Stock for each $1,000 of such
indebtedness.
3. SERIES D PREFERRED STOCK CAPITAL. The amount to be represented in
the capital account for the Series D Preferred Stock at all times for each
outstanding share of Series D Preferred Stock shall be an amount at least equal
to the sum of (1) $1,000 plus (2) to the extent that the Corporation has surplus
in its capital account, an amount equal to the accrued but unpaid dividends on
such share of Series D Preferred Stock and any Arrearage Interest on dividends
thereon in arrears to the date of determination plus (3) to the extent that the
Corporation has surplus in its capital account, an amount equal to the product
obtained by multiplying (a) the sum of (1) $1,000 plus (2) an amount equal to
the accrued but unpaid dividends on such share of Series D Preferred Stock and
any Arrearage Interest on dividends thereon in arrears to the date of
determination times (b) 18%. Upon original issuance of each share of Series D
Preferred Stock, an amount equal to $1,000 shall be credited to the Series D
Preferred Stock capital account of the Corporation and, to the extent at such
time the Corporation has surplus in its capital account, an amount equal to the
amount specified in the preceding clause (3) (or so much thereof as is in
surplus) shall be transferred from surplus to the Series D Preferred Stock
capital account. If at any time the Corporation shall have credited to the
Series D Preferred Stock capital account less than the full amount required by
the preceding clauses (1) through (3), then (x) if at any time thereafter the
Corporation has surplus in its capital account, the Corporation immediately
shall transfer surplus to the Series D Preferred Stock capital account to the
extent available and necessary to satisfy the requirements of the preceding
clauses (1) through (3), (y)
9
43
notwithstanding the particular shares of Series D Preferred Stock in respect of
which an amount in excess of $1,000 per share of Series D Preferred Stock shall
have been transferred to the Series D Preferred Stock capital account, any
amount in excess of $1,000 for each outstanding share of Series D Preferred
Stock shall be treated as Series D Preferred Stock capital pro rata for all
outstanding shares of Series D Preferred Stock and (z) upon any conversion of a
share of Series D Preferred Stock, an amount equal to $0.001 per share of Common
Stock issued upon such conversion shall be credited to the Common Stock capital
account and the balance in the Series D Preferred Stock capital account in
respect of such converted share of Series D Preferred Stock shall be retained in
the Series D Preferred Stock capital account, to the extent required under the
preceding clauses (1) through (3). Nothing in this Section 3 shall require the
Corporation in a balance sheet prepared in accordance with Generally Accepted
Accounting Principles to reflect more than $1,000 per share in Series D
Preferred Stock capital for purposes of such balance sheet, if such presentation
would not be in accordance with Generally Accepted Accounting Principles, so
long as the notes to any such balance sheet make adequate disclosure of the
requirements of this Section 3 and the capital accounts of the Corporation for
purposes of the General Corporation Law of the State of Delaware.
4. RANK. The shares of Series D Preferred Stock shall rank junior to
the Series C Preferred Stock of the Corporation, but senior to the Series A
Preferred Stock and the Common Stock of the Corporation, and senior to any
shares of any other series of Preferred Stock or any shares of any other class
of preferred stock of the Corporation, now issued or hereafter issued (unless
otherwise consented to in writing by the Majority Holders in advance of the
issuance thereof), as to payment of dividends and distribution of assets upon
liquidation, dissolution, or winding up of the Corporation, whether voluntary or
involuntary.
5. DIVIDENDS AND DISTRIBUTIONS.
(a) The holders of shares of Series D Preferred Stock shall be
entitled to receive, when, as, and if declared by the Board of Directors out of
funds legally available for such purpose, dividends at the rate of $55 per annum
per share, and no more (except as otherwise provided herein), which shall be
fully cumulative, shall accrue without interest (except as otherwise provided
herein as to dividends in arrears) from the date of original issuance of each
share of Series D Preferred Stock and shall be payable quarterly on each
Dividend Payment Date of each year commencing February 1, 1999 (except that if
any such date is not a Business Day, then such dividend shall be payable on the
next succeeding day that is a Business Day) to holders of record as they appear
on the stock books of the Corporation on such record dates, not more than ten
nor less than five days preceding the payment dates for such dividends, as shall
be fixed by the Board. Notwithstanding any other provision hereof, the rate of
dividends on the shares of Series D Preferred Stock shall be subject to increase
in accordance with Section 10(b)(4).
Dividends on the Series D Preferred Stock shall be paid in cash or,
subject to the limitations in Section 5(b), shares of Common Stock or any
combination of cash and shares of Common Stock, at the option of the Corporation
as hereinafter provided. The amount of the dividends payable per share of Series
D Preferred Stock for each quarterly dividend period shall be computed by
dividing the annual dividend amount by four. The amount of dividends payable
10
44
for the initial dividend period and any period shorter than a full quarterly
dividend period shall be computed on the basis of a 360-day year of twelve
30-day months. Dividends not paid on a Dividend Payment Date, whether or not
such dividends have been declared, will bear Arrearage Interest until paid. No
dividends or other distributions, other than dividends payable solely in shares
of any Junior Dividend Stock, shall be paid or set apart for payment on any
shares of Junior Dividend Stock, and no purchase, redemption, or other
acquisition shall be made by the Corporation of any shares of Junior Dividend
Stock unless and until all accrued and unpaid dividends on the Series D
Preferred Stock and Arrearage Interest on dividends in arrears at the rate
specified herein shall have been paid or declared and set apart for payment.
If at any time any dividend on any Senior Dividend Stock shall be in
default, in whole or in part, no dividend shall be paid or declared and set
apart for payment on the Series D Preferred Stock unless and until all accrued
and unpaid dividends with respect to the Senior Dividend Stock, including the
full dividends for the then current dividend period, shall have been paid or
declared and set apart for payment, without interest. No full dividends shall be
paid or declared and set apart for payment on any Parity Dividend Stock for any
period unless all accrued but unpaid dividends (and Arrearage Interest on
dividends in arrears) have been, or contemporaneously are, paid or declared and
set apart for such payment on the Series D Preferred Stock. No full dividends
shall be paid or declared and set apart for payment on the Series D Preferred
Stock for any period unless all accrued but unpaid dividends have been, or
contemporaneously are, paid or declared and set apart for payment on the Parity
Dividend Stock for all dividend periods terminating on or prior to the date of
payment of such full dividends. When dividends are not paid in full upon the
Series D Preferred Stock and the Parity Dividend Stock, all dividends paid or
declared and set apart for payment upon shares of Series D Preferred Stock (and
Arrearage Interest on dividends in arrears) and the Parity Dividend Stock shall
be paid or declared and set apart for payment pro rata, so that the amount of
dividends paid or declared and set apart for payment per share on the Series D
Preferred Stock and the Parity Dividend Stock shall in all cases bear to each
other the same ratio that accrued and unpaid dividends per share on the shares
of Series D Preferred Stock and the Parity Dividend Stock bear to each other.
Any references to "distribution" contained in this Section 5 shall
not be deemed to include any stock dividend or distributions made in connection
with any liquidation, dissolution, or winding up of the Corporation, whether
voluntary or involuntary.
(b) If the Corporation elects in the exercise of its sole
discretion to issue shares of Common Stock in payment of dividends on the Series
D Preferred Stock with respect to any Dividend Payment Date, the Corporation
shall (1) give notice to the holders of the Series D Preferred Stock at least 14
days prior to the applicable Dividend Payment Date of the Corporation's election
to exercise such right and (2) deliver, or cause to be delivered, by the third
Trading Day after such Dividend Payment Date to each holder of such shares the
number of whole shares of Common Stock arrived at by dividing the per share
Conversion Price (determined as if the applicable Dividend Payment Date were a
Conversion Date) of such shares of Common Stock into the total amount of cash
dividends such holder would be entitled to receive if the aggregate dividends on
the Series D Preferred Stock held by such holder which are
11
45
being paid in shares of Common Stock were being paid in cash; provided, however,
that if shares of Common Stock for such dividend are not delivered to holders of
Series D Preferred Stock on or prior to the third Trading Day after a Dividend
Payment Date, then the Corporation shall not be entitled to pay such dividend in
shares of Common Stock and such dividend, together with Arrearage Interest from
the applicable Dividend Payment Date, shall be payable solely in cash. No
fractional shares of Common Stock shall be issued in payment of dividends. In
lieu thereof, the Corporation shall pay cash in an amount equal to the product
of (x) the Trading Price of the Common Stock for the 12 consecutive Trading Days
ending on and including the Trading Day immediately preceding such Dividend
Payment Date times (y) the fraction of a share of Common Stock which would
otherwise be issuable by the Corporation. The Corporation shall not exercise its
right to issue shares of Common Stock in payment of dividends on Series D
Preferred Stock if:
(1) the number of shares of Common Stock at the time
authorized, unissued and unreserved for all purposes, together with the number
of shares of Common Stock held in the Corporation's treasury, is insufficient to
pay the portion of such dividends to be paid in shares of Common Stock;
(2) the issuance or delivery of shares of Common Stock as a
dividend payment would require registration with or approval of any governmental
authority under any law or regulation, and such registration or approval has not
been effected or obtained;
(3) the shares of Common Stock to be issued as a dividend
payment have not been authorized for listing, upon official notice of issuance,
on any securities exchange or market on which the Common Stock is then listed;
or have not been approved for quotation if the Common Stock is traded in the
over-the-counter market;
(4) the Conversion Price (determined as if the applicable
Dividend Payment Date were a Conversion Date) is less than the par value of one
share of Common Stock;
(5) the shares of Common Stock to be issued as a dividend (A)
cannot be sold or transferred without restriction by holders of shares of Series
D Preferred Stock who receive such shares of Common Stock as a dividend payment
and who are not Affiliates of the Corporation or (B) are no longer listed on the
NYSE, the AMEX or the Nasdaq;
(6) the issuance of shares of Common Stock in payment of
dividends on Series D Preferred Stock held by any holder of shares of Series D
Preferred Stock would result in such holder (including all Aggregated Persons of
such holder) beneficially owning more than 4.9% of the Common Stock, determined
as provided in the proviso to the second sentence of Section 9(a)(1) or would
result in the issuance to such holder (including all Aggregated Persons of such
holder) of an aggregate number of shares of Common Stock upon conversion of
shares of Series D Preferred Stock or in payment of dividends on shares of
Series D Preferred Stock in excess of the 4.9% limitation provided in Section
9(a)(2);
(7) an Optional Redemption Event shall have occurred and on
the applicable Dividend Payment Date any holder of shares of Series D Preferred
Stock shall be
12
46
entitled to exercise optional redemption rights under Section 10 hereof by
reason of such Optional Redemption Event or shall have exercised such optional
redemption rights and the Corporation shall not have paid the applicable
Optional Redemption Price.
Shares of Common Stock issued in payment of dividends on Series D
Preferred Stock pursuant to this Section shall be, and for all purposes shall be
deemed to be, validly issued, fully paid and nonassessable shares of Common
Stock of the Corporation; the issuance and delivery thereof is hereby
authorized; and the dispatch in full thereof will be, and for all purposes shall
be deemed to be, payment in full of the cumulative dividends to which holders
are entitled on the applicable Dividend Payment Date.
(c) Neither the Corporation nor any subsidiary of the
Corporation shall (1) make any Tender Offer for outstanding shares of Common
Stock, unless the Corporation contemporaneously therewith makes an offer, or (2)
enter into an agreement regarding a Tender Offer for outstanding shares of
Common Stock by any Person other than the Corporation or any subsidiary of the
Corporation, unless such Person agrees with the Corporation to make an offer, in
either such case to each holder of outstanding shares of Series D Preferred
Stock to purchase for cash at the time of purchase in such Tender Offer the same
percentage of shares of Series D Preferred Stock held by such holder as the
percentage of outstanding shares of Common Stock offered to be purchased in such
Tender Offer at a price per share of Series D Preferred Stock equal to the
greater of (i) the quotient obtained by dividing (a) the sum of (1) $1,000 plus
(2) an amount equal to the accrued but unpaid dividends on such share of Series
D Preferred Stock and any Arrearage Interest on dividends thereon in arrears to
the date of purchase pursuant to this Section 5(c) by (b) 0.9 and (ii) an amount
equal to the product obtained by multiplying (x) the number of shares of Common
Stock which would, but for the purchase pursuant to such Tender Offer, be
issuable on conversion in accordance with Section 9(a) of one share of Series D
Preferred Stock if a Conversion Notice were given by the holder of such share of
Series D Preferred Stock on the date of purchase pursuant to such Tender Offer
(determined without regard to any limitation on beneficial ownership contained
in the second sentence of Section 9(a)(1) or in Section 9(a)(2) times (y) the
price per share of Common Stock offered in such Tender Offer.
6. LIQUIDATION PREFERENCE. In the event of a liquidation,
dissolution, or winding up of the Corporation, whether voluntary or involuntary,
the holders of Series D Preferred Stock shall be entitled to receive out of the
assets of the Corporation, whether such assets constitute stated capital or
surplus of any nature, an amount per share of Series D Preferred Stock equal to
the Liquidation Preference, and no more, before any payment shall be made or any
assets distributed to the holders of Junior Liquidation Stock; provided,
however, that such rights shall accrue to the holders of Series D Preferred
Stock only in the event that the Corporation's payments with respect to the
liquidation preference of the holders of Senior Liquidation Stock are fully met.
After the liquidation preferences of the Senior Liquidation Stock are fully met,
the entire assets of the Corporation available for distribution shall be
distributed ratably among the holders of the Series D Preferred Stock and any
Parity Liquidation Stock in proportion to the respective preferential amounts to
which each is entitled (but only to the extent of such preferential amounts).
After payment in full of the liquidation price of the
13
47
shares of the Series D Preferred Stock and the Parity Liquidation Stock, the
holders of such shares shall not be entitled to any further participation in any
distribution of assets by the Corporation. Neither a consolidation or merger of
the Corporation with another corporation nor a sale or transfer of all or part
of the Corporation's assets for cash, securities, or other property in and of
itself will be considered a liquidation, dissolution, or winding up of the
Corporation.
7. NO SINKING FUND. The shares of Series D Preferred Stock shall not
be entitled to the benefits of any sinking fund for the redemption or repurchase
of shares of Series D Preferred Stock.
8. REDEMPTION AT OPTION OF CORPORATION.
(a) Optional Redemption.
(1) So long as (x) the Corporation shall be in compliance in
all material respects with its obligations to the holders of the Series D
Preferred Stock (including, without limitation, its obligations under the
Exchange Agreement and this Certificate of Designation) and (y) on the date the
Corporation gives the Redemption Notice and on the Redemption Date, the
Corporation has Cash and Cash Equivalent Balances (excluding investment
securities) which are sufficient, after taking into account the Corporation's
cash requirements during the period from the date the Redemption Notice is given
to the Redemption Date, to pay the Redemption Price of the shares of Series D
Preferred Stock to be redeemed, the Corporation shall have the right to redeem
all or any part of the outstanding shares of Series D Preferred Stock pursuant
to this Section 8(a) at the Redemption Price. In order to exercise it right of
redemption under this Section 8(a), the Corporation shall give a Redemption
Notice to the holders of shares of Series D Preferred Stock not less than 20 or
more than 30 days prior to the Redemption Date.
(2) On the Redemption Date (or such later date as a holder of
shares of Series D Preferred Stock shall surrender to the Corporation the
certificate(s) for the shares of Series D Preferred Stock redeemed), the
Corporation shall pay to or upon the order of each holder of shares of Series D
Preferred Stock by wire transfer of immediately available funds to such account
as shall be specified for such purpose by such holder in an amount equal to the
Redemption Price of all of such holder's shares of Series D Preferred Stock to
be redeemed. A holder of shares of Series D Preferred Stock which are redeemed
pursuant to this Section 8(a) shall not be entitled to payment of the Redemption
Price of such shares of Series D Preferred Stock until such holder shall have
surrendered the certificate(s) for such shares of Series D Preferred Stock to
the Corporation or, in the case of the loss, theft or destruction of any such
certificate, given indemnity in accordance with Section 14(b). If the
Corporation shall fail to pay the Redemption Price of any shares of Series D
Preferred Stock in full when due, then the amount thereof shall bear interest to
the extent not prohibited by applicable law at the rate of 12% per annum from
the due date thereof until paid in full.
(3) Notwithstanding the giving of a Redemption Notice, each
holder of shares of Series D Preferred Stock shall be entitled to convert in
accordance with Section 9 any shares of Series D Preferred Stock which are to be
redeemed at any time prior to (1) the
14
48
Redemption Date or (2) if the Corporation fails to pay the Redemption Price in
full to such holder on the Redemption Date, the date on which the Corporation
pays the Redemption Price in full to such holder for all shares of Series D
Preferred Stock to be redeemed from such holder.
(4) Any redemption of shares of Series D Preferred Stock
pursuant to this Section 8(a) shall be made as nearly as practical pro rata from
all holders of shares of Series D Preferred Stock outstanding, subject to
reduction of the shares of Series D Preferred Stock to be redeemed from any
holder by reason of conversions of shares of Series D Preferred Stock of such
holder between the date the Redemption Notice is given and the Redemption Date.
(5) Upon receipt by the Corporation from a holder of shares of
Series D Preferred Stock of certificates for shares of Series D Preferred Stock
evidencing a greater number of shares of Series D Preferred Stock than the
number of shares of Series D Preferred Stock to be redeemed in accordance with
this Section 8(a), the Corporation shall, within three Trading Days after such
surrender, issue and deliver to or upon the order of such holder a new
certificate for the balance of shares of Series D Preferred Stock, if any.
(b) No Other Redemption at the Option of the Corporation.
Except as otherwise specifically provided in Section 8(a), the Corporation shall
not have any right to redeem any shares of Series D Preferred Stock at the
option of the Corporation.
9. CONVERSION.
(a) Conversion at Option of Holder.
(1) Conversion Right. The holders of the Series D Preferred
Stock may convert at any time all or from time to time any part of their
outstanding shares of Series D Preferred Stock into fully paid and nonassessable
shares of Common Stock and such other securities and property as hereinafter
provided. Commencing on the Issuance Date, and at any time thereafter, each
share of Series D Preferred Stock may be converted at the office of the
Corporation or at such additional office or offices, if any, as the Board of
Directors may designate, into such number of fully paid and nonassessable shares
of Common Stock (calculated as to each conversion to the nearest 1/100th of a
share) determined by dividing (x) the sum of (i) $1,000 plus (ii) an amount
equal to the accrued but unpaid dividends on the share of Series D Preferred
Stock being converted and any Arrearage Interest on dividends thereon in arrears
to the applicable Conversion Date by (y) the Conversion Price on the applicable
Conversion Date; provided, however, that in no event shall any holder of shares
of Series D Preferred Stock be entitled to convert any shares of Series D
Preferred Stock in excess of that number of shares of Series D Preferred Stock
upon conversion of which the sum of (1) the number of shares of Common Stock
beneficially owned by such holder (including shares of Common Stock beneficially
owned by all Aggregated Persons of such holder) (other than shares of Common
Stock deemed beneficially owned by such holder or any Aggregated Person of such
holder through the ownership of (x) unconverted shares of Series D Preferred
Stock and (y) the unconverted or unexercised portion of any instrument which
contains limitations similar to those set forth in this sentence) and (2) the
number of shares of Common Stock issuable upon the conversion of the number of
shares of Series D Preferred Stock with respect to which the
15
49
determination in this proviso is being made, would result in beneficial
ownership by such holder and all Aggregated Persons of such holder of more than
4.9% of the outstanding shares of Common Stock.
(2) Certain Limitations on Conversion Rights. Notwithstanding
any other provision of this Certificate of Designation, in no event shall any
holder of shares of Series D Preferred Stock be entitled on any date to convert
a number of shares of Series D Preferred Stock in excess of that number of
shares of Series D Preferred Stock upon conversion of which such holder and any
Aggregated Person of such holder would have acquired, through conversion of
shares of Series D Preferred Stock or otherwise, a number of shares of Common
Stock in excess of the Converted Restriction Amount during the 30-day period
ending on and including the date of the determination being made pursuant to
this Section 9(a)(2) (other than shares of Common Stock deemed beneficially
owned by such holder or any Aggregated Person of such holder through the
ownership of (x) unconverted shares of Series D Preferred Stock and (y) the
unconverted or unexercised portion of any instrument which contains limitations
similar to those set forth in this sentence).
(3) Beneficial Ownership. For purposes of the proviso to the
second sentence of Section 9(a)(1) and for purposes of Section 9(a)(2), (x)
beneficial ownership shall be determined in accordance with Section 13(d) of the
1934 Act and Regulation 13D-G thereunder, except as otherwise provided in clause
(1) of the proviso to the second sentence of Section 9(a)(1) or as provided in
Section 9(a)(2) and (y) the Corporation shall be entitled to rely, and shall be
fully protected in relying, on any statement or representation made by a holder
of shares of Series D Preferred Stock to the Corporation in connection with a
particular conversion, without any obligation on the part of the Corporation to
make any inquiry or investigation or to examine its records or the records of
any transfer agent for the Common Stock and without any liability of the
Corporation with respect thereto.
(b) Other Provisions.
(1) The holders of shares of Series D Preferred Stock at the
close of business on the record date for any dividend payment to holders of
Series D Preferred Stock shall be entitled to receive the dividend payable on
such shares on the corresponding dividend payment date notwithstanding the
conversion thereof after the record date for such dividend payment date or the
Corporation's default in payment of the dividend due on such dividend payment
date; provided, however, that the holder of shares of Series D Preferred Stock
converted during the period between the close of business on any record date for
a dividend payment and the opening of business on the corresponding dividend
payment date must pay to the Corporation, within five days after receipt by such
holder, an amount equal to the dividend payable on such shares on such dividend
payment date if such dividend is paid by the Corporation to such holder. A
holder of shares of Series D Preferred Stock on a record date for a dividend
payment who (or whose transferee) converts any of such shares into shares of
Common Stock on or after such dividend payment date will receive the dividend
payable by the Corporation on such shares of Series D Preferred Stock on such
dividend payment date, and the converting holder need not make any payment of
the amount of such dividend in connection with
16
50
such conversion of shares of Series D Preferred Stock. Except as provided above,
no adjustment shall be made in respect of cash dividends on Common Stock or
Series D Preferred Stock that may be accrued and unpaid at the date of
conversion of shares of Series D Preferred Stock.
(2) The right of the holders of Series D Preferred Stock to
convert their shares shall be exercised by delivering (which may be made by
telephone line facsimile transmission, which shall be conclusively deemed for
all purposes of this Certificate of Designation to have been given on the date
sent if the sender shall have received electronic confirmation of the receipt by
the Conversion Agent of such facsimile transmission) to the Conversion Agent a
Conversion Notice at the address or telephone line facsimile number provided in
the form of Conversion Notice set forth in Section 13(a) (or such other address
or facsimile number of the Conversion Agent as shall be provided by the
Corporation by notice to the holders of the shares of Series D Preferred Stock),
with a copy to the Corporation at its address or telephone line facsimile number
provided in or pursuant to Section 14 (a); provided, however, that any failure
or delay in giving a copy of a Conversion Notice to the Corporation shall not
affect the validity of or Conversion Date for such Conversion Notice. The number
of shares of Common Stock to be issued upon each conversion of shares of Series
D Preferred Stock shall be the number set forth in the applicable Conversion
Notice, which number shall be conclusive absent manifest error. The Corporation
shall notify a holder who has given a Conversion Notice of any claim of manifest
error within three Trading Days after such holder gives such Conversion Notice,
and no such claim of error shall limit or delay performance of the Corporation's
obligation to issue upon such conversion the number of shares of Common Stock
which are not in dispute. A Conversion Notice shall be deemed for all purposes
to be in proper form unless the Corporation notifies a holder of shares of
Series D Preferred Stock being converted within three Trading Days after a
Conversion Notice has been given (which notice shall specify all defects in such
Conversion Notice), and any Conversion Notice containing any such defect shall
nonetheless be effective on the date given if the converting holder agrees to
correct all such defects promptly.
(3) If a holder of Series D Preferred Stock elects to convert
any shares of Series D Preferred Stock in accordance with Section 9(a), such
holder shall not be required to surrender the certificate(s) representing such
shares of Series D Preferred Stock physically to the Corporation unless all of
the shares of Series D Preferred Stock represented thereby are so converted.
Each holder of shares of Series D Preferred Stock and the Corporation shall
maintain records showing the number of shares so converted and the dates of such
conversions or shall use such other method, satisfactory to such holder and the
Corporation, so as to not require physical surrender of such certificates upon
each such conversion. In the event of any dispute or discrepancy, such records
of the Corporation shall be controlling and determinative in the absence of
manifest error. Notwithstanding the foregoing, if any shares of Series D
Preferred Stock evidenced by a particular certificate therefor are converted as
aforesaid, the holder of Series D Preferred Stock may not transfer the
certificate(s) representing such shares of Series D Preferred Stock unless such
holder first physically surrenders such certificate(s) to the Corporation,
whereupon the Corporation will forthwith issue and deliver upon the order of
such holder of shares of Series D Preferred Stock new certificate(s) of like
tenor, registered as such holder of shares of Series D Preferred Stock (upon
payment by such holder of shares of Series D
17
51
Preferred Stock of any applicable transfer taxes) may request, representing in
the aggregate the remaining number of shares of Series D Preferred Stock
represented by such certificate(s). Each holder of shares of Series D Preferred
Stock, by acceptance of a certificate for such shares, acknowledges and agrees
that (1) by reason of the provisions of this paragraph, following conversion of
any shares of Series D Preferred Stock represented by such certificate, the
number of shares of Series D Preferred Stock represented by such certificate may
be less than the number of shares stated on such certificate and (2) the
Corporation may place one or more legends on the certificates for shares of
Series D Preferred Stock which refers to or describes the provisions of this
paragraph. The Corporation may by notice to any holder of shares of Series D
Preferred Stock require such holder to surrender the certificate(s) for such
holder's shares of Series D Preferred Stock in exchange for issuance by the
Corporation of one or more new certificates for the number of shares evidenced
by the certificate(s) so surrendered.
(4) The Corporation shall pay any transfer tax arising in
connection with any conversion of shares of Series D Preferred Stock except that
the Corporation shall not, however, be required to pay any tax which may be
payable in respect of any transfer involved in the issue and delivery upon
conversion of shares of Common Stock or other securities or property in a name
other than that of the holder of the shares of the Series D Preferred Stock
being converted, and the Corporation shall not be required to issue or deliver
any such shares or other securities or property unless and until the Person or
Persons requesting the issuance thereof shall have paid to the Corporation the
amount of any such tax or shall have established to the satisfaction of the
Corporation that such tax has been paid. A holder of shares of Series D
Preferred Stock who converts such shares shall be responsible for the amount of
any withholding tax payable in connection with such conversion.
(5) (A) The Corporation shall duly reserve and at all times
prior to the Stockholder Approval will continue to reserve 6,285,000 shares of
its authorized and unissued Common Stock, free from preemptive rights, for
issuance upon conversion of the shares of Series D Preferred Stock (subject to
reduction from time to time for shares of Common Stock issued upon conversion of
shares of Series D Preferred Stock). From and after the date of the Stockholder
Approval, the Corporation will duly reserve, free from preemptive rights, for
issuance upon conversion of the shares of Series D Preferred Stock a number of
shares of its authorized and issued Common Stock equal to 175% of the number of
shares of Common Stock which would be issuable on conversion of all authorized
shares of Series D Preferred Stock on the Issuance Date if all of such shares of
Series D Preferred Stock were outstanding on such date (determined without
regard to the limitations on conversion continued in Section 9(a)), subject to
reduction from time to time for shares of Common Stock issued upon conversion of
shares of Series D Preferred Stock. The Corporation (and any successor
corporation) shall take all action necessary so that a number of shares of the
authorized but unissued Common Stock (or common stock in the case of any
successor corporation) equal to the number of shares of Common Stock (or such
common stock) issuable upon conversion of the Series D Preferred Stock
outstanding, determined without regard to any limitation on beneficial ownership
contained in Section 9(a), are at all times reserved by the Corporation (or any
successor corporation), free from preemptive rights, for such conversion,
subject to the provisions of the next succeeding paragraph. If the Corporation
shall issue any securities or make any change in its capital structure which
would
18
52
change the number of shares of Common Stock into which each share of the Series
D Preferred Stock shall be convertible as herein provided, the Corporation shall
at the same time also make proper provision so that thereafter there shall be a
sufficient number of shares of Common Stock authorized and reserved, free from
preemptive rights, for conversion of the outstanding Series D Preferred Stock on
the new basis. If at any time the number of authorized but unissued shares of
Common Stock shall be insufficient to permit the Corporation to reserve such
number of shares of Common Stock, the Corporation promptly shall seek such
corporate action as may, in the opinion of its counsel, be necessary to increase
its authorized but unissued shares of Common Stock to such number of shares as
shall be sufficient to meet such requirement.
(B) The Initial Reserve Amount shall be allocated among the
shares of Series D Preferred Stock at the time of initial issuance thereof pro
rata based on the total number of authorized shares of Series D Preferred Stock
provided in Section 2. Each certificate for shares of Series D Preferred Stock
initially issued shall bear a notation as to the number of shares constituting
the portion of the Initial Reserve Amount allocated to the shares of Series D
Preferred Stock represented by such certificate for purposes of conversion
thereof. Upon surrender of any certificate for shares of Series D Preferred
Stock for transfer or re-registration thereof (or, at the option of the holder
of such certificate, for conversion pursuant to Section 9(a) of less than all of
the shares of Series D Preferred Stock represented thereby), the Corporation
shall make a notation on the new certificate issued upon such transfer or
re-registration or evidencing such unconverted shares, as the case may be, as to
the number of shares of Common Stock from the Initial Reserve Amount remaining
available for conversion of the shares of Series D Preferred Stock evidenced by
such new certificate. If any certificate for shares of Series D Preferred Stock
is surrendered for division into two or more certificates representing an
aggregate number of shares of Series D Preferred Stock equal to the number of
shares of Series D Preferred Stock represented by the certificate so surrendered
(as reduced by any contemporaneous conversion of shares of Series D Preferred
Stock represented by the certificate so surrendered), each certificate issued on
such division shall bear a notation of the portion of the Initial Reserve Amount
allocated thereto determined by pro rata allocation of the remaining portion of
the Initial Reserve Amount allocated to the certificate so surrendered. If any
shares of Series D Preferred Stock represented by a single certificate are
converted in full pursuant to Section 9, all of the portion of the Initial
Reserve Amount allocated to such shares of Series D Preferred Stock which
remains unissued after such conversion shall be re-allocated pro rata to the
outstanding shares of Series D Preferred Stock held of record by the holder of
record at the close of business on the date of such conversion of the shares of
Series D Preferred Stock so converted, and if there shall be no other shares of
Series D Preferred Stock held of record by such holder at the close of business
on such date, then such portion of the Initial Reserve Amount shall be allocated
pro rata among the shares of Series D Preferred Stock outstanding at the close
of business on such date. The provisions of this Section 9(b)(5)(B) shall be
inapplicable after the Stockholder Approval is obtained. If shares of Series D
Preferred Stock are not issued to MMC/GATX in accordance with Section 2, the
shares from the Initial Reserve Amount which were available for allocation to
such shares of Series D Preferred Stock shall be allocated to the issued shares
of Series D Preferred Stock pro rata based on the amounts thereof initially
issued.
19
53
(6) (A) In case of any consolidation or merger of the
Corporation with any other corporation (other than a wholly-owned subsidiary of
the Corporation) in which the Corporation is not the surviving corporation, or
in case of any sale or transfer of all or substantially all of the assets of the
Corporation, or in the case of any share exchange pursuant to which all of the
outstanding shares of Common Stock are converted into other securities or
property, the Corporation shall make appropriate provision or cause appropriate
provision to be made so that each holder of shares of Series D Preferred Stock
then outstanding shall have the right thereafter to convert such shares of
Series D Preferred Stock into the kind of shares of stock and other securities
and property receivable upon such consolidation, merger, sale, transfer, or
share exchange by a holder of shares of Common Stock into which such shares of
Series D Preferred Stock could have been converted immediately prior to the
effective date of such consolidation, merger, sale, transfer, or share exchange
and on a basis which preserves the economic benefits of the conversion rights of
the holders of shares of Series D Preferred Stock on a basis as nearly as
practical as such rights exist hereunder prior thereto. If, in connection with
any such consolidation, merger, sale, transfer, or share exchange, each holder
of shares of Common Stock is entitled to elect to receive securities, cash, or
other assets upon completion of such transaction, the Corporation shall provide
or cause to be provided to each holder of Series D Preferred Stock the right to
elect prior to the completion of such transaction the securities, cash, or other
assets into which the Series D Preferred Stock held by such holder shall be
convertible after completion of any such transaction on the same terms and
subject to the same conditions applicable to holders of the Common Stock
(including, without limitation, notice of the right to elect, limitations on the
period in which such election shall be made, and the effect of failing to
exercise the election). Notwithstanding the forgoing, in connection with any
such merger, consolidation, sale, transfer or exchange, the Corporation shall
have the right, in lieu of making provision for preservation of economic
benefits of the conversion rights of the holders of shares of Series D Preferred
Stock, to redeem all outstanding shares of Series D Preferred Stock immediately
after completion of such transaction at a redemption price per share of Series D
Preferred Stock in cash equal to the Business Combination Redemption Price. Such
right of redemption shall be exercised by notice from the Corporation to the
holders of shares of Series D Preferred Stock stating that the Corporation is
exercising its redemption right under this Section 9(b)(5), which notice shall
be given at least 20 days and not more than 30 days prior to completion of such
transaction and shall specify that such redemption shall occur on the Business
Day immediately following the date of completion of such transaction. On the
date specified in such notice (or such later date as a holder of shares of
Series D Preferred Stock surrenders such holder's certificates for shares of
Series D Preferred Stock redeemed) the Corporation shall make payment in
immediately available funds of the applicable Business Combination Redemption
Price to each holder of shares of Series D Preferred Stock to be redeemed to
such account as specified by such holder in writing to the Corporation at least
one Business Day prior to such payment of the Business Combination Redemption
Price. A holder of shares of Series D Preferred Stock which are redeemed
pursuant to this Section 9(b)(5) shall not be entitled to payment of the
Business Combination Redemption Price of such shares of Series D Preferred Stock
until such holder shall have surrendered the certificate(s) for such shares of
Series D Preferred Stock to the Corporation or, in the case of the loss, theft
or destruction of any such certificate, given indemnity in accordance with
Section 13(b). If the Corporation shall fail to pay the Business Combination
Redemption Price of any shares of Series
20
54
D Preferred Stock in full when due, then the amount thereof shall bear interest
to the extent not prohibited by applicable law at the rate of 12% per annum from
the due date thereof until paid in full. Notwithstanding the giving of a notice
of redemption pursuant to this Section 9(b)(6), each holder of shares of Series
D Preferred Stock shall be entitled to convert in accordance with this Section 9
any shares of Series D Preferred Stock which are to be redeemed at any time
prior to (1) the redemption date specified in the notice of redemption or (2) if
the Corporation fails to pay the Business Combination Redemption Price in full
to such holder when due, the date on which the Corporation pays the Business
Combination Redemption Price in full to such holder for all shares of Series D
Preferred Stock to be redeemed from such holder. The Corporation shall not
effect any such transaction unless it shall have complied with the provisions of
this paragraph. The above provisions shall similarly apply to successive
consolidations, mergers, sales, transfers, or share exchanges.
(B) Whenever the Corporation shall propose to take any of the
actions specified in this Section 9(b)(6), the Corporation shall cause a notice
to be mailed, at least 20 days prior to the date on which the books of the
Corporation will close or on which the security holders entitled to participate
in such transaction will be determined, to the holders of record of the
outstanding Series D Preferred Stock on the date of such notice. Such notice
shall specify the action proposed to be taken by the Corporation and the date as
of which holders of record of the Common Stock shall participate in any such
actions or be entitled to exchange their Common Stock for securities or other
property, as the case may be.
(7) Upon receipt by the Conversion Agent from a holder of
shares of Series D Preferred Stock of a Conversion Notice, the Corporation shall
issue and deliver or cause to be issued and delivered to or upon the order of
such holder certificates for the Common Stock issuable upon such conversion by
the close of business on the third Trading Day after such Conversion Notice is
received, and as of the close of business on the date of such receipt such
holder (or such holder's assignee) shall be deemed to be the holder of record of
the Common Stock issuable upon such conversion, and all rights with respect to
the shares of Series D Preferred Stock so converted shall forthwith terminate
except the right to receive the Common Stock or other securities, cash, or other
assets, as herein provided, on such conversion. If a holder of Series D
Preferred Stock shall have given a Conversion Notice in accordance with the
terms of this Certificate of Designation, the Corporation's obligation to issue
and deliver the certificates for Common Stock issuable upon such conversion
shall be absolute and unconditional, irrespective of any action or inaction by
the converting holder to enforce the same, any waiver or consent with respect to
any provision thereof, the recovery of any judgment against any Person or any
action to enforce the same, any failure or delay in the enforcement of any other
obligation of the Corporation to the holder of record, or any setoff,
counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the holder or any other Person of any obligation to the Corporation,
or any violation or alleged violation of law by such holder or any other Person,
and irrespective of any other circumstance which might otherwise limit such
obligation of the Corporation to such holder in connection with such conversion;
provided, however, that nothing herein shall limit or prejudice the right of the
Corporation to pursue any such claim in any other manner permitted by applicable
law.
21
55
The occurrence of an event which requires an equitable adjustment of
the Trading Price as contemplated by the definition thereof in Section 1 shall
in no way restrict or delay the right of any holder of shares of Series D
Preferred Stock to receive shares of Common Stock upon conversion of shares of
Series D Preferred Stock, and the Corporation shall use its best efforts to
implement each such adjustment on terms reasonably acceptable to the Majority
Holders within two Trading Days after such occurrence.
If the Corporation fails to issue and deliver the certificates for
the Common Stock to the holder converting shares of Series D Preferred Stock as
and when required to do so, in addition to any other liabilities the Corporation
may have hereunder and under applicable law (1) the Corporation shall pay or
reimburse such holder on demand for all out-of-pocket expenses, including,
without limitation, reasonable fees and expenses of legal counsel, incurred by
such holder as a result of such failure, (2) the Conversion Price applicable to
such conversion shall be reduced by one-tenth of a percentage point from the
Conversion Price otherwise applicable to such conversion for each Trading Day
during the period from the date the Corporation was required to deliver such
shares of Common Stock to the date the Corporation so delivers such shares of
Common Stock; provided, however, that in no event shall any such reduction be
made for any Trading Day in such period which is after the date which is 120
days after the date the Corporation was required to deliver such shares of
Common Stock in connection with such conversion, and (3) such holder may by
written notice or oral notice (promptly confirmed in writing) given at any time
prior to delivery to such holder of the certificates for the shares of Common
Stock issuable upon such conversion of shares of Series D Preferred Stock,
rescind such conversion, whereupon such holder shall have the right to convert
such shares of Series D Preferred Stock thereafter in accordance herewith;
provided, however, that the Corporation shall not be liable to any holder of
shares of Series D Preferred Stock under the preceding clause (1) or clause (2)
to the extent the failure of the Corporation to deliver or to cause to be
delivered such shares of Common Stock results from fire, flood, storm,
earthquake, shipwreck, strike, war, acts of terrorism, crash involving
facilities of a common carrier, acts of God, or any similar event outside the
control of the Corporation (it being understood that the action or failure to
act of the Conversion Agent shall not be deemed an event outside the control of
the Corporation except to the extent resulting from fire, flood, storm,
earthquake, shipwreck, strike, war, acts of terrorism, crash involving
facilities of a common carrier, acts of God, the bankruptcy, liquidation or
reorganization of the Conversion Agent under any bankruptcy, insolvency or other
similar law or any similar event outside the control of the Conversion Agent). A
holder of shares of Series D Preferred Stock who has given a Conversion Notice
shall notify the Corporation in writing (or by telephone conversation, confirmed
in writing) as promptly as practicable after becoming aware that shares of
Common Stock issued upon such conversion have not been received as provided in
this Section 9(b)(7).
(8) No fractional shares of Common Stock shall be issued upon
conversion of Series D Preferred Stock but, in lieu of any fraction of a share
of Common Stock and the related right which would otherwise be issuable in
respect of the aggregate number of shares of Series D Preferred Stock
surrendered for conversion at one time by the same holder, the Corporation shall
pay in cash to such holder at the time of issuance of shares of Common Stock in
connection with such conversion an amount equal to the product of (i) the
arithmetic average
22
56
of the Market Price of a share of Common Stock on the three consecutive Trading
Days ending on the Trading Day immediately preceding the Conversion Date times
(ii) such fraction of a share of Common Stock
10. REDEMPTION UPON AN OPTIONAL REDEMPTION EVENT.
(a) Redemption Right Upon Optional Redemption Event. If an
Optional Redemption Event occurs, then each holder of shares of Series D
Preferred Stock shall have the right, at such holder's option, to require the
Corporation to redeem all of such holder's shares of Series D Preferred Stock,
or any portion thereof, on the date that is three Business Days after the date
of the Holder Notice given with respect to such Optional Redemption Event. Each
holder of shares of Series D Preferred Stock shall have the right to require the
Corporation to redeem all or any such portion of such holder's shares of Series
D Preferred Stock if an Optional Redemption Event occurs at any time while any
of such holder's shares of Series D Preferred Stock are outstanding at a price
per share of Series D Preferred Stock equal to the Optional Redemption Price.
(b) Notices; Method of Exercising Optional Redemption Rights,
Etc.
(1) On or before the fifth Business Day after the occurrence
of an Optional Redemption Event, the Corporation shall give to each holder of
outstanding shares of Series D Preferred Stock a Corporation Notice of the
occurrence of such Optional Redemption Event and of the redemption right set
forth herein arising as a result thereof. The Corporation Notice shall set
forth:
(A) the date by which the optional redemption right must be
exercised, which date shall be at least 30 days after the date such Corporation
Notice is given, and
(B) a description of the procedure (set forth below) which
each such holder must follow to exercise such holder's optional redemption
right.
No failure of the Corporation to give a Corporation Notice or defect
therein shall limit the right of any holder of shares of Series D Preferred
Stock to exercise the optional redemption right or affect the validity of the
proceedings for the redemption of such holder's shares of Series D Preferred
Stock.
(2) To exercise its optional redemption right, each holder of
outstanding shares of Series D Preferred Stock shall deliver to the Corporation
on or before the thirtieth day after a Corporation Notice is given to such
holder (or if no Corporation Notice has been given to such holder, within forty
days after such holder first learns of the Optional Redemption Event) a Holder
Notice to the Corporation setting forth the name of such holder and the number
of such holder's shares of Series D Preferred Stock to be redeemed. A Holder
Notice may be revoked by such holder giving such Holder Notice by giving notice
of such revocation to the Corporation at any time prior to the time the
Corporation pays the Optional Redemption Price to such holder.
23
57
(3) If a holder of shares of Series D Preferred Stock shall
have given a Holder Notice, on the date which is three Business Days after the
date such Holder Notice is given (or such later date as such holder surrenders
such holder's certificates for the shares of Series D Preferred Stock redeemed)
the Corporation shall make payment in immediately available funds of the
applicable Optional Redemption Price to such account as specified by such holder
in writing to the Corporation at least one Business Day prior to the applicable
redemption date. A holder of shares of Series D Preferred Stock which are
redeemed pursuant to this Section shall not be entitled to payment of the
Optional Redemption Price of such shares of Series D Preferred Stock until such
holder shall have surrendered the certificate(s) for such shares of Series D
Preferred Stock to the Corporation or, in the case of the loss, theft or
destruction of any such certificate, given indemnity in accordance with Section
14(b).
(4) Notwithstanding any other provision of this Certificate of
Designation, if an Optional Redemption Event occurs by reason of the occurrence
of an event described in clause (1), (2) or (3) of the definition of the term
Optional Redemption Event, and such occurrence is by reason of events which are
not solely within the control of the Corporation, the Corporation shall have the
right to give a Control Notice to the holders of shares of Series D Preferred
Stock at any time after such Optional Redemption Event occurs and prior to the
earlier of (1) the date on which all holders of shares of Series D Preferred
Stock who had the right (other than as limited by this Section 10(b)(4)) to
require redemption of any shares of Series D Preferred Stock by reason of the
occurrence of such Optional Redemption Event no longer have such right and (2)
the applicable Optional Redemption Date by reason of the earliest Holder Notice
given by any holder of shares of Series D Preferred Stock by reason of such
Optional Redemption Event. If the Corporation timely gives such Control Notice
and an Adjustment Notice (which may be combined in a single notice) to the
holders of shares of Series D Preferred Stock, then in lieu of payment of the
Optional Redemption Price by reason of any such Optional Redemption Event and
commencing on the first date on which such Optional Redemption Event occurs the
following adjustments shall take effect:
(A) In the case of an Optional Redemption Event described in
clause (1) of the definition of the term Optional Redemption Event, for a period
of 180 days after the occurrence of such Optional Redemption Event (i) the
Conversion Price will be 80% of the amount which the Conversion Price would
otherwise be and (ii) the cumulative dividend shall accrue on each share of the
Series D Preferred Stock at the rate of $180 per annum.
(B) In the case of an Optional Redemption Event described in
clause (2) of the definition of the term Optional Redemption Event, for so long
as such Optional Redemption Event continues (i) the Conversion Price will be 80%
of the amount which the Conversion Price would otherwise be and (ii) the
cumulative dividend shall accrue on each share of Series D Preferred Stock at
the rate of $180 per annum.
(C) In the case of an Optional Redemption Event described in
clause (3) of the definition of the term Optional Redemption Event, for so long
as any shares of Preferred Stock are outstanding (i) the Conversion Price will
be 70% of the amount which the
24
58
Conversion Price would otherwise be and (ii) the cumulative dividend shall
accrue on each share of Series D Preferred Stock at the rate of $300 per annum.
For purposes of this Section 10(b)(4), an Optional Redemption Event
described in clause (1), (2) or (3) of the definition of the term Optional
Redemption Event shall be deemed to have occurred by reason of events which are
not solely within the control of the Corporation if a requirement of the
Corporation to redeem, or a right of any holder of shares of Series D Preferred
Stock to require redemption of, shares of Series D Preferred Stock by reason
thereof would result in the Corporation being required to classify the Series D
Preferred Stock as redeemable preferred stock on a balance sheet of the
Corporation prepared in accordance with Generally Accepted Accounting
Principles, and, in the case of an Optional Redemption Event described in clause
(3) of the definition of the term Optional Redemption Event, the Board or the
stockholders of the Corporation do not have the right to approve or disapprove
the transactions resulting in such event.
(c) Other.
(1) If the Corporation fails to pay in full when due the
Optional Redemption Price for the number of shares of Series D Preferred Stock
specified in a Holder Notice, then the amount thereof shall bear interest to the
extent not prohibited by applicable law at the rate of 12% per annum from the
due date thereof until paid in full.
(2) In connection with a redemption pursuant to this Section
10 of less than all of the shares of Series D Preferred Stock evidenced by a
particular certificate, promptly, but in no event later than three Business Days
after surrender of such certificate to the Corporation, the Corporation shall
issue and deliver to such holder a replacement certificate for the shares of
Series D Preferred Stock evidenced by such certificate which have not been
redeemed.
(3) A Holder Notice given by a holder of shares of Series D
Preferred Stock shall be deemed for all purposes to be in proper form unless the
Corporation notifies such holder in writing within three Business Days after
such Holder Notice has been given (which notice shall specify all defects in the
Holder Notice), and any Holder Notice containing any such defect shall
nonetheless be effective on the date given if such holder promptly undertakes in
writing to correct all such defects. Notwithstanding the absence of any such
undertaking from such holder, no such claim of error shall limit or delay
performance of the Corporation's obligation to redeem all shares of Series D
Preferred Stock not in dispute.
11. VOTING RIGHTS; CERTAIN RESTRICTIONS.
(a) Voting Rights. Except as otherwise required by law or
expressly provided herein, shares of Series D Preferred Stock shall not be
entitled to vote on any matter.
(b) Certificate of Incorporation; Certain Stock. The
affirmative vote or written consent of the Majority Holders, voting separately
as a class, will be required for (1) any amendment, alteration, or repeal,
whether by merger or consolidation or otherwise, of the
25
59
Corporation's Certificate of Incorporation if the amendment, alteration, or
repeal materially and adversely affects the rights, preferences or privileges of
the Series D Preferred Stock, or (2) the creation or issuance of any Senior
Dividend Stock or Senior Liquidation Stock; provided, however, that any increase
in the authorized Preferred Stock of the Corporation or the creation and
issuance of any stock which is both Junior Dividend Stock and Junior Liquidation
Stock shall not be deemed to affect materially and adversely such rights,
preferences or privileges and any such increase or creation and issuance may be
made without any such vote by the holders of Series D Preferred Stock except as
otherwise required by law; and provided further, however, that no such
amendment, alteration or repeal shall (i) reduce the Optional Redemption Price,
Redemption Price or the amount payable to a holder of shares of Series D
Preferred Stock pursuant to Section 5(c), (ii) reduce the percentage in, or
otherwise change the definition of Majority Holders, (iii) change the method of
calculating the Conversion Price in a manner adverse to the holders of shares of
Series D Preferred Stock or reduce the number of shares of Common Stock issuable
upon any conversion of shares of Series D Preferred Stock or (iv) amend, modify
or repeal any provision of this Section 11(b), unless in each such case referred
to in the preceding clauses (i) through (iv) such amendment, modification or
repeal has been approved by the affirmative vote or written consent of the
holders of all outstanding shares of Series D Preferred Stock, voting separately
or as a class.
(c) Repurchases of Series D Preferred Stock. The Corporation
shall not repurchase or otherwise acquire any shares of Series D Preferred Stock
(other than pursuant to Section 8(a)) unless the Corporation offers to
repurchase or otherwise acquire simultaneously a pro rata portion of each
holder's shares of Series D Preferred Stock for cash at the same price per
share.
(d) Other. So long as any shares of Series D Preferred Stock
are outstanding:
(1) Limitation on Indebtedness. The Corporation will not
itself, and will not permit any subsidiary of the Corporation to, create,
assume, incur, in any manner become liable in respect of, including, without
limitation, by reason of any business combination transaction, or suffer to
exist (all of which are referred to herein as "incurring"), any Indebtedness
other than Permitted Indebtedness.
(2) Payment of Obligations. The Corporation will pay and
discharge, and will cause each subsidiary of the Corporation to pay and
discharge, all their respective material obligations and liabilities, including,
without limitation, tax liabilities, except where the same may be contested in
good faith by appropriate proceedings.
(3) Maintenance of Property; Insurance.
(A) The Corporation will keep, and will cause each subsidiary
of the Corporation to keep, all material property useful and necessary in its
business in good working order and condition, ordinary wear and tear excepted.
26
60
(B) The Corporation will maintain, and will cause each
subsidiary of the Corporation to maintain, with financially sound and
responsible insurance companies, insurance in at least such amounts and against
such risks as are usually insured against in the same geographic region by
companies of comparable size that are engaged in the same or a similar business,
subject to customary deductibles.
(4) Conduct of Business and Maintenance of Existence. The
Corporation will continue, and will cause each subsidiary of the Corporation to
continue, to engage in business of the same general type as conducted by the
Corporation and such subsidiaries at the time this Certificate of Designation is
filed with the Secretary of State of the State of Delaware, and will preserve,
renew and keep in full force and effect, and will cause each subsidiary of the
Corporation to preserve, renew and keep in full force and effect, their
respective corporate existence and their respective material rights, privileges
and franchises necessary or desirable in the normal conduct of business.
(5) Compliance with Laws. The Corporation will comply, and
will cause each subsidiary of the Corporation to comply, in all material
respects with all applicable laws, ordinances, rules, regulations, decisions,
orders and requirements of governmental authorities and courts (including,
without limitation, environmental laws) except (i) where compliance therewith is
contested in good faith by appropriate proceedings or (ii) where non-compliance
therewith could not reasonably be expected to have a material adverse effect on
the business, condition (financial or otherwise), operations, performance,
properties or prospects of the Corporation and its subsidiaries taken as a
whole.
(6) Investment Company Act. The Corporation will not be or
become an open-end investment trust, unit investment trust or face-amount
certificate company that is or is required to be registered under Section 8 of
the Investment Company Act of 1940, as amended, or any successor provision.
(7) Transactions with Affiliates. The Corporation will not,
and will not permit any subsidiary of the Corporation to, directly or
indirectly, pay any funds to or for the account of, make any investment (whether
by acquisition of stock or Indebtedness, by loan, advance, transfer of property,
guarantee or other agreement to pay, purchase or service, directly or
indirectly, any Indebtedness, or otherwise) in, lease, sell, transfer or
otherwise dispose of any assets, tangible or intangible, to, or participate in,
or effect any transaction in connection with, any joint enterprise or other
joint arrangement with, any Affiliate of the Corporation, except, on terms to
the Corporation or such subsidiary no less favorable than terms that could be
obtained by the Corporation or such subsidiary from a Person that is not an
Affiliate of the Corporation, as determined in good faith by the Board of
Directors.
12. OUTSTANDING SHARES. For purposes of this Certificate of
Designation, all shares of Series D Preferred Stock shall be deemed outstanding
except (i) from the date a Conversion Notice is given by a holder of Series D
Preferred Stock, all shares of Series D Preferred Stock converted into Common
Stock and (ii) from the date of registration of transfer, all shares of Series D
Preferred Stock held of record by the Corporation or any subsidiary or
27
61
Affiliate (as defined herein) of the Corporation (other than any original holder
of shares of Series D Preferred Stock) and (iii) from the applicable Redemption
Date, Optional Redemption Date or date of redemption pursuant to Section
9(b)(6)(A), all shares of Series D Preferred Stock which are redeemed, so long
as in each case the Redemption Price, Optional Redemption Price or Business
Combination Redemption Price, as the case may be, of such shares of Series D
Preferred Stock shall have been paid by the Corporation as and when due
hereunder.
28
62
13. FORMS OF NOTICES.
(a) Notice of Conversion of Series D Convertible Preferred
Stock.
NOTICE OF CONVERSION
OF
SERIES D CONVERTIBLE PREFERRED STOCK
OF
SHAMAN PHARMACEUTICALS, INC.
TO: BankBoston, N.A.,
as Conversion Agent
000 Xxxxxx Xxxxxx
Xxxxxx, Xxxxxxxxxxxxx 00000
Attention: Client Administration
Facsimile No.: (000) 000-0000
cc: Shaman Pharmaceuticals, Inc.
000 Xxxx Xxxxx Xxxxxx
Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
Attention: Chief Financial Officer
Facsimile No.: (000) 000-0000
(1) Pursuant to the terms of the Series D Convertible Preferred
Stock (the "Preferred Stock"), of Shaman Pharmaceuticals, Inc., a Delaware
corporation (the "Corporation"), the undersigned (the "Holder") hereby elects to
convert _______________ shares of the Preferred Stock, including accrued and
unpaid dividends per share of $________ and Arrearage Interest per share of
$________ into shares of Common Stock, $0.001 par value (the "Common Stock"), of
the Corporation, at a Conversion Price per share of Common Stock of $________ or
such other securities into which the Preferred Stock is currently convertible.
Capitalized terms used in this Notice and not otherwise defined herein have the
respective meanings provided in the Certificate of Designation of Series D
Convertible Preferred Stock.
(2) The number of shares of Common Stock issuable upon the
conversion of the shares of Preferred Stock to which this Notice relates is
__________________________.
(3) Check (and complete, if applicable) one of the following:
/__/ (A) Set forth below or on a schedule which accompanies this
Notice are the Trading Prices during the Measurement Period
applicable to this Notice and an indication of the Trading Price
used to determine the Conversion Price set forth above.
29
63
Date Trading Price
---- -------------
1. __________________________ $____________________
2. __________________________ $____________________
3. __________________________ $____________________
4. __________________________ $____________________
5. __________________________ $____________________
6. __________________________ $____________________
7. __________________________ $____________________
8. __________________________ $____________________
9. __________________________ $____________________
10. __________________________ $____________________
11. __________________________ $____________________
12. __________________________ $____________________
/__/ (B) The conversion to which this Notice relates is based on the
fixed Conversion Price specified in clause (a) of the definition of
such term in the Certificate of Designation.
(4) Please issue certificates for the number of shares of Common
Stock or other securities into which such number of shares of Preferred Stock is
convertible in the name(s) specified immediately below or, if additional space
is necessary, on an attachment hereto:
----------------------------------- -----------------------------------------
Name Name
----------------------------------- -----------------------------------------
Address Address
----------------------------------- -----------------------------------------
SS or Tax ID Number SS or Tax ID Number
30
64
(5) The undersigned hereby represents to the Corporation that the
exercise of conversion rights contained in this Notice does not violate the
provisions of Section 9(a) of this Certificate of Designation relating to
beneficial ownership in excess of 4.9% of the Common Stock.
(6) If the shares of Common Stock issuable upon conversion of the
Preferred Stock have not been registered for resale under the 1933 Act, as
amended (the "1933 Act") and are not being offered or sold pursuant to Rule 144
under the 1933 Act (or any successor or replacement rule or provision), the
Holder represents and warrants that (i) the shares of Common Stock not so
registered are being acquired for the account of the Holder for investment, and
not with a view to, or for resale in connection with, the public distribution
thereof other than pursuant to registration under the 1933 Act or an exemption
from registration under the 1933 Act, and that the Holder has no present
intention of distributing or reselling the shares of Common Stock not so
registered other than pursuant to registration under the 1933 Act or an
exemption from registration under the 1933 Act and (ii) the Holder is an
"accredited investor" as defined in Regulation D under the 1933 Act. The Holder
further agrees that (A) the shares of Common Stock not so registered shall not
be sold or transferred unless (i) they first shall have been registered under
the 1933 Act, (ii) the Corporation first shall have been furnished with an
opinion of legal counsel reasonably satisfactory to the Corporation to the
effect that such sale or transfer is exempt from the registration requirements
of the 1933 Act or (iii) such shares are offered or sold pursuant to Rule 144
under the 1933 Act (or any successor or replacement rule or provision), and (B)
until such shares are registered for resale under the 1933 Act, the Corporation
may place a legend on the certificate(s) for the shares of Common Stock not so
registered to that effect and place a stop-transfer restriction in its records
relating to the shares of Common Stock not so registered, all in accordance with
the Exchange Agreement by which the Holder is bound.
Date
--------------------------- --------------------------------------------
Signature of Holder
(Must be signed exactly as name
appears on the Preferred Stock Certificate.)
31
65
(b) Form of Redemption Notice.
REDEMPTION NOTICE
(SECTION 8(a) OF CERTIFICATE OF DESIGNATION OF
SERIES D CONVERTIBLE PREFERRED STOCK)
TO:
--------------------------------
(Name of Holder)
(1) Pursuant to the terms of the Series D Convertible Preferred
Stock (the "Preferred Stock"), Shaman Pharmaceuticals, Inc., a Delaware
corporation (the "Corporation"), hereby notifies the above-named holder (the
"Holder") that the Corporation is exercising its right to redeem _____________
shares of Preferred Stock held by the Holder in accordance with Section 8(a) of
the Certificate of Designation of the Series D Convertible Preferred Stock (the
"Certificate of Designation"):
(2) The Redemption Date is December 30, 1998.
(3) The Redemption Price per share of Preferred Stock is $_________.
(4) Upon surrender to the Corporation of the certificate(s) for the
shares of Preferred Stock to be redeemed (but in no event earlier than the
Redemption Date), the Corporation will make payment of the applicable Redemption
Price in accordance with the Certificate of Designation.
(5) Capitalized terms used herein and not otherwise defined herein
have the respective meanings provided in the Certificate of Designation.
SHAMAN PHARMACEUTICALS, INC.
By
---------------------------------------
Title:
32
66
(c) Form of Corporation Notice.
CORPORATION NOTICE
(SECTION 10(b)(1) OF CERTIFICATE OF DESIGNATION OF
SERIES D CONVERTIBLE PREFERRED STOCK)
TO:
--------------------------------
(Name of Holder)
(1) An Optional Redemption Event described in the Certificate of
Designation (the "Certificate of Designation") of Series D Convertible Preferred
Stock, par value $0.001 per share (the "Preferred Stock"), of Shaman
Pharmaceuticals, Inc., a Delaware corporation (the "Corporation"), occurred on
______________________, ____. As a result of such Optional Redemption Event, the
above-named holder (the "Holder") is entitled to exercise its optional
redemption rights pursuant to Section 10(b)(2) of the Certificate of
Designation.
(2) The Holder's optional redemption right must be exercised on or
before ___________, ______.
(3) At or before the date set forth in the preceding paragraph (2),
the Holder must deliver to the Corporation:
(a) a Holder Notice, in the form set forth in Section 13(d) of the
Certificate of Designation; and
(b) the certificates for the shares of Preferred Stock to be
redeemed, duly endorsed for transfer to the Corporation the shares to be
redeemed.
(4) Capitalized terms used herein and not otherwise defined herein
have the respective meanings provided in the Certificate of Designation.
Date SHAMAN PHARMACEUTICALS, INC.
-------------------------------
By
--------------------------------------
Title:
33
67
(d) Form of Holder Notice.
HOLDER NOTICE
(SECTION 10(b)(2) OF CERTIFICATE OF DESIGNATION OF
SERIES D CONVERTIBLE PREFERRED STOCK)
TO: SHAMAN PHARMACEUTICALS, INC.
(1) Pursuant to the terms of the Series D Convertible Preferred
Stock, par value $0.001 per share (the "Preferred Stock"), of Shaman
Pharmaceuticals, Inc., a Delaware corporation (the "Corporation"), the
undersigned hereby elects to exercise its right to require redemption by the
Corporation pursuant to Sections 10(a) and 10(b) of the Certificate of
Designation of Series D Convertible Preferred Stock (the "Certificate of
Designation") of ______ shares of Preferred Stock at an Optional Redemption
Price per share in cash equal to the product obtained by multiplying (a) the sum
of (i) $1,000 plus (ii) an amount equal to $____ for the accrued but unpaid
dividends on each share of Series D Preferred Stock to be redeemed and any
Arrearage Interest on dividends thereon in arrears to the date of redemption
times (b) 118% .
(2) The aggregate Optional Redemption Price of all shares of
Preferred Stock to be redeemed from the undersigned is $____.
(3) Capitalized terms used herein and not otherwise defined herein
have the respective meanings provided in the Certificate of Designation.
Date: NAME OF HOLDER:
------------------------------
By
--------------------------------------
Signature of Registered Holder
(Must be signed exactly as name
appears on the stock certificate.)
34
68
(e) Form of Control Notice.
CONTROL NOTICE
(SECTION 10(b)(4) OF CERTIFICATE OF DESIGNATION OF
SERIES D CONVERTIBLE PREFERRED STOCK)
TO:
--------------------------------
(Name of Holder)
(1) Pursuant to the terms of the Series D Convertible Preferred
Stock, par value $0.001 per share (the "Preferred Stock"), Shaman
Pharmaceuticals, Inc., a Delaware corporation (the "Corporation"), hereby
notifies the above-named holder (the "Holder") that in accordance with the
Certificate of Designation of the Series D Convertible Preferred Stock (the
"Certificate of Designation") and by reason of events which are not solely
within the control of the Corporation, on _____________(fill in date) an
Optional Redemption Event subject to Section 10(b)(4) of the Certificate of
Designation occurred.
(2) Attached to this Notice is an Auditors' Determination with
respect to the occurrence referred to in paragraph (1).
(3) Capitalized terms used herein and not otherwise defined herein
have the respective meanings provided in the Certificate of Designation.
Date SHAMAN PHARMACEUTICALS, INC.
---------------------------
By
---------------------------------------
Title:
35
69
(f) Form of Adjustment Notice.
ADJUSTMENT NOTICE
(SECTIONS 10(b)(4) OF CERTIFICATE OF DESIGNATION OF
SERIES D CONVERTIBLE PREFERRED STOCK)
VIA FACSIMILE
TO:
--------------------------------
(Name of Holder)
(1) Pursuant to the terms of the Series D Convertible Preferred
Stock, par value $0.001 per share (the "Preferred Stock"), Shaman
Pharmaceuticals, Inc., a Delaware corporation (the "Corporation"), confirms to
the above-named holder (the "Holder") of shares of Preferred Stock that on
____________ (fill in date) the Corporation gave the Holder and each other
holder of shares of Preferred Stock a Control Notice in accordance with the
Certificate of Designation of the Preferred Stock (the "Certificate of
Designation"), and hereby notifies the Holder of the adjustments set forth
below.
(2) Effective on _________(fill in date), the Conversion Price of
the Preferred Stock is ____% (fill in percentage) of the amount the Conversion
Price would otherwise be without regard to adjustments pursuant to Section
10(b)(4) of the Certificate of Designation.
(3) Effective on _________(fill in date), cumulative dividends shall
accrue on each outstanding share of Preferred Stock in the amount of $ ____ per
annum.
(4) The foregoing adjustments to the Conversion Price and the
cumulative annual dividend amount will continue in effect until a subsequent
Adjustment Notice is given to the Holder.
(5) Capitalized terms used herein and not otherwise defined herein
have the respective meanings provided in the Certificate of Designation.
Date SHAMAN PHARMACEUTICALS, INC.
---------------------------
By
---------------------------------------
Title:
36
70
14. MISCELLANEOUS.
(a) Notices. Any notices required or permitted to be given
under the terms of this Certificate of Designation shall be in writing and shall
be delivered personally (which shall include telephone line facsimile
transmission) or by courier, and shall be deemed given upon receipt, (a) in the
case of the Corporation, addressed to the Corporation at 000 Xxxx Xxxxx Xxxxxx,
Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000, Attention: President and Chief Executive
Officer (telephone line facsimile transmission number (000) 000-0000), or (b) in
the case of any holder of shares of Series D Preferred Stock, at such holder's
address or telephone line facsimile transmission number shown on the stock books
maintained by the Corporation with respect to the Series D Preferred Stock or
such other address as the Corporation shall have provided by notice to the
holders of shares of Series D Preferred Stock in accordance with this Section or
any holder of shares of Series D Preferred Stock shall have provided to the
Corporation in accordance with this Section.
(b) Replacement of Certificates. Upon receipt by the
Corporation of evidence reasonably satisfactory to the Corporation of the
ownership of and the loss, theft, destruction or mutilation of any certificate
for shares of Series D Preferred Stock and (1) in the case of loss, theft or
destruction, of indemnity from the record holder of the certificate for such
shares of Series D Preferred Stock reasonably satisfactory in form to the
Corporation (and without the requirement to post any bond or other security) or
(2) in the case of mutilation, upon surrender and cancellation of the
certificate for such shares of Series D Preferred Stock, the Corporation will
execute and deliver to such holder a new certificate for such shares of Series D
Preferred Stock without charge to such holder.
37
71
IN WITNESS WHEREOF, Shaman Pharmaceuticals, Inc. has caused this
certificate to be signed by one of its officers thereunto duly authorized as of
the ___ day of ____________, 1998.
SHAMAN PHARMACEUTICALS, INC.
By:
--------------------------------------
Xxxx X. Xxxxx, President and Chief
Executive Officer
72
SCHEDULE C
Form of Current Report on Form 8-K
C-1
73
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) DECEMBER ___, 1998
--------------------------------------------------------------------------------
SHAMAN PHARMACEUTICALS, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
DELAWARE 0-21022 00-0000000
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
000 XXXX XXXXX XXX., XXXXX XXX XXXXXXXXX, XXXXXXXXXX 00000
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (000) 000-0000
--------------------------------------------------------------------------------
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
74
Item 5. Other Events.
On December 10, 1998, Shaman Pharmaceuticals, Inc. (the
"Company") and certain institutional investors exchanged an aggregate of
$4,786,225.41 million (including accrued interest) of the Company's Senior
Subordinated Convertible Notes due August 29, 2000 (the "Notes") for an
aggregate of 4,784 shares of the Company's Series D Convertible Preferred Stock
(the "Series D Preferred Stock"). The principal terms of the Series D Preferred
Stock are as follows:
Voting. The holders of the Series D Preferred Stock are not
entitled to vote on any matter, except that the affirmative vote of a majority
of the holders of Series D Preferred Stock is required for (a) any amendment,
alteration or repeal of the Company's Certificate of Incorporation if the
amendment, alteration or repeal materially and adversely affects the rights,
preferences or privileges of the Series D Preferred Stock or (b) the creation or
issuance of any capital stock with rights senior to the Series D Preferred Stock
with respect to dividends or liquidation.
Dividends. The holders of shares of Series D Preferred Stock
shall be entitled to receive, when, as and if declared by the Company's Board of
Directors out of funds legally available therefor, cumulative dividends at the
rate of $55 per year per share, paid quarterly on each of February 1, May 1,
August 1 and November 1, commencing February 1, 1999. Such dividends may be paid
in cash or, subject to certain limitations, shares of Common Stock.
Liquidation Preference. In the event of a liquidation,
dissolution, sale or winding up of the Company, holders of the Series D
Preferred Stock shall be entitled to receive, prior and in preference to the
holders of the Common Stock and the Series A Preferred Stock, but subordinate to
the holders of the Series C Preferred Stock, an amount equal to $1,000 per
share, plus any accrued and unpaid dividends.
Conversion. Each share of Series D Convertible Preferred Stock
shall be convertible at any time and from time to time into such number of
shares of Common Stock determined by dividing (a) the sum of (i) $1,000 plus
(ii) the accrued and unpaid dividends thereon by (b) the lesser of (i) $1.125
per share (subject to adjustment) or (ii) 90% of the lowest per share trading
price of the Common Stock for the 12 trading day period ending on the trading
day prior to the date of conversion. A holder may not convert shares of Series D
Preferred Stock (x) if such conversion would result in beneficial ownership by
such holder and its affiliates of more than 4.9% of the outstanding shares of
Common Stock or (y) if such holder and its affiliates would have acquired,
during the 30-day period ending on the applicable date of conversion, through
conversion of shares of Series D Preferred Stock or otherwise, a number of
shares of Common Stock in excess of 4.9% of the Common Stock outstanding on the
applicable date of conversion.
Redemption. The Series D Preferred Stock is, subject to certain
conditions, redeemable at the option of the Company on December 30, 1998. In
addition, the Series D Preferred Stock is redeemable upon the occurrence of
certain events, including (a) the absence, for a period of five consecutive
trading days, of a reported sale price of the Common Stock on any of The Nasdaq
National Market, The Nasdaq SmallCap Market, the New York Stock Exchange or the
American Stock Exchange, (b) the failure of the Common Stock to be listed on The
Nasdaq National Market, The Nasdaq SmallCap Market, the New York Stock Exchange
or the American Stock Exchange, (c) the completion of a merger or consolidation
of the Company or other business combination, (d) the adoption of an amendment
to the Company's charter that disproportionately, materially and adversely
affects the rights of the holders of Series D Preferred Stock, (e) the inability
of any holder of shares of Series D Preferred Stock to effect a resale of the
Common Stock for a certain time period by reason of the Company's failure to
meet its obligations under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, or (f) the Company's breach of a
material obligation owed the holders of Series D Preferred Stock. Should any of
the events in (a), (b) or (c) above occur by reason of events not solely within
the control of the Company and certain other conditions are met, the Company may
elect not to redeem any Series D Preferred Stock requested to be redeemed.
75
Priority. The Series D Preferred Stock ranks senior to the
Company's Common Stock and Series A Preferred Stock, but junior to the Company's
Series C Preferred Stock, as to dividends and distribution of assets upon
liquidation, dissolution or winding up of the Company.
Item 7. Financial Statements and Exhibits.
(c) Exhibits. The following documents are filed as exhibits to this report:
3.1 Certificate of Designation of Series D Preferred Stock.
10.70 Exchange Agreement, dated as of December 10, 1998, by
and between the Company and certain entities.
99.1 Press Release
76
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
SHAMAN PHARMACEUTICALS, INC.
DATE: December __, 1998 By:
--------------------------------------
Xxxx X. Xxxxx, President and
Chief Executive Officer
77
EXHIBIT INDEX
EXHIBIT
NUMBER DOCUMENT DESCRIPTION
------- --------------------
3.1 Certificate of Designation of Series D Preferred Stock.
10.70 Exchange Agreement, dated as of December 10, 1998, by and between
the Company and certain entities.
99.1 Press Release
78
SCHEDULE D
Form of Opinion of Law Offices of Xxxxx X Xxxxx
D-1
79
LAW OFFICES OF
XXXXX X XXXXX
ATTORNEYS AT LAW
PENTHOUSE XXXXX
00 XXXX 00XX XXXXXX
XXX XXXX, XX 00000
TELEPHONE (000) 000-0000
FACSIMILE (000) 000-0000
December 10, 1998
To Each Person Listed on
the Attached Schedule A
RE: SHAMAN PHARMACEUTICALS, INC.
Ladies and Gentlemen:
We have acted as special counsel to Delta Opportunity Fund, Ltd.,
a British Virgin Islands corporation, and Overbrook Fund I, LLC, a New York
limited liability company, in connection with the issuance by Shaman
Pharmaceuticals, Inc., a Delaware corporation (the "Company"), of shares of its
Series D Convertible Preferred Stock, $0.001 par value (the "Series D Preferred
Stock"), in exchange for the Company's outstanding Senior Subordinated
Convertible Notes due August 29, 2000 (the "Notes"). The exchange of shares of
Series D Preferred Stock for Notes is being made pursuant to the Exchange
Agreement, dated as of December 10, 1998 (the "Exchange Agreement"), by and
between the Company and the several holders of Notes named therein (the
"Holders"). In connection with the issuance of shares of Series D Preferred
Stock, pursuant to the Exchange Agreement the Company has agreed to issue to the
Holders Warrants to purchase shares of Common Stock. Capitalized terms used
herein and not otherwise defined herein shall have the respective meanings
specified in the Exchange Agreement.
The Company filed a Registration Statement (Registration No.
333-31843) on Form S-3 (as amended to the date the same was ordered effective,
the "Registration Statement") under the Securities Act of 1933, as amended (the
"1933 Act"), with the Securities and Exchange Commission (the "SEC") on July 23,
1997 relating to the resale of shares of Common Stock
80
To Each Person Listed on
the Attached Schedule A
December 10, 1998
Page 2
issuable upon conversion of the Notes and in payment of interest on the Notes.
The Company has informed us that the Registration Statement was ordered
effective by the SEC on August 29, 1997 and remains effective.
The shares of Series D Preferred Stock are being issued by the
Company without registration under the 1933 Act in reliance by the Company on an
exemption from registration thereunder. We have been informed by the Company,
and the Company and the Holders have been advised by Xxxxxxx, Phleger & Xxxxxxxx
LLP ("BP&H"), counsel to the Company, that the shares of Series D Preferred
Stock may be issued pursuant to the Exchange Agreement without registration
under the 1933 Act pursuant to the exemption provided by Section 3(a)(9) of the
1933 Act. We have been informed by BP&H that they have had informal discussions
with the staff of the SEC to seek the staff's view as to whether or not the
Registration Statement and the related Prospectus may be used for resale of the
Conversion Shares by the Holders named therein. BP&H has advised us that they
were informed by the staff that their inquiry regarding such use of the
Registration Statement is a novel question on which neither the SEC nor its
staff has previously taken a formal or informal position. Pursuant to the
Exchange Agreement, the Company has agreed to file under the 1934 Act a Current
Report on Form 8-K or a revised Prospectus pursuant to Rule 424(c) under the
1933 Act with the SEC within one business day after the date of the Closing in
order that the information contained in the Prospectus will be current with
respect to the transactions contemplated by the Exchange Agreement.
In connection with this opinion, we have examined and relied on
originals or copies, certified or otherwise identified to our satisfaction, of
such corporate records, documents, agreements or other instruments of the
Company and the Holders orders, rulings and certificates of public officials,
officers and representatives of the Company, the Holders and such other persons,
have made investigations of law, and have discussed with officers and other
representatives of the Company and the Holders such questions of fact, as we
have deemed proper and necessary as a basis for the opinions hereinafter
expressed.
81
To Each Person Listed on
the Attached Schedule A
December 10, 1998
Page 3
In our examination, we have assumed the genuineness of all
signatures, the legal capacity of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of
all documents submitted to us as certified or photostatic copies and the
authenticity of the originals of such latter documents. As to certain factual
matters, we have relied upon statements and representations of officers and
other representatives of the Company, the Holders and others.
Based upon the foregoing, we are of the opinion that, assuming
the representations and warranties of the Company in the Exchange Agreement are
true and correct, once the Company updates the Prospectus in accordance with
Section 3.b.(14) of the Exchange Agreement, the Conversion Shares may be offered
and sold pursuant to the Registration Statement by the Holders named in the
Registration Statement in accordance with the plan of distribution set forth in
the Prospectus without further registration under the 1933 Act.
In rendering this opinion, we have reviewed the provisions of the
Exchange Agreement, including, without limitation, Section 7.b. thereof, which
permit the Holders to sell or otherwise transfer Conversion Shares in a
transaction other than pursuant to the Registration Statement without
registration under the 1933 Act. In connection with any such sale or other
transfer, the Exchange Agreement requires receipt by the Company of an opinion
of counsel reasonably satisfactory in form, scope and substance to the Company
to the effect that the Shares to be sold or transferred may be sold or
transferred pursuant to an exemption from registration under the 1933 Act.
In rendering this opinion we have assumed, among other things,
the following:
(a) that the Exchange Agreement constitutes the legal, valid and
binding obligations, enforceable in accordance with its terms, of the
Company and the respective Holders and that the shares of Series D
Preferred Stock are duly authorized, validly issued, fully paid and
non-assessable and that the Conversion Shares are duly authorized and,
when
82
To Each Person Listed on
the Attached Schedule A
December 10, 1998
Page 4
issued upon conversion of the shares of Series D Preferred Stock, will
be validly issued, fully-paid and non-assessable; and
(b) that the Conversion Shares will be issued by the Company to
the Holders upon conversion of the shares of Series D Preferred Stock in
accordance with the terms of the Certificate of Designation.
We express no opinion as to the accuracy or completeness of the information
contained in the Registration Statement or the Prospectus.
We are members of the bar of the State of New York and we express
no opinion as to the laws of any jurisdiction other than the federal laws of the
United States as in effect on the date hereof.
This opinion is strictly limited to the matters expressly stated
herein and no other or more extensive opinion is intended, implied or to be
inferred beyond the matters expressly stated herein. This opinion is furnished
solely for your benefit in connection with the transactions referred to in the
Exchange Agreement, and may not be relied upon by any other person, firm or
corporation for any other purpose, without our prior written consent.
Very truly yours,
Xxxxx X. Xxxxx
83
SCHEDULE A
Shaman Pharmaceuticals, Inc.
000 Xxxx Xxxxx Xxxxxx
Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
Delta Opportunity Fund, Ltd.
c/o International Fund Administration, Ltd.
Suite 464
48 Par La Ville Road
Xxxxxxxx HM11
Bermuda
NP Partners
c/o Citadel Investment Group, LLC
000 Xxxx Xxxxxxxxxx Xxxxxx
0xx Xxxxx
Xxxxxxx, Xxxxxxxx 00000
Olympus Securities, Ltd.
c/o Citadel Investment Group, LLC
000 Xxxx Xxxxxxxxxx Xxxxxx
0xx Xxxxx
Xxxxxxx, Xxxxxxxx 00000
OTATO Limited Partnership
Post Office Box 1845GT
Grand Cayman
BWI, Cayman Islands
Overbrook Fund I, LLC
c/o Overbrook Management Corp.
000 Xxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxx, Xxx Xxxx 00000
84
SCHEDULE E
Form of Conversion Agent Agreement
E-1
85
CONVERSION AGENT AGREEMENT
THIS CONVERSION AGENT AGREEMENT, dated as of December 10, 1998, by
and among SHAMAN PHARMACEUTICALS, INC., a Delaware corporation (the "Company"),
BANKBOSTON, N.A., as Conversion Agent (the "Conversion Agent"), and each of the
holders of Warrants (as defined below) and Series D Preferred Stock (as defined
below) named on the signature pages hereto (each, an "Original Holder" and
collectively, the "Original Holders").
W I T N E S S E T H:
WHEREAS, pursuant to the Exchange Agreement, dated as of December
10, 1998, by and between the Company and the Original Holders (the "Exchange
Agreement"), the Company has agreed, upon the terms and subject to the
conditions of the Exchange agreement, to issue Common Stock Purchase Warrants
("Warrants") to the Original Holders and the Original Holders have agreed, upon
the terms and subject to the conditions of the Exchange Agreement, to exchange
outstanding Senior Subordinated Convertible Notes (the "Notes") issued by the
Company for shares (the "Preferred Shares") of Series D Convertible Preferred
Stock, $0.001 par value per share (the "Preferred Stock"), of the Company; and
WHEREAS, as a condition precedent to the several obligations of the
Original Holders to exchange their Notes for the Preferred Shares, the Original
Holders require the execution and delivery of this Agreement by the Company and
the Conversion Agent to assure that the Original Holders and each other holder
of the Preferred Shares or Warrants (such other holders, together with the
Original Holders, the "Holders") will be assured of the timely issuance and
receipt of shares of Common Stock, $.001 par value (the "Common Stock"), of the
Company upon exercise of Warrants or conversion of Preferred Shares;
NOW THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:
1. DELIVERIES.
(a) Contemporaneously with the execution and delivery of this
Agreement, the Company is delivering to the Conversion Agent the following:
(1) a list showing the name and address of each
registered holder of the Warrants and the date of issuance and number of shares
of Common Stock initially issuable upon exercise of each Warrant;
(2) the Form of Subscription (the "Subscription Form")
relating to the Warrants;
(3) the form of Notice of Conversion of Series D
Convertible Preferred Stock (the "Conversion Notice") relating to the Preferred
Stock; and
86
(4) an opinion of Xxxxxxx, Phleger & Xxxxxxxx LLP,
counsel to the Company, as to the due authorization, validity of issuance and
fully-paid and non-assessable nature of the shares (the "Warrant Shares")
issuable upon exercise of the Warrants and the shares (the "Conversion Shares"
and, together with the Warrant Shares, the "Common Shares") of Common Stock
issuable upon conversion of the Preferred Shares.
(b) Contemporaneously with the execution and delivery of this
Agreement, the Law Offices of Xxxxx X Xxxxx is delivering to the Conversion
Agent an opinion of the Law Offices of Xxxxx X Xxxxx to the effect that the
Conversion Shares may be sold pursuant to the Existing Registration Statement.
(c) On the date of issuance of Preferred Shares pursuant to
the Exchange Agreement, the Company will deliver to the Conversion Agent a list
showing the name and address of each holder of record of Preferred Stock and the
date of issuance and number of shares of Preferred Stock issued to each Holder.
The Company agrees to promptly advise the Conversion Agent in writing of any
changes to the initial lists of holders of record of Preferred Stock and
Warrants and the amounts of such securities so held, including changes resulting
from the issuance of less than all Common Shares issuable upon the conversion or
exercise of a particular certificate for Preferred Shares or Warrants.
2. ISSUANCE OF COMMON SHARES.
(a) The Company hereby appoints the Conversion Agent, and the
Conversion Agent hereby agrees to act, as exercise agent for the Warrants and as
conversion agent for the Preferred Stock. The Company hereby irrevocably
instructs the Conversion Agent to (i) issue Warrant Shares upon exercise of the
Warrants from time to time in accordance with the terms of the Warrants upon
receipt of a Subscription Form from a Holder of any Warrant and a written
confirmation from the Company that the Company has received the purchase price
therefor (a "Payment Confirmation") and (ii) except as provided in Section
3(c),to issue Conversion Shares upon conversion of all or any part of the
outstanding Preferred Shares from time to time upon receipt of a Conversion
Notice. A Conversion Notice may be given by telephone line facsimile
transmission to the Conversion Agent or otherwise given to the Conversion Agent,
in each such case at the address and in the manner provided in Section 6(g). A
converting or exercising Holder shall give a copy of each of the Conversion
Notice and the Subscription Form to the Company. Any failure or delay in the
giving of such copy of the Conversion Notice by a Holder to the Company shall
not affect the validity of or the Conversion Date (as defined in the Certificate
of Designation of the Preferred Stock (the "Certificate of Designation")) for
any such Conversion Notice. The Company shall confirm to the Conversion Agent
its receipt of a copy of each Subscription Form. Any delay in the giving of a
copy of the Subscription Form by a Holder to the Company shall stay the
Company's obligation to give a Payment Confirmation to the Conversion Agent as
set forth in Section 3(a) until such copy is received. The Company agrees to
deliver to the Conversion Agent by telephone line facsimile transmission or by
overnight courier copies of any Conversion Notice or Subscription Form which the
Conversion Agent advises the Company have not yet been received by the
Conversion Agent. The certificates for Preferred Shares need not be surrendered
in connection with the
2
87
conversion thereof by a Holder unless all of the outstanding Preferred Shares
evidenced by a particular certificate are so converted. The Company may by
notice to any Holder from time to time require such Holder to surrender the
certificates for such Holder's Preferred Shares in exchange for the issuance by
the Company of one or more new certificate or certificates for a number of
shares of Preferred Stock equal to the number of outstanding shares of Preferred
Stock evidenced by the certificate(s) so surrendered.
(b) The certificates for Warrant Shares issued prior to
receipt by the Conversion Agent of an opinion of counsel (who may be counsel to
a Holder), which counsel shall be reasonably acceptable to the Conversion Agent,
that a registration statement under the Securities Act of 1933 Act, as amended
(the "1933 Act"), relating to the resale of Warrant Shares has been declared
effective by the Securities and Exchange Commission (the "SEC") shall bear the
following legend:
"The securities represented by this certificate have not been registered
under the Securities Act of 1933, as amended (the "Act"). The securities
have been acquired for investment and may not be sold, transferred or
assigned in the absence of an effective registration statement for the
securities under the Act or an opinion of counsel that registration is not
required under the Act."
Once the Conversion Agent receives such opinion of counsel,
thereafter (1) upon request of the holder of any such Warrant Shares, the
Conversion Agent will prepare and issue within three Trading Days after such
request substitute certificates without any restrictive legend for any
certificates for Warrant Shares issued prior to the date the Conversion Agent
receives such opinion of counsel and shall immediately remove any stop-transfer
restriction against such Warrant Shares and (2) neither the Company nor the
Conversion Agent shall place any restrictive legend or stop-transfer restriction
against Warrant Shares issued after the Conversion Agent receives such opinion
of counsel. Neither the Company nor the Conversion Agent shall place any
restrictive legend or stop transfer restriction against the Conversion Shares.
As used herein, "Trading Day" means a day on whichever of (x) the national
securities exchange or (y) the Nasdaq National Market which at the time
constitutes the principal securities market for the Common Stock is open for
general trading of securities.
3. CONVERSION AND EXERCISE OBLIGATIONS ABSOLUTE; NO CONTRARY
INSTRUCTIONS.
(a) Within one Trading Day after receipt by the Company of the
applicable purchase price for exercise of Warrants, the Company shall give the
Conversion Agent by telephone line facsimile transmission a Payment Confirmation
for such exercise. If a Holder shall have given to the Conversion Agent a
Subscription Form for exercise of Warrants and the Company shall have given to
the Conversion Agent a Payment Confirmation with respect to such exercise, or if
a Holder shall have given to the Conversion Agent a Conversion Notice for
conversion of Preferred Shares, the Conversion Agent shall issue and deliver as
stated in such Subscription Form the Warrant Shares issuable upon such exercise
or as stated in such Conversion Notice the Conversion Shares issuable upon such
conversion, as the case may be, within three Trading Days after such
subscription Form and Payment Confirmation are received
3
88
or such Conversion Notice is given, as the case may be, and the Holder
exercising or converting shall be deemed to be the holder of record of the
Common Shares issuable upon such exercise or conversion, and all rights with
respect to that portion of the Warrants so exercised or the Preferred Shares so
converted shall forthwith terminate except the right to receive the Common
Shares or other securities, cash, or other assets as provided in the Warrants or
the Certificate of Designation. The Conversion Agent agrees that, if a Holder
shall have given a Subscription Form or Conversion Notice and, in the case of an
exercise of a Warrant, the Company shall have given a Payment Confirmation, as
provided herein, the Conversion Agent shall issue and deliver the certificates
for Common Shares upon such exercise or conversion, irrespective of any action
or inaction by the exercising or converting Holder to enforce the same, any
waiver or consent with respect to any provision of the Warrants or the
Certificate of Designation, the recovery of any judgment against any person or
any action to enforce the same, any failure or delay in the enforcement of any
other obligation of the Company to such Holder, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by such
Holder or any other person of any obligation to the Company, or any violation or
alleged violation of law by such Holder or any other person, and irrespective of
any other circumstance which might otherwise limit such obligation of the
Company to such Holder in connection with such exercise or conversion; provided,
however, that nothing herein shall limit or prejudice the right of the Company
to pursue any such claim in any other manner permitted by applicable law. In
lieu of delivering physical certificates representing the Common Shares issuable
upon conversion of shares of Preferred Stock or exercise of Warrants, provided
the Conversion Agent is participating in the Depository Trust Company ("DTC")
Fast Automated Securities Transfer program, upon request of a Holder, the
Conversion Agent shall electronically transmit the Common Shares issuable upon
such conversion or exercise to such Holder by crediting the account of such
Holder or such Holder's broker with DTC through its Deposit Withdrawal Agent
Commission system.
(b) The Company agrees not to give any instruction to the
Conversion Agent which is contrary to this Agreement. Except as provided in
Section 3(c), the Company hereby irrevocably instructs the Conversion Agent to
disregard, and the Conversion Agent hereby agrees that it will disregard, any
instruction by the Company not to issue Conversion Shares or Warrant Shares, as
the case may be, following receipt by the Conversion Agent of a Conversion
Notice or Subscription Form and Payment Confirmation, in accordance with this
Agreement. The Company shall not appoint any transfer agent (other than the
Conversion Agent) or registrar for its Common Stock unless at the time of such
appointment any such successor enters into an agreement of like tenor with this
Agreement.
(c) As set forth in the Certificate of Designation, the number
of Common Shares to be issued in connection with a particular conversion of
Preferred Shares is, absent manifest error, conclusively the number of Common
Shares stated in the applicable Conversion Notice. If in connection with a
particular conversion of Preferred Shares the Company determines that manifest
error has been made by virtue of the conversion price or other information set
forth in the applicable Conversion Notice, the Company shall, within three
Trading Days after a Holder gives such Conversion Notice, notify the Conversion
Agent and such Holder of such error (the "Error Notice"), which Error Notice
shall state the number of Common Shares in dispute (the "Disputed Shares"), and,
notwithstanding such Error Notice
4
89
from the Company, the Conversion Agent shall issue and deliver the number of
Common Shares not in dispute as and when required by this Agreement. A
Conversion Notice shall be deemed for all purposes to be in proper form unless
the Company otherwise notifies the Holder giving such Conversion Notice by
telephone line facsimile transmission within three Trading Days after a
Conversion Notice has been given (which notice from the Company shall specify
all defects in the Conversion Notice), and any Conversion Notice containing any
such defect shall nonetheless be effective on the date given if such Holder
promptly undertakes in writing to correct all such defects. If the Company shall
have notified the Conversion Agent and such Holder of any such claim of manifest
error, and the Company and such Holder do not agree as to a resolution of such
claim on or before the date of such notice by the Company of an error in such
Conversion Notice the Company shall on the date such notice is given submit the
dispute to Ernst & Young LLP or another firm of independent public accountants
of recognized national standing (the "Auditors") for determination and shall
instruct the Auditors to resolve such dispute and to notify the Company, the
Conversion Agent and such Holder within two Trading Days after such dispute is
submitted to the Auditors. Immediately after receipt of timely notice of the
Auditors' determination (but in any event within three Trading Days after the
applicable Conversion Notice is given to the Conversion Agent), the Conversion
Agent shall issue to the converting Holder any additional Common Shares to which
such Holder is entitled based on the determination of the Auditors. The
Conversion Agent is authorized and directed to rely on the Auditors'
determination. If the Auditors shall fail to notify the Conversion Agent of
their determination within three Trading Days after the applicable Conversion
Notice is given to the Conversion Agent, then the Conversion Agent shall, within
three Trading Days after the date the applicable Conversion Notice was given,
issue to the converting Holder any additional Common Shares to which such Holder
is entitled based on the applicable Conversion Notice. Such immediate and prompt
action shall be taken by all the parties hereto in order to assure that there
shall be full compliance with the Company's unqualified obligation that all
Common Shares issuable upon such conversion be issued by the due date therefor
as provided herein and in the Certificate of Designation.
(d) In order to assist the Conversion Agent in fulfilling its
obligations under this Agreement, the Company will use its best efforts to
contact the Conversion Agent promptly after the Company learns that a Conversion
Notice or Subscription Form has been given and will cooperate with the
Conversion Agent in providing such information as the Conversion Agent may
reasonably request, including written confirmation of the conversion
instructions in the Conversion Notice, the exercise instructions in the
Subscription Form, and the Company's receipt of the applicable purchase price
due upon exercise of Warrants; provided, however, that the Company's failure to
comply with this Section 3(d) shall not limit the obligations of the Company and
the Conversion Agent to issue certificates for Common Shares as and when
required by this Agreement.
(e) Notwithstanding anything to the contrary herein, prior to
the Stockholder Approval (as defined in the Certificate of Designation), in no
event shall the Conversion Agent issue to any holder a number of shares of
Common Stock in excess of such holder's portion of the Initial Reserve Amount,
as set forth on Schedule A attached hereto. Prior to the Stockholder Approval,
(i) if any shares of Series D Preferred Stock represented by a single
5
90
certificate are converted in full, all of the portion of the Initial Reserve
Amount allocated to such shares of Series D Preferred Stock which remains
unissued after such conversion shall be re-allocated pro rata to the outstanding
shares of Series D Preferred Stock held of record by the holder of record at the
close of business on the date of such conversion of the shares of Series D
Preferred Stock so converted, and if there shall be no other shares of Series D
Preferred Stock held of record by such holder at the close of business on such
date, then such portion of the Initial Reserve Amount shall be allocated pro
rata among the shares of Series D Preferred Stock outstanding at the close of
business on such date and (ii) if shares of Series D Preferred Stock are not
issued to MMC/GATX Partnership No. 1 or its designee, the shares from the
Initial Reserve Amount which were available for allocation to such shares of
Series D Preferred Stock shall be allocated to the issued shares of Series D
Preferred Stock pro rata based on the amounts thereof initially issued. In any
such instance, the Company shall provide to the Conversion Agent an updated
Schedule A to be substituted for the Schedule A attached hereto.
4. CONVERSION AGENT DUTIES.
(a) The obligations and duties of the Conversion Agent under
this Agreement are at all times and in all respects subject to the requirements
of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the
rules and regulations of the SEC thereunder applicable to transfer agents
registered with the SEC. This Agreement relates only to the Conversion Agent's
duties as exercise agent for the Warrants and conversion agent for the Preferred
Stock and does not otherwise limit or affect the Conversion Agent's other
duties, obligations and agreements relating to its service as transfer agent and
registrar for the Common Stock.
(b) The Conversion Agent shall not, and is not being requested
to, serve as transfer agent for the Preferred Stock or the Warrants. The
Conversion Agent shall not be required to maintain records of the names of the
holders of record of the Preferred Stock and Warrants and the amounts of such
securities so held from time to time or to effect or record any transfers
thereof. The Conversion Agent shall be entitled to rely solely on lists and
other written information provided by the Company from time to time with respect
to the holders of Preferred Stock and Warrants and the respective amounts of
such securities so held.
5. INDEMNIFICATION. The Company agrees to indemnify and hold
harmless the Conversion Agent, each officer, director, employee and agent of the
Conversion Agent, and each person, if any, who controls the Conversion Agent
within the meaning of the 1933 Act or the 1934 Act against any losses, claims,
damages or liabilities, joint or several, to which it, they or any of them, or
such controlling person, may become subject, under the 1933 Act, the 1934 Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon the performance by the
Conversion Agent of its duties pursuant to this Agreement; and will reimburse
the Conversion Agent, and each officer, director, employee and agent of the
Conversion Agent, and each such controlling person for any legal or other
expenses reasonably incurred by it or any of them in connection with
investigating or defending any such loss, claim, damage, liability or action;
provided, however, that the Company will not be liable in any case if such loss,
claim, damage or liability arises out of or is based upon
6
91
any action not taken in good faith, or any act or omission that constitutes
gross negligence or willful misconduct. Promptly after receipt by an indemnified
party under this Section 5 of notice of the commencement of any action, such
indemnified party will, if a claim in respect thereof is to be made against the
Company under this Section 5, notify in writing the Company of the commencement
thereof, and failure so to notify the Company will relieve the Company from any
liability under this Section 5 as to the particular item for which
indemnification is then being sought if such failure shall have materially
prejudiced the Company's right to defend or contest such action, but not from
any other liability which it may have to any indemnified party. In case any such
action is brought against any indemnified party, and it notifies the Company of
the commencement thereof, the Company will be entitled to participate with any
other indemnifying party, similarly notified, to assume the defense thereof,
with counsel who shall be to the reasonable satisfaction of such indemnified
party, and after notice from such indemnifying party to such indemnified party
under this Section 5, shall be liable for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense
thereof other than reasonable costs of investigation. The Company shall not be
liable to any such indemnified party on account of any settlement of any claim
or action effected without the consent of the Company.
6. REMEDIES FOR ERRORS IN CONVERSION OF PREFERRED STOCK. In the
event that any holder delivers a Conversion Notice which, pursuant to Section
3(c) is determined to contain a manifest error, such delivery shall be deemed to
be a breach of this Agreement. In the event that a holder delivers a Conversion
Notice determined to contain a manifest error, and the Conversion Agent has
issued the Disputed Shares to the holder delivering such Conversion Notice prior
to receipt by the Conversion Agent of an Error Notice, such holder shall, within
three Trading Days of the final determination with respect to the manifest
error, deliver the Disputed Shares to the Conversion Agent for cancellation. In
the event that such holder has sold or otherwise transferred to a third party
the Disputed Shares and therefore cannot deliver the Disputed Shares to the
Conversion Agent for cancellation, the Conversion Agent shall subtract the
number of the Disputed Shares from the number of shares of Common Stock issuable
to such holder in connection with any future conversion of the Preferred Stock
by such holder, up to the aggregate number of Disputed Shares. If the Conversion
Notice containing the manifest error converts all shares of Preferred Stock such
holder is entitled to convert, such holder shall, within three Trading Days of
the final determination with respect to the manifest error, deliver to the
Conversion Agent for cancellation a number of shares of Common Stock purchased
on the open market equal to the number of Disputed Shares.
7. MISCELLANEOUS.
(a) This Agreement shall be governed by and interpreted in
accordance with the laws of the State of New York.
(b) This Agreement may be executed in counterparts and by the
parties hereto on separate counterparts, all of which together shall constitute
one and the same instrument. A facsimile transmission of this Agreement bearing
a signature on behalf of a party hereto shall be legally binding on such party.
7
92
(c) The headings of this Agreement are for convenience of
reference and shall not form part of, or affect the interpretation of, this
Agreement.
(d) If any provision of this Agreement shall be invalid or
unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement or the
validity or enforceability of this Agreement in any other jurisdiction.
(e) No failure or delay by any party in exercising any right
or remedy under or in connection with this Agreement or otherwise, and no course
of dealing between the parties, shall operate as a waiver thereof or amendment
of this Agreement, nor shall any single or partial exercise of any such right or
power, or any abandonment or discontinuance of steps to enforce such a right or
power, preclude any other or further exercise thereof or exercise of any other
right or power.
(f) Neither this Agreement nor any term hereof (including this
paragraph) may be amended, changed, waived, discharged or terminated unless such
amendment, change, waiver, discharge or termination is in writing signed by the
Company, the Conversion Agent, and, with respect to the Holders, the Majority
Holders (as defined in the Certificate of Designation).
(g) Any notices required or permitted to be given under the
terms of this Agreement shall be in writing and shall be sent by mail or
delivered personally (which shall include telephone line facsimile transmission)
or by courier and shall be effective five days after being placed in the mail,
if mailed, or upon receipt, if delivered personally or by courier, in each case
addressed to a party as follows:
if to the Company:
Shaman Pharmaceuticals, Inc.
000 Xxxx Xxxxx Xxxxxx
Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
Attention: President and Chief Executive Officer
Facsimile No.: (000) 000-0000
if to the Conversion Agent:
BankBoston, N.A., as Conversion Agent
000 Xxxxxx Xxxxxx
Xxxxxx, Xxxxxxxxxxxxx 00000
Attention: Client Administration
Facsimile No.: (000) 000-0000
if to any Original Holder:
8
93
at the address and facsimile number set forth below its signature
on the signature pages hereto
or, in the case of any Holder who is not an Original Holder, to such address as
such Holder shall have provided in writing to the Company and the Conversion
Agent for such purpose or, in each such case, such other address as a party
shall have provided by notice to the other parties in accordance with this
provision.
9
94
IN WITNESS WHEREOF, this Conversion Agent Agreement has been duly
executed by the parties hereto by their respective officers or other
representatives thereunto duly authorized as of the date first set forth above.
SHAMAN PHARMACEUTICALS, INC.
By:
--------------------------------------
Name:
Title:
BANKBOSTON, N.A.,
as Conversion Agent
By:
--------------------------------------
Name:
Title:
DELTA OPPORTUNITY FUND, LTD.
By:
--------------------------------------
Name:
Title:
Address:
c/o International Fund Administration,
Ltd.
Xxxxx 000
00 Xxx Xx Xxxxx Xxxx
Xxxxxxxx XX00
Xxxxxxx
Facsimile No.: (000) 000-0000
95
NP PARTNERS
By:
--------------------------------------
Name:
Title:
Address:
c/o Citadel Investment Group LLC
000 Xxxx Xxxxxxxxxx Xxxxxx
0xx Xxxxx
Xxxxxxx, Xxxxxxxx 00000
Facsimile No.: (000) 000-0000
OLYMPUS SECURITIES, LTD.
By:
--------------------------------------
Name:
Title:
Address:
c/o Citadel Investment Group LLC
000 Xxxx Xxxxxxxxxx Xxxxxx
0xx Xxxxx
Xxxxxxx, Xxxxxxxx 00000
Facsimile No.: (000) 000-0000
96
OMICRON PARTNERS, L.P.
BY OMICRON CAPITAL, L.P.
SUBADVISOR
By:
--------------------------------------
Name: Xxxxxxx X. Xxxxxx
Title: Principal
Address:
c/o Omicron Capital, L.P.
000 Xxxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Facsimile No.: (000) 000-0000
OTATO LIMITED PARTNERSHIP
By:
--------------------------------------
Name:
Title:
Address:
Post Office Box 1845GT
Grand Cayman
BWI, Cayman Islands
Facsimile No.: (000) 000-0000
OVERBROOK FUND I, LLC
By:
--------------------------------------
Name:
Title:
Address:
Overbrook Fund I, LLC
000 Xxxxx Xxxxxx
Xxxx 0000
Xxx Xxxx, Xxx Xxxx 00000-0000
Facsimile No.: (000) 000-0000
97
SCHEDULE A
INITIAL RESERVE AMOUNT
Name of Holder Initial Reserve Amount
-------------- ----------------------
Delta Opportunity Fund, Ltd. 1,566,000
NP Partners 1,055,000
Olympus Securities, Ltd. 1,055,000
Omicron Partners, L.P. 625,000
OTATO Limited Partnership 291,000
Overbrook Fund I, LLC 192,000
---------
TOTAL 4,784,000
98
SCHEDULE F
Form of Opinion of Xxxxxxx, Phleger & Xxxxxxxx LLP
F-1
99
[XXXXXXX PHLEGER & XXXXXXXX LLP ATTORNEYS AT LAW LETTERHEAD)
December 10, 1998
To the Holders Listed on
Schedule A Hereto
Ladies and Gentlemen:
We have acted as counsel for Shaman Pharmaceuticals, Inc., a
Delaware corporation (the "Company"), in connection with the exchange of its
Senior Convertible Notes for shares of its Series D Preferred Stock and warrants
to purchase Common Stock (the "Exchange") pursuant to the Exchange Agreement
dated as of December 10, 1998 (the "Exchange Agreement") by and among the
Company and you. This opinion letter is being rendered to you pursuant to
Section 6.b(10) of the Exchange Agreement in connection with the Closing of the
Exchange. Capitalized terms not otherwise defined in this opinion letter have
the meaning given them in the Exchange Agreement.
In connection with the opinions expressed herein we have made such
examination of matters of law and fact as we considered appropriate or advisable
for purposes hereof. We have also examined originals, or copies certified or
otherwise identified to our satisfaction, of such documents, corporate records,
certificates, including certificates of public officials, and other instruments
as we have deemed necessary or advisable for purposes of this opinion letter,
including those relating to the authorization, execution and delivery of the
Exchange Agreement. In addition, we have examined the following documents (the
items referred to in subclauses (i) through (iv) below herein referred to as the
"Transaction Documents" and the items referred to in subclauses (v) through (x)
below herein referred to as the "Company Documents"):
(i) executed copies of the Exchange Agreement;
(ii) the Certificate of Designation;
(iii) an executed copy of the Warrant delivered to each of you;
(iv) an executed copy of the Conversion Agent Agreement;
(v) the Certificate of Incorporation of the Company, including all
amendments thereto, as in effect on the date hereof;
(vi) the Bylaws of the Company, including all amendments thereto, as
in effect on the date hereof;
100
To the Holders Listed December 10, 1998
on Schedule A Hereto Page 2
(vii) resolutions of the Board of Directors of the Company adopted
at a duly called special meeting on October 20, 1998, authorizing the execution,
delivery and performance of the Transaction Documents and the transactions
contemplated thereby;
(viii) the certificate, dated December 10, 1998, of the Chief
Executive Officer of the Company, delivered pursuant to Section 6.b(6) of the
Exchange Agreement;
(ix) the certificate, dated December 10, 1998, of the Secretary of
the Company, delivered pursuant to Section 6.b(9) of the Exchange Agreement,
certifying: (A) the Certificate of Incorporation and Bylaws of the Company as in
effect on such date, (B) a true copy of the resolutions of the Board of
Directors of the Company, adopted on October 20, 1998, authorizing, among other
things, the execution, delivery and performance of the Transaction Documents and
the transactions contemplated thereby, and (C) the incumbency, authority and
true signatures of the officers of the Company authorized to sign the
Transaction Documents and any other documents and certificates delivered in
connection therewith;
(x) specimen certificates for the Series D Preferred Stock and the
Common Stock; and
(xi) such other documents as we have deemed necessary or appropriate
as a basis for the opinions hereinafter expressed.
We have also examined photostatic or facsimile copies of the
agreements (the "Material Agreements") identified as such in and filed as
exhibits to the SEC Reports and any consents executed in connection with the
Material Agreements. In addition, we have obtained from public officials and
from officers and other representatives of the Company such other certificates
and assurances as we consider necessary for purposes of this opinion. In our
examination and review we have assumed the genuineness of all signatures, the
legal capacity of natural persons, the authenticity of the documents submitted
to us as originals, the conformity to the original documents of all documents
submitted to us as certified, facsimile or photostatic copies, and the
authenticity of the originals of such copies. As to any facts material to the
opinions hereinafter expressed which we did not independently establish or
verify, we have relied without investigation upon the representations and
warranties as to factual matters contained in and made by the Company pursuant
to the Exchange Agreement and upon certificates and statements of government
officials and representatives of the Company.
We have also assumed: (A) that with respect to documents executed by
parties other than the Company, (i) that each such other party had the power to
enter into and perform all its obligations thereunder, (ii) the due
authorization, execution and delivery of such documents by each such party and
(iii) that such documents constitute the legal, valid and binding obligations of
each such party; (B) that the representations and warranties made in the
Transaction Documents by the Holders are true and correct; (C) that any wire
transfers, drafts or checks tendered by the Holders will be honored; and (D) if
the Holder is a corporation or other
101
To the Holders Listed December 10, 1998
on Schedule A Hereto Page 3
entity, that such Holder has filed any required state franchise, income or
similar tax returns and has paid any required state franchise, income or similar
taxes.
Whenever a statement herein is qualified by the expressions "known
to us," "to our knowledge," "we are not aware" or a similar phrase or expression
with respect to our knowledge of matters of fact, it is intended to mean that
our knowledge is based upon the records, documents, instruments and certificates
described above and the current actual knowledge of the attorneys in this Firm
who have devoted substantive attention to the transactions contemplated by the
Note Documents or who are presently involved in substantive legal representation
of the Company (but not including any constructive or imputed notice of any
information) and that we have not otherwise undertaken any independent
investigations for the purpose of rendering this opinion.
This opinion letter relates solely to the laws of the States of
California and New York, the General Corporation Law of the State of Delaware
and the federal law of the United States, and we express no opinion with respect
to the effect or application of any other laws. Special rulings of authorities
administering such laws or opinions of other counsel have not been sought or
obtained.
Based upon our examination of and reliance upon the foregoing and
subject to the limitations, exceptions, qualifications and assumptions set forth
below and except as set forth in the Exchange Agreement and the Schedules
thereto, we are of the opinion that as of the date hereof:
1. The Company is a corporation duly incorporated, validly existing
and in good standing under the laws of the State of Delaware with the corporate
power and authority (i) to own, lease and operate its properties and to carry on
its business as, to our knowledge, it is now being conducted, (ii) to execute,
deliver and perform its obligations under the Transaction Documents and (iii) to
consummate the transactions contemplated by the Transaction Documents.
2. The Transaction Documents (i) have been duly and validly
authorized and duly executed and delivered by the Company and (ii) constitute
the legal, valid and binding obligations of the Company enforceable against the
Company in accordance with their respective terms.
3. The Preferred Stock has been duly authorized and, when issued in
exchange for the Notes pursuant to the Exchange Agreement, will be validly
issued, fully paid and non-assessable.
4. The Conversion Shares have been duly authorized and, when and if
issued upon conversion of the Preferred Stock in accordance with the Certificate
of Designation, will be validly issued, fully paid and non-assessable.
102
To the Holders Listed December 10, 1998
on Schedule A Hereto Page 4
5. The Warrant Shares have been duly authorized and, when and if
issued upon exercise of the Warrants in accordance with the terms of the
Warrants, will be validly issued, fully paid and non-assessable.
6. The authorized capital stock of the Company consists of (i)
40,000,000 shares of Common Stock and (ii) 1,000,000 shares of Preferred Stock,
$0.001 par value per share, of which 400,000 shares have been designated Series
A Preferred Stock and were outstanding as of November 30, 1998, 140,880 shares
have been designated Series C Preferred Stock, and of which up to 6,285 shares
have been authorized to be designated as shares of Series D Preferred, of which
up to 4,785 may be issued pursuant to the Exchange Agreement and of which up to
1,500 shares may be issued to MMC/GATX Partnership No. 1, a California general
partnership, or its designee. There are no preemptive or, to our knowledge,
similar rights outstanding of any stockholder of the Company that would entitle
such stockholder to acquire the Preferred Stock, the Warrants or the Common
Shares. The Common Stock is listed for trading on the Nasdaq National Market
("Nasdaq") and (i) to our knowledge, no suspension of trading in the Common
Stock is in effect and (ii) the Company and the Common Stock meet the criteria
for continued listing and trading on Nasdaq other than the Nasdaq Tangible Asset
Criterion. The authorized shares of Common Stock and outstanding securities to
purchase Common Stock conform in all material respects to the descriptions
thereof contained in the SEC Reports. To our knowledge, no holder of any of the
Company's securities has any rights, "demand," "piggy-back" or otherwise, to
have such securities registered with the SEC by reason of the intention to file,
filing or effectiveness of the Registration Statement, except where such rights
have been waived expressly or by expiration of the time period during which such
rights were required to be exercised.
7. Assuming that the representations and warranties of the Holders
in Section 5 of the Exchange Agreement are true and correct, the Company is not
required to obtain the consents, approvals or authorizations of any governmental
authority or agency under the General Corporation Law of the State of Delaware,
the laws of the State of California or New York or the laws of the United
States, as presently in effect and interpreted, or of the stockholders of the
Company in connection with the issuance of the Preferred Stock and the Warrants
as contemplated by the Exchange Agreement or the issuance of the Common Shares
upon conversion of the Preferred Stock or exercise of the Warrants, as the case
may be, other than such as may be required under any applicable state securities
or "blue sky" laws, as to which we express no opinion.
8. Except for those matters disclosed in the SEC Reports, we are not
aware that there is any action, suit, proceeding, inquiry or investigation
before or by any court, public board or governmental body pending, or threatened
in writing, against the Company, which questions the validity of the Transaction
Documents or the right of the Company to enter into the Transaction Documents.
103
To the Holders Listed December 10, 1998
on Schedule A Hereto Page 5
9. The execution, delivery and performance by the Company of the
Transaction Documents, and the issuance of the Preferred Shares, the Warrants,
the Common Shares, and the fulfillment of and the compliance with the respective
terms thereof by the Company, will not (i) violate or be in conflict with any
provision of the Certificate of Incorporation or Bylaws of the Company, (ii)
violate or be in conflict with any federal, California or New York law, statute,
rule or regulation which, to our knowledge, are applicable to the Company, or
the General Corporation Law of the State of Delaware, as presently in effect and
interpreted, (iii) conflict with or constitute a material breach of, or result
in a material default under (or with the giving of notice or lapse of time would
result in a material default under), any term or provision of any Material
Agreement, as such are identified in the Company's filings with the Securities
and Exchange Commission.
10. To our knowledge, the Company has timely filed with the SEC all
forms, reports and other documents required to be filed by it with the SEC under
the 1934 Act since January 1, 1997. All such forms, reports and other documents
complied, when filed, as to form, with all applicable requirements of the 1933
Act and the 1934 Act.
11. Assuming that the representations and warranties of the Holders
in Section 5 of the Exchange Agreement are true and correct, the Company may
issue the Preferred Stock and the Warrants to the Holders pursuant to the
Exchange Agreement and may issue the Common Shares to the Holders upon
conversion of the Notes or exercise of the Warrants, as the case may be, in each
such case without registration under the 1933 Act.
12. The Existing Registration Statement and the Prospectus contained
therein (other than the financial statements and financial statement schedules
and other financial and statistical information contained or incorporated by
reference therein, as to which we do not, and have not been requested to,
express any opinion) comply as to form in all material respects with the
applicable requirements of the 1933 Act and the rules and regulations
promulgated thereunder.
13. The SEC has informed us that the Existing Registration Statement
has become effective under the 1933 Act and, to our knowledge, no stop order
proceedings with respect thereto have been instituted or threatened in writing
by the SEC.
Our opinions expressed above are specifically subject to the
following limitations, exceptions, qualifications and assumptions:
(A) The legality, validity, binding nature and enforceability of the
Company's obligations under the Exchange Agreement may be subject to or limited
by (1) bankruptcy, insolvency, reorganization, arrangement, moratorium,
fraudulent transfer and other similar laws affecting the rights of creditors
generally; (2) general principles of equity (whether relief is sought in a
proceeding at law or in equity), including, without limitation, concepts of
materiality, reasonableness, good faith and fair dealing, and the discretion of
any court of competent
104
To the Holders Listed December 10, 1998
on Schedule A Hereto Page 6
jurisdiction in awarding specific performance or injunctive relief and other
equitable remedies; and (3), without limiting the generality of the foregoing,
the effect of California court decisions and statutes which indicate that
provisions of the Exchange Agreement which permit any of you to take action or
make determinations may be subject to a requirement that such action be taken or
such determinations be made on a reasonable basis in good faith or that it be
shown that such action is reasonably necessary for your protection.
(B) Our opinions are subject to the effect of judicial decisions
which may permit the introduction of extrinsic evidence to interpret the terms
of written contracts.
(C) We express no opinion as to your compliance with any Federal or
state law relating to your legal or regulatory status or the nature of your
business.
(D) We express no opinion as to the effect of subsequent issuances
of securities of the Company, to the extent that further issuances which may be
integrated with the Closing may include purchasers which do not meet the
definition of "accredited investors" under Rule 501 of Regulation D and
equivalent definitions under state securities or "blue sky" laws and to the
extent that notwithstanding its reservation of shares the Company may issue so
many shares of Common Stock that there are not enough remaining authorized but
unissued shares of Common Stock for the conversion of the Series D Preferred
Stock.
(E) We express no opinion as to:
(1) the Company's compliance or noncompliance with applicable
federal or state antifraud or antitrust statutes, laws, rules and regulations.
(2) the past, present or future fair market value of any
securities.
(3) to the enforceability under certain circumstances of
provisions indemnifying a party against, or requiring contributions toward, that
party's liability for its own wrongful or negligent acts, or where
indemnification or contribution is contrary to public policy or prohibited by
law. In this regard, we advise you that in the opinion of the Securities and
Exchange Commission indemnification of directors, officers and controlling
persons of an issuer against liabilities arising under the Securities Act of
1933, as amended, is against public policy and is therefore unenforceable.
(4) provisions prohibiting waivers of any terms or provisions of
any of the Transaction Documents other than in writing, or prohibiting oral
modifications thereof or modification by course of dealing to the extent such
provisions are inconsistent with applicable law;
(5) the effect of Section 1670.5 of the California Civil Code or
any other California law, federal law or equitable principle which provides that
a court may refuse to
105
To the Holders Listed December 10, 1998
on Schedule A Hereto Page 7
enforce, or may limit the application of, a contract or any clause thereof which
the court finds to have been unconscionable at the time it was made or contrary
to public policy.
(6) provisions purporting to require the award or payment of
attorneys' fees, expenses or costs in any action where the Holder is not the
prevailing party, or the impact of California Civil Code Section 1717 et seq. on
any such provisions;
(7) under certain circumstances, provisions to the effect that
rights or remedies are not exclusive, that every right or remedy is cumulative
and may be exercised in addition to or with any other right or remedy, that the
election of some particular remedy or remedies does not preclude recourse to one
or another remedy or that failure to exercise or delay in exercising rights or
remedies will not operate as a waiver of any such right or remedy;
(8) any provision providing for the exclusive jurisdiction of a
particular court or purporting to waive rights to trial by jury, service of
process or objections to the laying of venue or to forum on the basis of forum
non conveniens, in connection with any litigation arising out of or pertaining
to the Transaction Documents;
(9) provisions providing for an increase in the rate of interest
or imposing a late charge or penalty in the event of delinquency or default;
(10) provisions purporting to designate the Holders as the
Company's agent or attorney in fact;
(11) provisions purporting to waive any applicable statutes of
limitation;
(12) provisions of the Transaction Documents to the extent that
they purport to exclude conflict of law principles under California law;
(13) the law of the State of California limiting the rates of
interest legally chargeable or collectible.
(14) The enforceability under certain circumstances of
provisions expressly or by implication waiving broadly or vaguely stated rights,
unknown future rights, or defenses to obligations or rights granted by law, when
such waivers are against public policy or prohibited by law;
106
To the Holders Listed December 10, 1998
on Schedule A Hereto Page 8
This opinion letter is rendered as of the date first written above
solely for your benefit in connection with the Exchange Agreement and may not be
delivered to, quoted or relied upon by any person other than you, or for any
other purpose, without our prior written consent. Our opinion is expressly
limited to the matters set forth above and we render no opinion, whether by
implication or otherwise, as to any other matters relating to the Company. We
assume no obligation to advise you of facts, circumstances, events or
developments which hereafter may be brought to our attention and which may
alter, affect or modify the opinions expressed herein.
Very truly yours,
XXXXXXX, XXXXXXX & XXXXXXXX LLP
107
SCHEDULE G
Form of Warrant
G-1
108
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES HAVE BEEN ACQUIRED FOR
INVESTMENT AND MAY NOT BE RESOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR AN OPINION OF COUNSEL THAT SUCH REGISTRATION IS NOT
REQUIRED UNDER SAID ACT.
No. W-___ Right to Purchase ________ shares of Common
Stock of Shaman Pharmaceuticals, Inc.
SHAMAN PHARMACEUTICALS, INC.
COMMON STOCK PURCHASE WARRANT
SHAMAN PHARMACEUTICALS, INC., a Delaware corporation (the
"Company"), hereby certifies that, for value received, or registered assigns
(the "Holder"), is entitled, subject to the terms set forth below, to purchase
from the Company at any time or from time to time after January 1, 1999 and
before the Expiration Date (as hereinafter defined) (___________) fully paid and
nonassessable shares of Common Stock at a purchase price per share equal to the
Purchase Price (as hereinafter defined). Such number of shares of Common Stock
and the Purchase Price are subject to adjustment as provided in this Warrant.
As used herein the following terms, unless the context otherwise
requires, have the following respective meanings:
"Closing Sale Price" means the closing sale price of the Common
Stock on the principal securities market on which the Common Stock may
at the time be listed or, if there have been no sales on any such
exchange on such day, the average of the highest bid and lowest asked
prices on the principal securities market at the end of such day, or, if
on such day the Common Stock is not so listed, the average of the
representative bid and asked prices quoted on Nasdaq or, if on such day
the Common Stock is not so quoted on Nasdaq, on Nasdaq SmallCap as of
4:00 p.m., New York City time, or, if on such day the Common Stock is
not quoted on Nasdaq or Nasdaq SmallCap, the average of the highest bid
and lowest asked price on such day in the domestic over-the-counter
market as reported by the National Quotation Bureau, Incorporated, or
any similar successor organization.
"Common Stock" means the Company's Common Stock, par value
$0.001 per share, as authorized on the date hereof, and any other
securities into which or for which the Common Stock may be converted or
exchanged pursuant to a plan of recapitalization, reorganization,
merger, amalgamation, sale of assets or otherwise.
109
"Company" means Shaman Pharmaceuticals, Inc. and any corporation
that shall succeed to or assume the obligation of Shaman
Pharmaceuticals, Inc. hereunder in accordance with the terms hereof.
"Conversion Agent Agreement" means the Conversion Agent
Agreement, dated as of December 10, 1998, by and among the Company, the
Exercise Agent, the original Holder of this Warrant and the other
holders of securities of the Company parties thereto.
"Exchange Agreement" means the Exchange Agreement, dated as of
December 10, 1998, by and between the Company and the original Holder of
this Warrant and the other holders of the Company's securities who are
parties thereto.
"Exercise Agent" means BankBoston, N.A., or its duly appointed
successor who shall be serving as transfer agent and registrar for the
Common Stock and who shall have been authorized by the Company to act as
exercise agent for this Warrant in accordance with the Conversion Agent
Agreement and the name, address and telephone line facsimile
transmission number of which shall have been given to the Holder by
notice from the Company.
"Exercise Restriction Amount" means on any date of determination
a number of shares of Common Stock equal to 4.9% of the shares
outstanding on such date.
"Expiration Date" means 5:00 p.m., San Francisco, California
time on December 9, 2003.
"Market Price" of any security on any date means the closing bid
price of such security on such date on Nasdaq, Nasdaq SmallCap or such
other securities exchange or other market on which such security is
listed for trading which constitutes the principal securities market for
such security, as reported by Bloomberg, L.P.
"Nasdaq" means The Nasdaq National Market.
"Nasdaq SmallCap" means The Nasdaq SmallCap Market.
"1934 Act" means the Securities Exchange Act of 1934, as
amended.
"1933 Act" means the Securities Act of 1933, as amended.
"Other Securities" means any stock (other than the Common Stock)
and other securities of the Company or any other person (corporate or
otherwise) which the Holder at any time shall be entitled to receive, or
shall have received, on the exercise of this Warrant, in lieu of or in
addition to Common Stock, or which at any time shall be issuable or
shall have been issued in exchange for or in replacement of Common Stock
or Other Securities pursuant to Section 4.
-2-
110
"Purchase Price" means 150% of the arithmetic average of the
Market Price of the Common Stock for each Trading Day during the month
of December 1998 (subject to equitable adjustment from time to time on
terms reasonably acceptable to the Majority Holders for (i) stock
splits, (ii) stock dividends, (iii) combinations, (iv) capital
reorganizations, (v) issuance to all holders of Common Stock of rights
or warrants to purchase shares of Common Stock, (vi) the distribution by
the Corporation to all holders of Common Stock of evidences of
indebtedness of the Corporation or cash (other than regular quarterly
cash dividends), (vii) tender offers by the Corporation or any
subsidiary of the Corporation or other repurchases of shares of Common
Stock in one or more transactions which, individually or in the
aggregate, result in the purchase of more than 10% of the Common Stock
outstanding, and (viii) similar events relating to the Common Stock, in
each such case which occur or with respect to which "ex-" trading
commences during December 1998).
"Trading Day" means a day on whichever of (x) the national
securities exchange or (y) Nasdaq or Nasdaq SmallCap which at the time
constitutes the principal securities market for the Common Stock is open
for general trading of securities.
1. EXERCISE OF WARRANT.
1.1 EXERCISE. (a) This Warrant may be exercised by the Holder in
full or in part at any time or from time to time during the exercise period
specified in the first paragraph hereof until the Expiration Date by surrender
of this Warrant and the subscription form annexed hereto (duly executed by the
Holder), to the Company, and by making payment, in cash or by certified or
official bank check payable to the order of the Company, in the amount obtained
by multiplying (a) the number of shares of Common Stock designated by the Holder
in the Subscription Form in the form attached hereto by (b) the Purchase Price
then in effect. On any partial exercise, the Company will forthwith issue and
deliver to or upon the order of the Holder a new Warrant or Warrants of like
tenor, in the name of the Holder or as the Holder (upon payment by the Holder of
any applicable transfer taxes) may request, providing in the aggregate on the
face or faces thereof for the purchase of the number of shares of Common Stock
for which such Warrant or Warrants may still be exercised.
(b) (1) Notwithstanding any other provision of this Warrant, in
no event shall the Holder be entitled at any time to purchase a number of shares
of Common Stock on exercise of this Warrant in excess of that number of shares
upon purchase of which the sum of (1) the number of shares of Common Stock
beneficially owned by the Holder and any person whose beneficial ownership of
shares of Common Stock would be aggregated with the Holder's beneficial
ownership of shares of Common Stock for purposes of Section 13(d) of the 1934
Act and Regulation 13D-G thereunder (each such person other than the Holder an
"Aggregated Person" and all such persons other than the Holder, collectively,
the "Aggregated Persons") (other than shares of Common Stock deemed beneficially
owned by the Holder or any Aggregated Person through the ownership of the
unexercised portion of this Warrant, any shares of the Company's Series C
Convertible Preferred Stock, any shares of the Company's Series D Convertible
Preferred Stock, any of the Company's Senior Subordinated Convertible Notes or
-3-
111
any other securities which contain limitations similar to this Section 1(b)) and
(2) the number of shares of Common Stock issuable upon exercise of the portion
of this Warrant with respect to which the determination in this sentence is
being made, would result in beneficial ownership by the Holder and all
Aggregated Persons of more than 4.9% of the outstanding shares of Common Stock.
(2) Notwithstanding any other provision of this Warrant, in no event
shall the Holder be entitled on any date to exercise this Warrant for a number
of shares of Common Stock upon exercise of which the Holder and any Aggregated
Person of the Holder would have acquired, through exercise of this Warrant,
conversion of shares of Series D Preferred Stock or otherwise, a number of
shares of Common Stock in excess of the Exercise Restriction Amount during the
30-day period ending on and including the date of the determination being made
pursuant to this Section 1.1(b)(2) (other than shares of Common Stock deemed
beneficially owned by the Holder or any Aggregated Person of the Holder through
the ownership of (x) the unexercised portion of this Warrant, (y) unconverted
shares of Series D Preferred Stock and (z) the unconverted or unexercised
portion of any instrument which contains limitations similar to those set forth
in this sentence).
(3) For purposes of the immediately preceding sections 1.1(b)(1) and
1.1(b)(2), beneficial ownership shall be determined in accordance with Section
13(d) of the 1934 Act and Regulation 13D-G thereunder, except as otherwise
provided in clause (1) of the immediately preceding sentence. For purposes of
the second preceding sentence, the Company shall be entitled to rely, and shall
be fully protected in relying, on any statement or representation made by the
Holder to the Company in connection with a particular exercise of this Warrant,
without any obligation on the part of the Company to make any inquiry or
investigation or to examine its records or the records of any transfer agent for
the shares of Common Stock.
1.2 NET ISSUANCE. Notwithstanding anything to the contrary contained in
Section 1.1, the Holder may elect to exercise this Warrant in whole or in part
by receiving shares of Common Stock equal to the net issuance value (as
determined below) of this Warrant, or any part hereof, upon surrender of this
Warrant to the Company's transfer agent and registrar for the shares of Common
Stock together with the subscription form annexed hereto (duly executed by the
Holder), in which event the Company shall issue to the Holder a number of shares
of Common Stock computed using the following formula:
X = Y (A-B)
A
Where: X = the number of shares of Common Stock to be issued to the
Holder
Y = the number of shares of Common Stock as to which this
Warrant is to be exercised
-4-
112
A = the current fair market value of one share of Common
Stock calculated as of the last trading day immediately
preceding the exercise of this Warrant
B = the Purchase Price
As used herein, current fair market value of one share of Common
Stock as of a specified date shall mean the arithmetic average of the Closing
Sale Price over a period of five consecutive Trading Days consisting of the day
as of which the current fair market value of one share of Common Stock is being
determined (or if such day is not a Trading Day, the Trading Day next preceding
such day) and the four consecutive Trading Days prior to such day. If on the
date for which current fair market value is to be determined the Common Stock is
not listed on any securities exchange or quoted on Nasdaq, Nasdaq SmallCap or
the over-the-counter market, the current fair market value of one share of
Common Stock shall be the highest price per share which the Company could then
obtain from a willing buyer (not a current employee or director) for Common
Stock sold by the Company, from authorized but unissued shares, as determined in
good faith by the Board of Directors of the Company, unless prior to such date
the Company has become subject to a merger, acquisition, amalgamation or
consolidation pursuant to which the Company is not the surviving party, in which
case the current fair market value of one share of Common Stock shall be deemed
to be the value received by the holders of the shares of Common Stock for each
share pursuant to the Company's acquisition.
2. DELIVERY OF STOCK CERTIFICATES, ETC., ON EXERCISE. As soon as
practicable after the exercise of this Warrant, and in any event within three
Trading Days thereafter, the Company at its expense (including the payment by it
of any applicable issue or stamp taxes) will cause to be issued in the name of
and delivered to the Holder, or as the Holder (upon payment by the Holder of any
applicable transfer taxes) may direct, the number of fully paid and
nonassessable shares of Common Stock (or Other Securities) to which the Holder
shall be entitled on such exercise, in such denominations as may be requested by
the Holder, plus, in lieu of any fractional share to which the Holder would
otherwise be entitled, cash equal to such fraction multiplied by the then
current fair market value (as determined in accordance with subsection 1.2) of
one full share, together with any other stock or other securities any property
(including cash, where applicable) to which the Holder is entitled upon such
exercise pursuant to Section 1 or otherwise. Upon exercise of this Warrant as
provided herein, the Company's obligation to issue and deliver the certificates
for shares of Common Stock shall be absolute and unconditional, irrespective of
the absence of any action by the Holder to enforce the same, any waiver or
consent with respect to any provision thereof, the recovery of any judgment
against any person or any action to enforce the same, any failure or delay in
the enforcement of any other obligation of the Company to the Holder, or any
setoff, counterclaim, recoupment, limitation or termination, or any breach or
alleged breach by the Holder of any obligation to the Company or any violation
or alleged violation of law by the Holder or any other person, and irrespective
of any other circumstance which might otherwise limit such obligation of the
Company to the Holder in connection with such exercise; provided, however, that
nothing herein shall limit or prejudice the right of the Company to pursue any
such claim in any other manner permitted by applicable law. If the Company fails
to issue and deliver the shares of Common Stock to the
-5-
113
Holder pursuant to the first sentence of this paragraph as and when required to
do so, in addition to any other liabilities the Company may have hereunder and
under applicable law, the Company shall pay or reimburse the Holder on demand
for all out-of-pocket expenses including, without limitation, fees and expenses
of legal counsel, incurred by the Holder as a result of such failure and in
connection with enforcement by the Holder of its rights under this Warrant.
3. ADJUSTMENT FOR DIVIDENDS IN OTHER STOCK, PROPERTY, ETC.;
RECLASSIFICATION, ETC. In case at any time or from time to time, all the holders
of Common Stock (or Other Securities) shall have received, or (on or after the
record date fixed for the determination of stockholders eligible to receive)
shall have become entitled to receive, without payment therefor,
(a) other or additional stock or other securities or property
(other than cash) by way of dividend, or
(b) any cash (excluding cash dividends payable solely out of
earnings or earned surplus of the Company), or
(c) other or additional stock or other securities or property
(including cash) by way of spin-off, split-up, reclassification,
recapitalization, combination of shares or similar corporate
rearrangement,
other than additional shares of Common Stock (or Other Securities) issued as a
stock dividend or in a stock-split (adjustments in respect of which are provided
for in Section 5), then and in each such case the Holder, on the exercise hereof
as provided in Section 1, shall be entitled to receive the amount of stock and
other securities and property (including cash in the cases referred to in
subdivisions (b) and (c) of this Section 3) which the Holder would hold on the
date of such exercise if on the date of the event listed in subdivisions (a)
through (c) the Holder had been the holder of record of the number of shares of
Common Stock called for on the face of this Warrant and had thereafter, during
the period from the date of the event listed in subdivisions (a) through (c) to
and including the date of such exercise, retained such shares and all such other
or additional stock and other securities and property (including cash in the
case referred to in subdivisions (b) and (c) of this Section 3) receivable by
the Holder as aforesaid during such period, giving effect to all adjustments
called for during such period by Section 4.
4. EXERCISE UPON REORGANIZATION, CONSOLIDATION, MERGER, ETC. In
case at any time or from time to time, the Company shall (a) effect a
reorganization, (b) consolidate or amalgamate with or merge into any other
person, or (c) transfer all or substantially all of its properties or assets to
any other person under any plan or arrangement contemplating the dissolution of
the Company, then, in each such case, as a condition of such reorganization,
consolidation, amalgamation, merger, sale or conveyance, the Company shall give
at least 30 days notice to the Holder of such pending transaction whereby the
Holder shall have the right to exercise this Warrant prior to any such
reorganization, consolidation, amalgamation, merger, sale or conveyance. Any
exercise of this Warrant pursuant to notice under this Section shall be
conditioned upon the closing of such reorganization, consolidation,
amalgamation, merger, sale
-6-
114
or conveyance which is the subject of the notice and the exercise of this
Warrant shall not be deemed to have occurred until immediately prior to the
closing of such transaction.
5. ADJUSTMENT FOR EXTRAORDINARY EVENTS. In the event that the
Company shall (i) issue additional shares of Common Stock as a dividend or other
distribution on outstanding shares of Common Stock, (ii) subdivide or reclassify
its outstanding shares of Common Stock, or (iii) combine its outstanding shares
of Common Stock into a smaller number of shares of Common Stock, then, in each
such event, the Applicable Purchase Price shall, simultaneously with the
happening of such event, be adjusted by multiplying the Applicable Purchase
Price in effect immediately prior to such event by a fraction, the numerator of
which shall be the number of shares of Common Stock outstanding immediately
prior to such event and the denominator of which shall be the number of shares
of Common Stock outstanding immediately after such event, and the product so
obtained shall thereafter be the Applicable Purchase Price then in effect. The
Applicable Purchase Price, as so adjusted, shall be readjusted in the same
manner upon the happening of any successive event or events described herein in
this Section 5. The Holder shall thereafter, on the exercise hereof as provided
in Section 1, be entitled to receive that number of shares of Common Stock
determined by multiplying the number of shares of Common Stock which would be
issuable on such exercise immediately prior to such issuance by a fraction of
which (i) the numerator is the Applicable Purchase Price in effect immediately
prior to such issuance and (ii) the denominator is the Applicable Purchase Price
in effect on the date of such exercise.
6. FURTHER ASSURANCES. The Company will take all action that may
be necessary or appropriate in order that the Company may validly and legally
issue fully paid and nonassessable shares of stock, free from all taxes, liens
and charges with respect to the issue thereof, on the exercise of all or any
portion of this Warrant from time to time outstanding.
7. NOTICES OF RECORD DATE, ETC. In the event of
(a) any taking by the Company of a record of the holders of any
class of securities for the purpose of determining the holders thereof who are
entitled to receive any dividend on, or any right to subscribe for, purchase or
otherwise acquire any shares of stock of any class or any other securities or
property, or to receive any other right, or
(b) any capital reorganization of the Company, any
reclassification or recapitalization of the capital stock of the Company or any
transfer of all or substantially all of the assets of the Company to or
consolidation, amalgamation or merger of the Company with or into any other
person, or
(c) any voluntary or involuntary dissolution, liquidation or
winding-up of the Company,
then and in each such event the Company will mail or cause to be mailed to the
Holder, at least ten days prior to such record date, a notice specifying (i) the
date on which any such record is to be taken for the purpose of such dividend,
distribution or right, and stating the amount and character of such dividend,
distribution or right, (ii) the date on which any such reorganization,
-7-
115
reclassification, recapitalization, transfer, consolidation, amalgamation,
merger, dissolution, liquidation or winding-up is to take place, and the time,
if any is to be fixed, as of which the holders of record of shares of Common
Stock (or Other Securities) shall be entitled to exchange their shares of Common
Stock (or Other Securities) for securities or other property deliverable on such
reorganization, reclassification, recapitalization, transfer, consolidation,
amalgamation, merger, dissolution, liquidation or winding-up, and (iii) the
amount and character of any stock or other securities, or rights or options with
respect thereto, proposed to be issued or granted, the date of such proposed
issue or grant and the persons or class of persons to whom such proposed issue
or grant is to be offered or made. Such notice shall also state that the action
in question or the record date is subject to the effectiveness of a registration
statement under the 1933 Act or a favorable vote of stockholders if either is
required. Such notice shall be mailed at least ten days prior to the date
specified in such notice on which any such action is to be taken or the record
date, whichever is earlier.
8. RESERVATION OF SHARES, ETC., ISSUABLE ON EXERCISE OF WARRANTS.
The Company will at all times reserve and keep available out of its authorized
but unissued shares of capital stock, solely for issuance and delivery on the
exercise of this Warrant, a sufficient number of shares of Common Stock (or
Other Securities) to effect the full exercise of this Warrant and the exercise,
conversion or exchange of any other warrant or security of the Company
exercisable for, convertible into, exchangeable for or otherwise entitling the
holder to acquire shares of Common Stock (or Other Securities), and if at any
time the number of authorized but unissued shares of Common Stock (or Other
Securities) shall not be sufficient to effect such exercise, conversion or
exchange, the Company shall take such action as may be necessary to increase its
authorized but unissued shares of Common Stock (or Other Securities) to such
number as shall be sufficient for such purposes.
9. TRANSFER OF WARRANT. This Warrant shall inure to the benefit
of the successors to and assigns of the Holder. This Warrant and all rights
hereunder, in whole or in part, are registrable at the office or agency of the
Company referred to below by the Holder hereof in person or by his duly
authorized attorney, upon surrender of this Warrant properly endorsed.
10. REGISTER OF WARRANTS. The Company shall maintain, at the
principal office of the Company (or such other office as it may designate by
notice to the Holder hereof), a register in which the Company shall record the
name and address of the person in whose name this Warrant has been issued, as
well as the name and address of each successor and prior owner of such Warrant.
The Company shall be entitled to treat the person in whose name this Warrant is
so registered as the sole and absolute owner of this Warrant for all purposes.
11. EXCHANGE OF WARRANT. This Warrant is exchangeable, upon the
surrender hereof by the Holder at the office or agency of the Company referred
to in Section 10, for one or more new Warrants of like tenor representing in the
aggregate the right to subscribe for and purchase the number of shares of Common
Stock which may be subscribed for and purchased hereunder, each of such new
Warrants to represent the right to subscribe for and purchase such number of
shares as shall be designated by the Holder at the time of such surrender.
-8-
116
12. REPLACEMENT OF WARRANT. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of any such loss, theft or destruction of this
Warrant, on delivery of an indemnity agreement or security reasonably
satisfactory in form and amount to the Company or, in the case of any such
mutilation, on surrender and cancellation of this Warrant, the Company at its
expense will execute and deliver, in lieu thereof, a new Warrant of like tenor.
13. WARRANT AGENT. Pursuant to the Conversion Agent Agreement,
the Company has appointed the Exchange Agent as the Company's agent for the
purpose of issuing Common Stock (or Other Securities) on the exercise of this
Warrant pursuant to Section 1, and the Company may, by written notice to the
Holder, appoint an agent having an office in the United States of America for
the purpose of exchanging this Warrant pursuant to Section 11, and replacing
this Warrant pursuant to Section 12, or either of the foregoing, and thereafter
any such exchange or replacement, as the case may be, shall be made at such
office by such agent.
14. REMEDIES. The Company stipulates that the remedies at law of
the Holder in the event of any default or threatened default by the Company in
the performance of or compliance with any of the terms of this Warrant are not
and will not be adequate, and that such terms may be specifically enforced by a
decree for the specific performance of any agreement contained herein or by an
injunction against a violation of any of the terms hereof or otherwise.
15. NO RIGHTS OR LIABILITIES AS A STOCKHOLDER. This Warrant
shall not entitle the Holder to any voting rights or other rights as a
stockholder of the Company. No provision of this Warrant, in the absence of
affirmative action by the Holder to purchase shares of Common Stock, and no mere
enumeration herein of the rights or privileges of the Holder, shall give rise to
any liability of the Holder for the Applicable Purchase Price or as a
stockholder of the Company, whether such liability is asserted by the Company or
by creditors of the Company.
16. NOTICES, ETC. All notices and other communications from the
Company to the registered Holder shall be in writing and shall be mailed by
first class certified mail, postage prepaid, at such address as may have been
furnished to the Company in writing by the Holder or at the address shown for
the Holder on the register of Warrants referred to in Section 10.
17. TRANSFER RESTRICTIONS. By acceptance of this Warrant, the
Holder represents to the Company that the shares of Common Stock (or Other
Securities) issuable upon exercise of this Warrant will be acquired only for the
Holder's own account for investment and the Holder has no intention of making
any distribution, within the meaning of the 1933 Act, of such shares of Common
Stock (or Other Securities) except in compliance with the registration
requirements of the 1933 Act or pursuant to an exemption therefrom. The Holder
acknowledges and agrees that this Warrant and, except as otherwise provided in
the Exchange Agreement, the shares of Common Stock (or Other Securities)
issuable upon exercise of this Warrant (if any) have not been (and at the time
of acquisition by the Holder, will not have been or will not be), registered
under the 1933 Act or under the securities laws of any state, in reliance upon
certain exemptive provisions of such statutes. The Holder further recognizes and
acknowledges that because this Warrant and, except as provided in the Exchange
Agreement, the shares of Common
-9-
117
Stock (or Other Securities) issuable upon exercise of this Warrant (if any) are
unregistered, they may not be eligible for resale, and may only be resold in the
future pursuant to an effective registration statement under the 1933 Act and
any applicable state securities laws, or pursuant to a valid exemption from such
registration requirements. Unless the shares of Common Stock (or Other
Securities) issuable upon exercise of this Warrant have theretofore been
registered for resale under the 1933 Act, the Company may require, as a
condition to the issuance of shares of Common Stock (or Other Securities) upon
the exercise of this Warrant (i) in the case of an exercise in accordance with
Section 1.1 hereof, a confirmation as of the date of exercise of the Holder's
representations pursuant to this Section 17, or (ii) in the case of an exercise
in accordance with Section 1.2 hereof, an opinion of counsel reasonably
satisfactory to the Company that the shares of Common Stock (or Other
Securities) to be issued upon such exercise may be issued without registration
under the 1933 Act.
18. LEGEND. Unless theretofore registered for resale under the
1933 Act, each certificate for shares of Common Stock (or Other Securities)
issued upon exercise of this Warrant shall bear the following legend:
The securities represented by this certificate have not been registered
under the 1933 Act of 1933, as amended. The securities have been
acquired for investment and may not be resold, transferred or assigned
in the absence of an effective registration statement for the securities
under the 1933 Act of 1933, as amended, or an opinion of counsel that
registration is not required under said Act.
19. MISCELLANEOUS. This Warrant and any terms hereof may be
changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of such change, waiver, discharge
or termination is sought. This Warrant shall be construed and enforced in
accordance with and governed by the internal laws of the State of New York. The
headings in this Warrant are for purposes of reference only, and shall not limit
or otherwise affect any of the terms hereof. The invalidity or unenforceability
of any provision hereof shall in no way affect the validity or enforceability of
any other provision.
-10-
118
IN WITNESS WHEREOF, the Company has caused this Warrant to be
executed on its behalf by one of its officers thereunto duly authorized.
Dated: SHAMAN PHARMACEUTICALS, INC.
By:
--------------------------------------
Xxxx X. Xxxxx, President and Chief
Executive Officer
119
FORM OF SUBSCRIPTION
COMMON STOCK PURCHASE WARRANTS
OF
SHAMAN PHARMACEUTICALS, INC.
(To be signed only on exercise of Warrant)
TO: Bank Boston, N.A., as Exercise Agent
000 Xxxxxx Xxxxxx
Xxxxxx, Xxxxxxxxxxxxx 00000
Facsimile No.: (000) 000-0000
cc: Shaman Pharmaceuticals, Inc.
000 Xxxx Xxxxx Xxxxxx
Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000
Attention: Chief Financial Officer
Facsimile No.: (000) 000-0000
1. The undersigned Holder of the attached original, executed Warrant
issued by Shaman Pharmaceuticals, Inc., a Delaware corporation (the "Company")
hereby elects to exercise its purchase right under such Warrant with respect to
shares of Common Stock at the Purchase Price of $________ per share.
2. The undersigned Holder (check one):
[ ] (a) elects to pay the aggregate purchase price for such shares of
Common Stock (the "Exercise Shares") (i) by lawful money of the
United States or the enclosed certified or official bank check
payable in United States dollars to the order of the Company in
the amount of $___________, or (ii) by wire transfer of United
States funds to the account of the Company in the amount of
$____________, which transfer has been made before or
simultaneously with the delivery of this Form of Subscription
pursuant to the instructions of the Company;
or
[ ] (b) elects to receive shares of Common Stock having a value equal to
the value of the Warrant calculated in accordance with Section
1.2 of the Warrant.
3. Please issue a stock certificate or certificates representing the
appropriate number of shares of Common Stock in the name of the undersigned or
in such other names as is specified below:
4. The undersigned Holder hereby represents to the Company that the
exercise of the Warrant elected hereby does not violate Section 1.1(b) of the
Warrant.
S-1
120
5. Capitalized terms used in this Form of Subscription and not defined
herein have the respective meaning provided in the Warrant.
Dated:____________ ___, ____ -----------------------------------------
(Print Name - must conform to name of
Holder as specified on the face of the
Warrant)
-----------------------------------------
(Signature - must conform to name of
Holder as specified on the face of the
Warrant)
Address:
---------------------------------
---------------------------------
S-2
121
SCHEDULE 4(b)
Certain Antidilution Adjustments and Reserved Shares
Certain Antidilution Adjustments
No antidilution adjustment for any class of outstanding
securities will arise from the issuance of the shares of Series D Preferred and
the Warrants.
Reserved Shares as of November 30, 1998
Issuance of Common Stock Number of Shares
------------------------ ----------------
Shares to be issued under Registration Statement No. 333-67023 4,812,071
Options granted and exercisable prior to May 31, 1999 1,539,808
Shares issuable upon conversion of Series A Preferred Stock 543,133
Shares issuable to Lipha 342,231
Shares issuable as a result of Series C Preferred Stock dividends 83,583
Warrants to purchase Common Stock 1,329,206
---------
Total 8,650,032
